2025-03-22 16:07:09 - Response: [{"patFirstName":"Test Usr One    ","patType":"Special","patLastName":null,"patMiddleName":"-","patGender":"M","patientBirthDate":"-","patCrno":"939152100000382","patSampleNo":"250322MIC00001","patSampleType":"1002","patSampleCollectionDate":"2025-03-22","hisOrderId":"250322MIC000006","reqDno":"939151002225032210000201"},{"patFirstName":"Test Usr One    ","patType":"Special","patLastName":null,"patMiddleName":"-","patGender":"M","patientBirthDate":"-","patCrno":"939152100000382","patSampleNo":"250322MIC00000","patSampleType":"1002","patSampleCollectionDate":"2025-03-22","hisOrderId":"250322MIC000005","reqDno":"939151002225032210000101"},{"patFirstName":"Test Usr One    ","patType":"Special","patLastName":null,"patMiddleName":"-","patGender":"M","patientBirthDate":"-","patCrno":"939152100000382","patSampleNo":"250321MIC00001","patSampleType":"1002","patSampleCollectionDate":"2025-03-21","hisOrderId":"250321MIC000004","reqDno":"939151002225032110000201"}]
2025-03-22 16:07:09 - Save Patient Details API called for PACS 
2025-03-22 16:07:29 - Response: [{"patFirstName":"Test Usr One    ","patType":"Special","patLastName":null,"patMiddleName":"-","patGender":"M","patientBirthDate":"-","patCrno":"939152100000382","patSampleNo":"250322MIC00001","patSampleType":"1002","patSampleCollectionDate":"2025-03-22","hisOrderId":"250322MIC000006","reqDno":"939151002225032210000201"},{"patFirstName":"Test Usr One    ","patType":"Special","patLastName":null,"patMiddleName":"-","patGender":"M","patientBirthDate":"-","patCrno":"939152100000382","patSampleNo":"250322MIC00000","patSampleType":"1002","patSampleCollectionDate":"2025-03-22","hisOrderId":"250322MIC000005","reqDno":"939151002225032210000101"},{"patFirstName":"Test Usr One    ","patType":"Special","patLastName":null,"patMiddleName":"-","patGender":"M","patientBirthDate":"-","patCrno":"939152100000382","patSampleNo":"250321MIC00001","patSampleType":"1002","patSampleCollectionDate":"2025-03-21","hisOrderId":"250321MIC000004","reqDno":"939151002225032110000201"}]
2025-03-22 16:07:29 - Save Patient Details API called for PACS 
2025-03-22 16:07:29 - Update Status API called
2025-03-22 16:07:29 - Response Body:  Status Updated
2025-03-22 16:07:29 - Data sends to Mestria is started ::  
2025-03-22 16:07:29 - Query  : SELECT hrgstr_fname,hrgstr_mname, hrgstr_lname, patient_gender, hrgnum_puk,hivnum_sample_no,hivnum_sample_type,  pat_sample_collection_date FROM  patient_org_test_details WHERE org_test_status = 0
2025-03-22 16:07:29 - HL 7 :  MSH|^~\&|LIS|LAB|myla|BMX|20250322160729||OML^O33^OML_O33|MSG-20241007-101200-0377|P|2.5.1|||NE|AL||UNICODE UTF-8 PID|||939152100000382||Test Usr One    ^.^^^^^nill|CDAC TEST2|19681025|M|||nill^^nill^^nill^nill|||||S|PV1||E|GW-NEW CUBICAL WARD-J^8-FCGW-J-29^^ AIIMS^^^^^8-FCGW-J-29^||||^||||||||||||250322MIC00001SPM|1|250322MIC00001||BC^Blood Culture^99BMx|||^^|^^|||P^Patient^||||||20250322160729|SAC||||24008676 ORC|NW||||||||20250322160729TQ1|||||||||R^^OBR|1|714647||SU^SU^99BMx||||||^^||||||^|123456780
2025-03-22 16:07:29 - LIS is Connected on : 10.226.28.174 : 10002
2025-03-22 16:07:29 - Sent :  MSH|^~\&|LIS|LAB|myla|BMX|20250322160729||OML^O33^OML_O33|MSG-20241007-101200-0377|P|2.5.1|||NE|AL||UNICODE UTF-8 PID|||939152100000382||Test Usr One    ^.^^^^^nill|CDAC TEST2|19681025|M|||nill^^nill^^nill^nill|||||S|PV1||E|GW-NEW CUBICAL WARD-J^8-FCGW-J-29^^ AIIMS^^^^^8-FCGW-J-29^||||^||||||||||||250322MIC00001SPM|1|250322MIC00001||BC^Blood Culture^99BMx|||^^|^^|||P^Patient^||||||20250322160729|SAC||||24008676 ORC|NW||||||||20250322160729TQ1|||||||||R^^OBR|1|714647||SU^SU^99BMx||||||^^||||||^|123456780
2025-03-22 16:07:29 - Updated status to 1 for ID: 250322MIC00001
2025-03-22 16:07:30 - HL 7 :  MSH|^~\&|LIS|LAB|myla|BMX|20250322160730||OML^O33^OML_O33|MSG-20241007-101200-0377|P|2.5.1|||NE|AL||UNICODE UTF-8 PID|||939152100000382||Test Usr One    ^.^^^^^nill|CDAC TEST2|19681025|M|||nill^^nill^^nill^nill|||||S|PV1||E|GW-NEW CUBICAL WARD-J^8-FCGW-J-29^^ AIIMS^^^^^8-FCGW-J-29^||||^||||||||||||250322MIC00000SPM|1|250322MIC00000||BC^Blood Culture^99BMx|||^^|^^|||P^Patient^||||||20250322160730|SAC||||24008676 ORC|NW||||||||20250322160730TQ1|||||||||R^^OBR|1|714647||SU^SU^99BMx||||||^^||||||^|123456780
2025-03-22 16:07:30 - LIS is Connected on : 10.226.28.174 : 10002
2025-03-22 16:07:30 - Sent :  MSH|^~\&|LIS|LAB|myla|BMX|20250322160730||OML^O33^OML_O33|MSG-20241007-101200-0377|P|2.5.1|||NE|AL||UNICODE UTF-8 PID|||939152100000382||Test Usr One    ^.^^^^^nill|CDAC TEST2|19681025|M|||nill^^nill^^nill^nill|||||S|PV1||E|GW-NEW CUBICAL WARD-J^8-FCGW-J-29^^ AIIMS^^^^^8-FCGW-J-29^||||^||||||||||||250322MIC00000SPM|1|250322MIC00000||BC^Blood Culture^99BMx|||^^|^^|||P^Patient^||||||20250322160730|SAC||||24008676 ORC|NW||||||||20250322160730TQ1|||||||||R^^OBR|1|714647||SU^SU^99BMx||||||^^||||||^|123456780
2025-03-22 16:07:30 - Updated status to 1 for ID: 250322MIC00000
2025-03-22 16:07:31 - HL 7 :  MSH|^~\&|LIS|LAB|myla|BMX|20250322160731||OML^O33^OML_O33|MSG-20241007-101200-0377|P|2.5.1|||NE|AL||UNICODE UTF-8 PID|||939152100000382||Test Usr One    ^.^^^^^nill|CDAC TEST2|19681025|M|||nill^^nill^^nill^nill|||||S|PV1||E|GW-NEW CUBICAL WARD-J^8-FCGW-J-29^^ AIIMS^^^^^8-FCGW-J-29^||||^||||||||||||250321MIC00001SPM|1|250321MIC00001||BC^Blood Culture^99BMx|||^^|^^|||P^Patient^||||||20250322160731|SAC||||24008676 ORC|NW||||||||20250322160731TQ1|||||||||R^^OBR|1|714647||SU^SU^99BMx||||||^^||||||^|123456780
2025-03-22 16:07:31 - LIS is Connected on : 10.226.28.174 : 10002
2025-03-22 16:07:31 - Sent :  MSH|^~\&|LIS|LAB|myla|BMX|20250322160731||OML^O33^OML_O33|MSG-20241007-101200-0377|P|2.5.1|||NE|AL||UNICODE UTF-8 PID|||939152100000382||Test Usr One    ^.^^^^^nill|CDAC TEST2|19681025|M|||nill^^nill^^nill^nill|||||S|PV1||E|GW-NEW CUBICAL WARD-J^8-FCGW-J-29^^ AIIMS^^^^^8-FCGW-J-29^||||^||||||||||||250321MIC00001SPM|1|250321MIC00001||BC^Blood Culture^99BMx|||^^|^^|||P^Patient^||||||20250322160731|SAC||||24008676 ORC|NW||||||||20250322160731TQ1|||||||||R^^OBR|1|714647||SU^SU^99BMx||||||^^||||||^|123456780
2025-03-22 16:07:31 - Updated status to 1 for ID: 250321MIC00001
2025-03-22 16:08:00 - Response: [{"patFirstName":"Test Usr One    ","patType":"Special","patLastName":null,"patMiddleName":"-","patGender":"M","patientBirthDate":"-","patCrno":"939152100000382","patSampleNo":"250322MIC00001","patSampleType":"1002","patSampleCollectionDate":"2025-03-22","hisOrderId":"250322MIC000006","reqDno":"939151002225032210000201"},{"patFirstName":"Test Usr One    ","patType":"Special","patLastName":null,"patMiddleName":"-","patGender":"M","patientBirthDate":"-","patCrno":"939152100000382","patSampleNo":"250322MIC00000","patSampleType":"1002","patSampleCollectionDate":"2025-03-22","hisOrderId":"250322MIC000005","reqDno":"939151002225032210000101"}]
2025-03-22 16:08:00 - Save Patient Details API called for PACS 
2025-03-22 16:08:49 - Response: [{"patFirstName":"Test Usr One    ","patType":"Special","patLastName":null,"patMiddleName":"-","patGender":"M","patientBirthDate":"-","patCrno":"939152100000382","patSampleNo":"250322MIC00001","patSampleType":"1002","patSampleCollectionDate":"2025-03-22","hisOrderId":"250322MIC000006","reqDno":"939151002225032210000201"},{"patFirstName":"Test Usr One    ","patType":"Special","patLastName":null,"patMiddleName":"-","patGender":"M","patientBirthDate":"-","patCrno":"939152100000382","patSampleNo":"250322MIC00000","patSampleType":"1002","patSampleCollectionDate":"2025-03-22","hisOrderId":"250322MIC000005","reqDno":"939151002225032210000101"}]
2025-03-22 16:08:49 - Save Patient Details API called for PACS 
2025-03-22 16:08:49 - Update Status API called
2025-03-22 16:08:49 - Response Body:  Status Updated
2025-03-22 16:08:49 - Data sends to Mestria is started ::  
2025-03-22 16:08:49 - Query  : SELECT hrgstr_fname,hrgstr_mname, hrgstr_lname, patient_gender, hrgnum_puk,hivnum_sample_no,hivnum_sample_type,  pat_sample_collection_date FROM  patient_org_test_details WHERE org_test_status = 0
2025-03-22 16:08:49 - HL 7 :  MSH|^~\&|LIS|LAB|myla|BMX|20250322160849||OML^O33^OML_O33|MSG-20241007-101200-0377|P|2.5.1|||NE|AL||UNICODE UTF-8 PID|||939152100000382||Test Usr One    ^.^^^^^nill|CDAC TEST2|19681025|M|||nill^^nill^^nill^nill|||||S|PV1||E|GW-NEW CUBICAL WARD-J^8-FCGW-J-29^^ AIIMS^^^^^8-FCGW-J-29^||||^||||||||||||250322MIC00001SPM|1|250322MIC00001||BC^Blood Culture^99BMx|||^^|^^|||P^Patient^||||||20250322160849|SAC||||24008676 ORC|NW||||||||20250322160849TQ1|||||||||R^^OBR|1|714647||SU^SU^99BMx||||||^^||||||^|123456780
2025-03-22 16:08:49 - LIS is Connected on : 10.226.28.174 : 10002
2025-03-22 16:08:49 - Sent :  MSH|^~\&|LIS|LAB|myla|BMX|20250322160849||OML^O33^OML_O33|MSG-20241007-101200-0377|P|2.5.1|||NE|AL||UNICODE UTF-8 PID|||939152100000382||Test Usr One    ^.^^^^^nill|CDAC TEST2|19681025|M|||nill^^nill^^nill^nill|||||S|PV1||E|GW-NEW CUBICAL WARD-J^8-FCGW-J-29^^ AIIMS^^^^^8-FCGW-J-29^||||^||||||||||||250322MIC00001SPM|1|250322MIC00001||BC^Blood Culture^99BMx|||^^|^^|||P^Patient^||||||20250322160849|SAC||||24008676 ORC|NW||||||||20250322160849TQ1|||||||||R^^OBR|1|714647||SU^SU^99BMx||||||^^||||||^|123456780
2025-03-22 16:08:49 - Updated status to 1 for ID: 250322MIC00001
2025-03-22 16:08:50 - HL 7 :  MSH|^~\&|LIS|LAB|myla|BMX|20250322160850||OML^O33^OML_O33|MSG-20241007-101200-0377|P|2.5.1|||NE|AL||UNICODE UTF-8 PID|||939152100000382||Test Usr One    ^.^^^^^nill|CDAC TEST2|19681025|M|||nill^^nill^^nill^nill|||||S|PV1||E|GW-NEW CUBICAL WARD-J^8-FCGW-J-29^^ AIIMS^^^^^8-FCGW-J-29^||||^||||||||||||250322MIC00000SPM|1|250322MIC00000||BC^Blood Culture^99BMx|||^^|^^|||P^Patient^||||||20250322160850|SAC||||24008676 ORC|NW||||||||20250322160850TQ1|||||||||R^^OBR|1|714647||SU^SU^99BMx||||||^^||||||^|123456780
2025-03-22 16:08:50 - LIS is Connected on : 10.226.28.174 : 10002
2025-03-22 16:08:50 - Sent :  MSH|^~\&|LIS|LAB|myla|BMX|20250322160850||OML^O33^OML_O33|MSG-20241007-101200-0377|P|2.5.1|||NE|AL||UNICODE UTF-8 PID|||939152100000382||Test Usr One    ^.^^^^^nill|CDAC TEST2|19681025|M|||nill^^nill^^nill^nill|||||S|PV1||E|GW-NEW CUBICAL WARD-J^8-FCGW-J-29^^ AIIMS^^^^^8-FCGW-J-29^||||^||||||||||||250322MIC00000SPM|1|250322MIC00000||BC^Blood Culture^99BMx|||^^|^^|||P^Patient^||||||20250322160850|SAC||||24008676 ORC|NW||||||||20250322160850TQ1|||||||||R^^OBR|1|714647||SU^SU^99BMx||||||^^||||||^|123456780
2025-03-22 16:08:50 - Updated status to 1 for ID: 250322MIC00000
2025-03-22 16:11:30 - Response: [{"patFirstName":"Test Usr One    ","patType":"Special","patLastName":null,"patMiddleName":"-","patGender":"M","patientBirthDate":"-","patCrno":"939152100000382","patSampleNo":"250322MIC00001","patSampleType":"1002","patSampleCollectionDate":"2025-03-22","hisOrderId":"250322MIC000006","reqDno":"939151002225032210000201"},{"patFirstName":"Test Usr One    ","patType":"Special","patLastName":null,"patMiddleName":"-","patGender":"M","patientBirthDate":"-","patCrno":"939152100000382","patSampleNo":"250322MIC00000","patSampleType":"1002","patSampleCollectionDate":"2025-03-22","hisOrderId":"250322MIC000005","reqDno":"939151002225032210000101"}]
2025-03-22 16:11:30 - Save Patient Details API called for PACS 
2025-03-22 16:11:30 - Update Status API called
2025-03-22 16:11:30 - Response Body:  Status Updated
2025-03-22 16:11:30 - Data sends to Mestria is started ::  
2025-03-22 16:11:30 - Query  : SELECT hrgstr_fname,hrgstr_mname, hrgstr_lname, patient_gender, hrgnum_puk,hivnum_sample_no,hivnum_sample_type,  pat_sample_collection_date FROM  patient_org_test_details WHERE org_test_status = 0
2025-03-22 16:11:30 - HL 7 :  MSH|^~\&|LIS|LAB|myla|BMX|20250322161130||OML^O33^OML_O33|MSG-20241007-101200-0377|P|2.5.1|||NE|AL||UNICODE UTF-8 PID|||939152100000382||Test Usr One    ^.^^^^^nill|CDAC TEST2|19681025|M|||nill^^nill^^nill^nill|||||S|PV1||E|GW-NEW CUBICAL WARD-J^8-FCGW-J-29^^ AIIMS^^^^^8-FCGW-J-29^||||^||||||||||||250322MIC00001SPM|1|250322MIC00001||BC^Blood Culture^99BMx|||^^|^^|||P^Patient^||||||20250322161130|SAC||||24008676 ORC|NW||||||||20250322161130TQ1|||||||||R^^OBR|1|714647||SU^SU^99BMx||||||^^||||||^|123456780
2025-03-22 16:11:30 - LIS is Connected on : 10.226.28.174 : 10002
2025-03-22 16:11:30 - Sent :  MSH|^~\&|LIS|LAB|myla|BMX|20250322161130||OML^O33^OML_O33|MSG-20241007-101200-0377|P|2.5.1|||NE|AL||UNICODE UTF-8 PID|||939152100000382||Test Usr One    ^.^^^^^nill|CDAC TEST2|19681025|M|||nill^^nill^^nill^nill|||||S|PV1||E|GW-NEW CUBICAL WARD-J^8-FCGW-J-29^^ AIIMS^^^^^8-FCGW-J-29^||||^||||||||||||250322MIC00001SPM|1|250322MIC00001||BC^Blood Culture^99BMx|||^^|^^|||P^Patient^||||||20250322161130|SAC||||24008676 ORC|NW||||||||20250322161130TQ1|||||||||R^^OBR|1|714647||SU^SU^99BMx||||||^^||||||^|123456780
2025-03-22 16:11:30 - Updated status to 1 for ID: 250322MIC00001
2025-03-22 16:11:31 - HL 7 :  MSH|^~\&|LIS|LAB|myla|BMX|20250322161131||OML^O33^OML_O33|MSG-20241007-101200-0377|P|2.5.1|||NE|AL||UNICODE UTF-8 PID|||939152100000382||Test Usr One    ^.^^^^^nill|CDAC TEST2|19681025|M|||nill^^nill^^nill^nill|||||S|PV1||E|GW-NEW CUBICAL WARD-J^8-FCGW-J-29^^ AIIMS^^^^^8-FCGW-J-29^||||^||||||||||||250322MIC00000SPM|1|250322MIC00000||BC^Blood Culture^99BMx|||^^|^^|||P^Patient^||||||20250322161131|SAC||||24008676 ORC|NW||||||||20250322161131TQ1|||||||||R^^OBR|1|714647||SU^SU^99BMx||||||^^||||||^|123456780
2025-03-22 16:11:31 - LIS is Connected on : 10.226.28.174 : 10002
2025-03-22 16:11:31 - Sent :  MSH|^~\&|LIS|LAB|myla|BMX|20250322161131||OML^O33^OML_O33|MSG-20241007-101200-0377|P|2.5.1|||NE|AL||UNICODE UTF-8 PID|||939152100000382||Test Usr One    ^.^^^^^nill|CDAC TEST2|19681025|M|||nill^^nill^^nill^nill|||||S|PV1||E|GW-NEW CUBICAL WARD-J^8-FCGW-J-29^^ AIIMS^^^^^8-FCGW-J-29^||||^||||||||||||250322MIC00000SPM|1|250322MIC00000||BC^Blood Culture^99BMx|||^^|^^|||P^Patient^||||||20250322161131|SAC||||24008676 ORC|NW||||||||20250322161131TQ1|||||||||R^^OBR|1|714647||SU^SU^99BMx||||||^^||||||^|123456780
2025-03-22 16:11:31 - Updated status to 1 for ID: 250322MIC00000
2025-03-22 16:12:16 - Response: []
2025-03-22 16:12:16 - No pending data is available
2025-03-22 16:12:18 - Response: []
2025-03-22 16:12:18 - No pending data is available
2025-03-22 16:12:55 - Response: [{"patFirstName":"Test Usr One    ","patType":"Special","patLastName":null,"patMiddleName":"-","patGender":"M","patientBirthDate":"-","patCrno":"939152100000382","patSampleNo":"250322MIC00000","patSampleType":"1002","patSampleCollectionDate":"2025-03-22","hisOrderId":"250322MIC000005","reqDno":"939151002225032210000101"},{"patFirstName":"Test Usr One    ","patType":"Special","patLastName":null,"patMiddleName":"-","patGender":"M","patientBirthDate":"-","patCrno":"939152100000382","patSampleNo":"250322MIC00001","patSampleType":"1002","patSampleCollectionDate":"2025-03-22","hisOrderId":"250322MIC000006","reqDno":"939151002225032210000201"}]
2025-03-22 16:12:55 - Save Patient Details API called for PACS 
2025-03-22 16:13:19 - Response: [{"patFirstName":"Test Usr One    ","patType":"Special","patLastName":null,"patMiddleName":"-","patGender":"M","patientBirthDate":"-","patCrno":"939152100000382","patSampleNo":"250322MIC00000","patSampleType":"1002","patSampleCollectionDate":"2025-03-22","hisOrderId":"250322MIC000005","reqDno":"939151002225032210000101"},{"patFirstName":"Test Usr One    ","patType":"Special","patLastName":null,"patMiddleName":"-","patGender":"M","patientBirthDate":"-","patCrno":"939152100000382","patSampleNo":"250322MIC00001","patSampleType":"1002","patSampleCollectionDate":"2025-03-22","hisOrderId":"250322MIC000006","reqDno":"939151002225032210000201"}]
2025-03-22 16:13:19 - Save Patient Details API called for PACS 
2025-03-22 16:13:19 - Update Status API called
2025-03-22 16:13:19 - Response Body:  Status Updated
2025-03-22 16:13:19 - Data sends to Mestria is started ::  
2025-03-22 16:13:19 - Query  : SELECT hrgstr_fname,hrgstr_mname, hrgstr_lname, patient_gender, hrgnum_puk,hivnum_sample_no,hivnum_sample_type,  pat_sample_collection_date FROM  patient_org_test_details WHERE org_test_status = 0
2025-03-22 16:13:19 - HL 7 :  MSH|^~\&|LIS|LAB|myla|BMX|20250322161319||OML^O33^OML_O33|MSG-20241007-101200-0377|P|2.5.1|||NE|AL||UNICODE UTF-8 PID|||939152100000382||Test Usr One    ^.^^^^^nill|CDAC TEST2|19681025|M|||nill^^nill^^nill^nill|||||S|PV1||E|GW-NEW CUBICAL WARD-J^8-FCGW-J-29^^ AIIMS^^^^^8-FCGW-J-29^||||^||||||||||||250322MIC00000SPM|1|250322MIC00000||BC^Blood Culture^99BMx|||^^|^^|||P^Patient^||||||20250322161319|SAC||||24008676 ORC|NW||||||||20250322161319TQ1|||||||||R^^OBR|1|714647||SU^SU^99BMx||||||^^||||||^|123456780
2025-03-22 16:13:19 - LIS is Connected on : 10.226.28.174 : 10002
2025-03-22 16:13:19 - Sent :  MSH|^~\&|LIS|LAB|myla|BMX|20250322161319||OML^O33^OML_O33|MSG-20241007-101200-0377|P|2.5.1|||NE|AL||UNICODE UTF-8 PID|||939152100000382||Test Usr One    ^.^^^^^nill|CDAC TEST2|19681025|M|||nill^^nill^^nill^nill|||||S|PV1||E|GW-NEW CUBICAL WARD-J^8-FCGW-J-29^^ AIIMS^^^^^8-FCGW-J-29^||||^||||||||||||250322MIC00000SPM|1|250322MIC00000||BC^Blood Culture^99BMx|||^^|^^|||P^Patient^||||||20250322161319|SAC||||24008676 ORC|NW||||||||20250322161319TQ1|||||||||R^^OBR|1|714647||SU^SU^99BMx||||||^^||||||^|123456780
2025-03-22 16:13:19 - Updated status to 1 for ID: 250322MIC00000
2025-03-22 16:13:20 - HL 7 :  MSH|^~\&|LIS|LAB|myla|BMX|20250322161320||OML^O33^OML_O33|MSG-20241007-101200-0377|P|2.5.1|||NE|AL||UNICODE UTF-8 PID|||939152100000382||Test Usr One    ^.^^^^^nill|CDAC TEST2|19681025|M|||nill^^nill^^nill^nill|||||S|PV1||E|GW-NEW CUBICAL WARD-J^8-FCGW-J-29^^ AIIMS^^^^^8-FCGW-J-29^||||^||||||||||||250322MIC00001SPM|1|250322MIC00001||BC^Blood Culture^99BMx|||^^|^^|||P^Patient^||||||20250322161320|SAC||||24008676 ORC|NW||||||||20250322161320TQ1|||||||||R^^OBR|1|714647||SU^SU^99BMx||||||^^||||||^|123456780
2025-03-22 16:13:20 - LIS is Connected on : 10.226.28.174 : 10002
2025-03-22 16:13:20 - Sent :  MSH|^~\&|LIS|LAB|myla|BMX|20250322161320||OML^O33^OML_O33|MSG-20241007-101200-0377|P|2.5.1|||NE|AL||UNICODE UTF-8 PID|||939152100000382||Test Usr One    ^.^^^^^nill|CDAC TEST2|19681025|M|||nill^^nill^^nill^nill|||||S|PV1||E|GW-NEW CUBICAL WARD-J^8-FCGW-J-29^^ AIIMS^^^^^8-FCGW-J-29^||||^||||||||||||250322MIC00001SPM|1|250322MIC00001||BC^Blood Culture^99BMx|||^^|^^|||P^Patient^||||||20250322161320|SAC||||24008676 ORC|NW||||||||20250322161320TQ1|||||||||R^^OBR|1|714647||SU^SU^99BMx||||||^^||||||^|123456780
2025-03-22 16:13:20 - Updated status to 1 for ID: 250322MIC00001
2025-03-23 12:54:54 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250321MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250321MIC00001|URIN^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250321MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx

2025-03-23 12:54:54 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250323125454+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-23 12:54:54 - SAMPLE NO :250321MIC00001
2025-03-23 12:54:54 - SAMPLLE TypeURIN
2025-03-23 12:54:54 - Organism type :Staphylococcus aureus
2025-03-23 12:54:54 - MIC Value :>=^0.5
2025-03-23 12:54:54 - antiBiotic :P
2025-03-23 12:54:54 - antiBiotic :Benzylpenicillin
2025-03-23 12:54:54 - MIC Value :>=^4.0
2025-03-23 12:54:54 - antiBiotic :OX1
2025-03-23 12:54:54 - antiBiotic :Oxacillin
2025-03-23 12:54:54 - MIC Value :<=^0.5
2025-03-23 12:54:54 - antiBiotic :GM
2025-03-23 12:54:54 - antiBiotic :Gentamicin
2025-03-23 12:54:54 - MIC Value :=^1.0
2025-03-23 12:54:54 - antiBiotic :CIP
2025-03-23 12:54:54 - antiBiotic :Ciprofloxacin
2025-03-23 12:54:54 - MIC Value :=^2.0
2025-03-23 12:54:54 - antiBiotic :LEV
2025-03-23 12:54:54 - antiBiotic :Levofloxacin
2025-03-23 12:54:54 - MIC Value :=^0.5
2025-03-23 12:54:54 - antiBiotic :E
2025-03-23 12:54:54 - antiBiotic :Erythromycin
2025-03-23 12:54:54 - MIC Value :>=^4.0
2025-03-23 12:54:54 - antiBiotic :CM
2025-03-23 12:54:54 - antiBiotic :Clindamycin
2025-03-23 12:54:54 - MIC Value :>=^8.0
2025-03-23 12:54:54 - antiBiotic :LNZ
2025-03-23 12:54:54 - antiBiotic :Linezolid
2025-03-23 12:54:54 - MIC Value :=^1.0
2025-03-23 12:54:54 - antiBiotic :DAP
2025-03-23 12:54:54 - antiBiotic :Daptomycin
2025-03-23 12:54:54 - MIC Value :=^4.0
2025-03-23 12:54:54 - antiBiotic :TEC
2025-03-23 12:54:54 - antiBiotic :Teicoplanin
2025-03-23 12:54:54 - MIC Value :>=^32.0
2025-03-23 12:54:54 - antiBiotic :VA
2025-03-23 12:54:54 - antiBiotic :Vancomycin
2025-03-23 12:54:54 - MIC Value :<=^1.0
2025-03-23 12:54:54 - antiBiotic :TE
2025-03-23 12:54:54 - antiBiotic :Tetracycline
2025-03-23 12:54:54 - MIC Value :=^0.25
2025-03-23 12:54:54 - antiBiotic :TGC
2025-03-23 12:54:54 - antiBiotic :Tigecycline
2025-03-23 12:54:54 - MIC Value :<=^16.0
2025-03-23 12:54:54 - antiBiotic :FT
2025-03-23 12:54:54 - antiBiotic :Nitrofurantoin
2025-03-23 12:54:54 - MIC Value :<=^0.03
2025-03-23 12:54:54 - antiBiotic :RA
2025-03-23 12:54:54 - antiBiotic :Rifampicin
2025-03-23 12:54:54 - MIC Value :<=^10.0
2025-03-23 12:54:54 - antiBiotic :SXT
2025-03-23 12:54:54 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-23 12:56:49 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250321MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250321MIC00001|URIN^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250321MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx

2025-03-23 12:56:49 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250323125649+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-23 12:56:49 - SAMPLE NO :250321MIC00001
2025-03-23 12:56:49 - SAMPLLE TypeURIN
2025-03-23 12:56:49 - Organism type :Staphylococcus aureus
2025-03-23 12:56:49 - MIC Value :>=^0.5
2025-03-23 12:56:49 - antiBiotic :P
2025-03-23 12:56:49 - antiBiotic :Benzylpenicillin
2025-03-23 12:56:49 - MIC Value :>=^4.0
2025-03-23 12:56:49 - antiBiotic :OX1
2025-03-23 12:56:49 - antiBiotic :Oxacillin
2025-03-23 12:56:49 - MIC Value :<=^0.5
2025-03-23 12:56:49 - antiBiotic :GM
2025-03-23 12:56:49 - antiBiotic :Gentamicin
2025-03-23 12:56:49 - MIC Value :=^1.0
2025-03-23 12:56:49 - antiBiotic :CIP
2025-03-23 12:56:49 - antiBiotic :Ciprofloxacin
2025-03-23 12:56:49 - MIC Value :=^2.0
2025-03-23 12:56:49 - antiBiotic :LEV
2025-03-23 12:56:49 - antiBiotic :Levofloxacin
2025-03-23 12:56:49 - MIC Value :=^0.5
2025-03-23 12:56:49 - antiBiotic :E
2025-03-23 12:56:49 - antiBiotic :Erythromycin
2025-03-23 12:56:49 - MIC Value :>=^4.0
2025-03-23 12:56:49 - antiBiotic :CM
2025-03-23 12:56:49 - antiBiotic :Clindamycin
2025-03-23 12:56:49 - MIC Value :>=^8.0
2025-03-23 12:56:49 - antiBiotic :LNZ
2025-03-23 12:56:49 - antiBiotic :Linezolid
2025-03-23 12:56:49 - MIC Value :=^1.0
2025-03-23 12:56:49 - antiBiotic :DAP
2025-03-23 12:56:49 - antiBiotic :Daptomycin
2025-03-23 12:56:49 - MIC Value :=^4.0
2025-03-23 12:56:49 - antiBiotic :TEC
2025-03-23 12:56:49 - antiBiotic :Teicoplanin
2025-03-23 12:56:49 - MIC Value :>=^32.0
2025-03-23 12:56:49 - antiBiotic :VA
2025-03-23 12:56:49 - antiBiotic :Vancomycin
2025-03-23 12:56:49 - MIC Value :<=^1.0
2025-03-23 12:56:49 - antiBiotic :TE
2025-03-23 12:56:49 - antiBiotic :Tetracycline
2025-03-23 12:56:49 - MIC Value :=^0.25
2025-03-23 12:56:49 - antiBiotic :TGC
2025-03-23 12:56:49 - antiBiotic :Tigecycline
2025-03-23 12:56:49 - MIC Value :<=^16.0
2025-03-23 12:56:49 - antiBiotic :FT
2025-03-23 12:56:49 - antiBiotic :Nitrofurantoin
2025-03-23 12:56:49 - MIC Value :<=^0.03
2025-03-23 12:56:49 - antiBiotic :RA
2025-03-23 12:56:49 - antiBiotic :Rifampicin
2025-03-23 12:56:49 - MIC Value :<=^10.0
2025-03-23 12:56:49 - antiBiotic :SXT
2025-03-23 12:56:49 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-23 12:59:59 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250321MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250321MIC00001|URIN^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250321MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx

2025-03-23 12:59:59 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250323125959+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-23 12:59:59 - SAMPLE NO :250321MIC00001
2025-03-23 12:59:59 - SAMPLLE TypeURIN
2025-03-23 12:59:59 - Organism type :Staphylococcus aureus
2025-03-23 12:59:59 - MIC Value :>=^0.5
2025-03-23 12:59:59 - antiBiotic :P
2025-03-23 12:59:59 - antiBiotic :Benzylpenicillin
2025-03-23 12:59:59 - MIC Value :>=^4.0
2025-03-23 12:59:59 - antiBiotic :OX1
2025-03-23 12:59:59 - antiBiotic :Oxacillin
2025-03-23 12:59:59 - MIC Value :<=^0.5
2025-03-23 12:59:59 - antiBiotic :GM
2025-03-23 12:59:59 - antiBiotic :Gentamicin
2025-03-23 12:59:59 - MIC Value :=^1.0
2025-03-23 12:59:59 - antiBiotic :CIP
2025-03-23 12:59:59 - antiBiotic :Ciprofloxacin
2025-03-23 12:59:59 - MIC Value :=^2.0
2025-03-23 12:59:59 - antiBiotic :LEV
2025-03-23 12:59:59 - antiBiotic :Levofloxacin
2025-03-23 12:59:59 - MIC Value :=^0.5
2025-03-23 12:59:59 - antiBiotic :E
2025-03-23 12:59:59 - antiBiotic :Erythromycin
2025-03-23 12:59:59 - MIC Value :>=^4.0
2025-03-23 12:59:59 - antiBiotic :CM
2025-03-23 12:59:59 - antiBiotic :Clindamycin
2025-03-23 12:59:59 - MIC Value :>=^8.0
2025-03-23 12:59:59 - antiBiotic :LNZ
2025-03-23 12:59:59 - antiBiotic :Linezolid
2025-03-23 12:59:59 - MIC Value :=^1.0
2025-03-23 12:59:59 - antiBiotic :DAP
2025-03-23 12:59:59 - antiBiotic :Daptomycin
2025-03-23 12:59:59 - MIC Value :=^4.0
2025-03-23 12:59:59 - antiBiotic :TEC
2025-03-23 12:59:59 - antiBiotic :Teicoplanin
2025-03-23 12:59:59 - MIC Value :>=^32.0
2025-03-23 12:59:59 - antiBiotic :VA
2025-03-23 12:59:59 - antiBiotic :Vancomycin
2025-03-23 12:59:59 - MIC Value :<=^1.0
2025-03-23 12:59:59 - antiBiotic :TE
2025-03-23 12:59:59 - antiBiotic :Tetracycline
2025-03-23 12:59:59 - MIC Value :=^0.25
2025-03-23 12:59:59 - antiBiotic :TGC
2025-03-23 12:59:59 - antiBiotic :Tigecycline
2025-03-23 12:59:59 - MIC Value :<=^16.0
2025-03-23 12:59:59 - antiBiotic :FT
2025-03-23 12:59:59 - antiBiotic :Nitrofurantoin
2025-03-23 12:59:59 - MIC Value :<=^0.03
2025-03-23 12:59:59 - antiBiotic :RA
2025-03-23 12:59:59 - antiBiotic :Rifampicin
2025-03-23 12:59:59 - MIC Value :<=^10.0
2025-03-23 12:59:59 - antiBiotic :SXT
2025-03-23 12:59:59 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-23 13:16:39 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250321MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250321MIC00001|URIN^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250321MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx

2025-03-23 13:16:39 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250323131639+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-23 13:16:39 - SAMPLE NO :250321MIC00001
2025-03-23 13:16:39 - SAMPLLE TypeURIN
2025-03-23 13:16:39 - Organism type :Staphylococcus aureus
2025-03-23 13:16:39 - MIC Value :>=^0.5
2025-03-23 13:16:39 - antiBiotic :P
2025-03-23 13:16:39 - antiBiotic :Benzylpenicillin
2025-03-23 13:16:39 - MIC Value :>=^4.0
2025-03-23 13:16:39 - antiBiotic :OX1
2025-03-23 13:16:39 - antiBiotic :Oxacillin
2025-03-23 13:16:39 - MIC Value :<=^0.5
2025-03-23 13:16:39 - antiBiotic :GM
2025-03-23 13:16:39 - antiBiotic :Gentamicin
2025-03-23 13:16:39 - MIC Value :=^1.0
2025-03-23 13:16:39 - antiBiotic :CIP
2025-03-23 13:16:39 - antiBiotic :Ciprofloxacin
2025-03-23 13:16:39 - MIC Value :=^2.0
2025-03-23 13:16:39 - antiBiotic :LEV
2025-03-23 13:16:39 - antiBiotic :Levofloxacin
2025-03-23 13:16:39 - MIC Value :=^0.5
2025-03-23 13:16:39 - antiBiotic :E
2025-03-23 13:16:39 - antiBiotic :Erythromycin
2025-03-23 13:16:39 - MIC Value :>=^4.0
2025-03-23 13:16:39 - antiBiotic :CM
2025-03-23 13:16:39 - antiBiotic :Clindamycin
2025-03-23 13:16:39 - MIC Value :>=^8.0
2025-03-23 13:16:39 - antiBiotic :LNZ
2025-03-23 13:16:39 - antiBiotic :Linezolid
2025-03-23 13:16:39 - MIC Value :=^1.0
2025-03-23 13:16:39 - antiBiotic :DAP
2025-03-23 13:16:39 - antiBiotic :Daptomycin
2025-03-23 13:16:39 - MIC Value :=^4.0
2025-03-23 13:16:39 - antiBiotic :TEC
2025-03-23 13:16:39 - antiBiotic :Teicoplanin
2025-03-23 13:16:39 - MIC Value :>=^32.0
2025-03-23 13:16:39 - antiBiotic :VA
2025-03-23 13:16:39 - antiBiotic :Vancomycin
2025-03-23 13:16:39 - MIC Value :<=^1.0
2025-03-23 13:16:39 - antiBiotic :TE
2025-03-23 13:16:39 - antiBiotic :Tetracycline
2025-03-23 13:16:39 - MIC Value :=^0.25
2025-03-23 13:16:39 - antiBiotic :TGC
2025-03-23 13:16:39 - antiBiotic :Tigecycline
2025-03-23 13:16:39 - MIC Value :<=^16.0
2025-03-23 13:16:39 - antiBiotic :FT
2025-03-23 13:16:39 - antiBiotic :Nitrofurantoin
2025-03-23 13:16:39 - MIC Value :<=^0.03
2025-03-23 13:16:39 - antiBiotic :RA
2025-03-23 13:16:39 - antiBiotic :Rifampicin
2025-03-23 13:16:39 - MIC Value :<=^10.0
2025-03-23 13:16:39 - antiBiotic :SXT
2025-03-23 13:16:39 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-23 13:18:07 - Data sends to Mestria is started  for sample no ::  250321MIC00001
2025-03-23 13:18:07 - Response from API: []
2025-03-23 13:18:07 - Sample no or cr no. not found: []
2025-03-23 13:18:07 - Query  : SELECT hrgstr_fname,hrgstr_mname, hrgstr_lname, patient_gender, hrgnum_puk,hivnum_sample_no,hivnum_sample_type,  pat_sample_collection_date FROM  patient_org_test_details WHERE org_test_status = 0 and hivnum_sample_no=?
2025-03-23 13:19:32 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|URIN^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-23 13:19:32 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250323131932+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-23 13:19:32 - SAMPLE NO :250322MIC00001
2025-03-23 13:19:32 - SAMPLLE TypeURIN
2025-03-23 13:19:32 - Organism type :Staphylococcus aureus
2025-03-23 13:19:32 - MIC Value :>=^0.5
2025-03-23 13:19:32 - antiBiotic :P
2025-03-23 13:19:32 - antiBiotic :Benzylpenicillin
2025-03-23 13:19:32 - MIC Value :>=^4.0
2025-03-23 13:19:32 - antiBiotic :OX1
2025-03-23 13:19:32 - antiBiotic :Oxacillin
2025-03-23 13:19:32 - MIC Value :<=^0.5
2025-03-23 13:19:32 - antiBiotic :GM
2025-03-23 13:19:32 - antiBiotic :Gentamicin
2025-03-23 13:19:32 - MIC Value :=^1.0
2025-03-23 13:19:32 - antiBiotic :CIP
2025-03-23 13:19:32 - antiBiotic :Ciprofloxacin
2025-03-23 13:19:32 - MIC Value :=^2.0
2025-03-23 13:19:32 - antiBiotic :LEV
2025-03-23 13:19:32 - antiBiotic :Levofloxacin
2025-03-23 13:19:32 - MIC Value :=^0.5
2025-03-23 13:19:32 - antiBiotic :E
2025-03-23 13:19:32 - antiBiotic :Erythromycin
2025-03-23 13:19:32 - MIC Value :>=^4.0
2025-03-23 13:19:32 - antiBiotic :CM
2025-03-23 13:19:32 - antiBiotic :Clindamycin
2025-03-23 13:19:32 - MIC Value :>=^8.0
2025-03-23 13:19:32 - antiBiotic :LNZ
2025-03-23 13:19:32 - antiBiotic :Linezolid
2025-03-23 13:19:32 - MIC Value :=^1.0
2025-03-23 13:19:32 - antiBiotic :DAP
2025-03-23 13:19:32 - antiBiotic :Daptomycin
2025-03-23 13:19:32 - MIC Value :=^4.0
2025-03-23 13:19:32 - antiBiotic :TEC
2025-03-23 13:19:32 - antiBiotic :Teicoplanin
2025-03-23 13:19:32 - MIC Value :>=^32.0
2025-03-23 13:19:32 - antiBiotic :VA
2025-03-23 13:19:32 - antiBiotic :Vancomycin
2025-03-23 13:19:32 - MIC Value :<=^1.0
2025-03-23 13:19:32 - antiBiotic :TE
2025-03-23 13:19:32 - antiBiotic :Tetracycline
2025-03-23 13:19:32 - MIC Value :=^0.25
2025-03-23 13:19:32 - antiBiotic :TGC
2025-03-23 13:19:32 - antiBiotic :Tigecycline
2025-03-23 13:19:32 - MIC Value :<=^16.0
2025-03-23 13:19:32 - antiBiotic :FT
2025-03-23 13:19:32 - antiBiotic :Nitrofurantoin
2025-03-23 13:19:32 - MIC Value :<=^0.03
2025-03-23 13:19:32 - antiBiotic :RA
2025-03-23 13:19:32 - antiBiotic :Rifampicin
2025-03-23 13:19:32 - MIC Value :<=^10.0
2025-03-23 13:19:32 - antiBiotic :SXT
2025-03-23 13:19:32 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-23 13:20:24 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|URIN^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-23 13:20:24 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250323132024+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-23 13:20:24 - SAMPLE NO :250322MIC00001
2025-03-23 13:20:24 - SAMPLLE TypeURIN
2025-03-23 13:20:24 - Organism type :Staphylococcus aureus
2025-03-23 13:20:24 - MIC Value :>=^0.5
2025-03-23 13:20:24 - antiBiotic :P
2025-03-23 13:20:24 - antiBiotic :Benzylpenicillin
2025-03-23 13:20:24 - MIC Value :>=^4.0
2025-03-23 13:20:24 - antiBiotic :OX1
2025-03-23 13:20:24 - antiBiotic :Oxacillin
2025-03-23 13:20:24 - MIC Value :<=^0.5
2025-03-23 13:20:24 - antiBiotic :GM
2025-03-23 13:20:24 - antiBiotic :Gentamicin
2025-03-23 13:20:24 - MIC Value :=^1.0
2025-03-23 13:20:24 - antiBiotic :CIP
2025-03-23 13:20:24 - antiBiotic :Ciprofloxacin
2025-03-23 13:20:24 - MIC Value :=^2.0
2025-03-23 13:20:24 - antiBiotic :LEV
2025-03-23 13:20:24 - antiBiotic :Levofloxacin
2025-03-23 13:20:24 - MIC Value :=^0.5
2025-03-23 13:20:24 - antiBiotic :E
2025-03-23 13:20:24 - antiBiotic :Erythromycin
2025-03-23 13:20:24 - MIC Value :>=^4.0
2025-03-23 13:20:24 - antiBiotic :CM
2025-03-23 13:20:24 - antiBiotic :Clindamycin
2025-03-23 13:20:24 - MIC Value :>=^8.0
2025-03-23 13:20:24 - antiBiotic :LNZ
2025-03-23 13:20:24 - antiBiotic :Linezolid
2025-03-23 13:20:24 - MIC Value :=^1.0
2025-03-23 13:20:24 - antiBiotic :DAP
2025-03-23 13:20:24 - antiBiotic :Daptomycin
2025-03-23 13:20:24 - MIC Value :=^4.0
2025-03-23 13:20:24 - antiBiotic :TEC
2025-03-23 13:20:24 - antiBiotic :Teicoplanin
2025-03-23 13:20:24 - MIC Value :>=^32.0
2025-03-23 13:20:24 - antiBiotic :VA
2025-03-23 13:20:24 - antiBiotic :Vancomycin
2025-03-23 13:20:24 - MIC Value :<=^1.0
2025-03-23 13:20:24 - antiBiotic :TE
2025-03-23 13:20:24 - antiBiotic :Tetracycline
2025-03-23 13:20:24 - MIC Value :=^0.25
2025-03-23 13:20:24 - antiBiotic :TGC
2025-03-23 13:20:24 - antiBiotic :Tigecycline
2025-03-23 13:20:24 - MIC Value :<=^16.0
2025-03-23 13:20:24 - antiBiotic :FT
2025-03-23 13:20:24 - antiBiotic :Nitrofurantoin
2025-03-23 13:20:24 - MIC Value :<=^0.03
2025-03-23 13:20:24 - antiBiotic :RA
2025-03-23 13:20:24 - antiBiotic :Rifampicin
2025-03-23 13:20:24 - MIC Value :<=^10.0
2025-03-23 13:20:24 - antiBiotic :SXT
2025-03-23 13:20:24 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-23 13:33:21 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|URIN^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-23 13:33:21 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250323133321+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-23 13:33:21 - SAMPLE NO :250322MIC00001
2025-03-23 13:33:21 - SAMPLLE TypeURIN
2025-03-23 13:33:21 - Organism type :Staphylococcus aureus
2025-03-23 13:33:21 - MIC Value :>=^0.5
2025-03-23 13:33:21 - antiBiotic :P
2025-03-23 13:33:21 - antiBiotic :Benzylpenicillin
2025-03-23 13:33:21 - MIC Value :>=^4.0
2025-03-23 13:33:21 - antiBiotic :OX1
2025-03-23 13:33:21 - antiBiotic :Oxacillin
2025-03-23 13:33:21 - MIC Value :<=^0.5
2025-03-23 13:33:21 - antiBiotic :GM
2025-03-23 13:33:21 - antiBiotic :Gentamicin
2025-03-23 13:33:21 - MIC Value :=^1.0
2025-03-23 13:33:21 - antiBiotic :CIP
2025-03-23 13:33:21 - antiBiotic :Ciprofloxacin
2025-03-23 13:33:21 - MIC Value :=^2.0
2025-03-23 13:33:21 - antiBiotic :LEV
2025-03-23 13:33:21 - antiBiotic :Levofloxacin
2025-03-23 13:33:21 - MIC Value :=^0.5
2025-03-23 13:33:21 - antiBiotic :E
2025-03-23 13:33:21 - antiBiotic :Erythromycin
2025-03-23 13:33:21 - MIC Value :>=^4.0
2025-03-23 13:33:21 - antiBiotic :CM
2025-03-23 13:33:21 - antiBiotic :Clindamycin
2025-03-23 13:33:21 - MIC Value :>=^8.0
2025-03-23 13:33:21 - antiBiotic :LNZ
2025-03-23 13:33:21 - antiBiotic :Linezolid
2025-03-23 13:33:21 - MIC Value :=^1.0
2025-03-23 13:33:21 - antiBiotic :DAP
2025-03-23 13:33:21 - antiBiotic :Daptomycin
2025-03-23 13:33:21 - MIC Value :=^4.0
2025-03-23 13:33:21 - antiBiotic :TEC
2025-03-23 13:33:21 - antiBiotic :Teicoplanin
2025-03-23 13:33:21 - MIC Value :>=^32.0
2025-03-23 13:33:21 - antiBiotic :VA
2025-03-23 13:33:21 - antiBiotic :Vancomycin
2025-03-23 13:33:21 - MIC Value :<=^1.0
2025-03-23 13:33:21 - antiBiotic :TE
2025-03-23 13:33:21 - antiBiotic :Tetracycline
2025-03-23 13:33:21 - MIC Value :=^0.25
2025-03-23 13:33:21 - antiBiotic :TGC
2025-03-23 13:33:21 - antiBiotic :Tigecycline
2025-03-23 13:33:21 - MIC Value :<=^16.0
2025-03-23 13:33:21 - antiBiotic :FT
2025-03-23 13:33:21 - antiBiotic :Nitrofurantoin
2025-03-23 13:33:21 - MIC Value :<=^0.03
2025-03-23 13:33:21 - antiBiotic :RA
2025-03-23 13:33:21 - antiBiotic :Rifampicin
2025-03-23 13:33:21 - MIC Value :<=^10.0
2025-03-23 13:33:21 - antiBiotic :SXT
2025-03-23 13:33:21 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-23 13:35:04 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|URIN^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-23 13:35:04 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250323133504+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-23 13:35:04 - SAMPLE NO :250322MIC00001
2025-03-23 13:35:04 - SAMPLLE TypeURIN
2025-03-23 13:35:04 - Organism type :Staphylococcus aureus
2025-03-23 13:35:04 - MIC Value :>=^0.5
2025-03-23 13:35:04 - antiBiotic :P
2025-03-23 13:35:04 - antiBiotic :Benzylpenicillin
2025-03-23 13:35:04 - MIC Value :>=^4.0
2025-03-23 13:35:04 - antiBiotic :OX1
2025-03-23 13:35:04 - antiBiotic :Oxacillin
2025-03-23 13:35:04 - MIC Value :<=^0.5
2025-03-23 13:35:04 - antiBiotic :GM
2025-03-23 13:35:04 - antiBiotic :Gentamicin
2025-03-23 13:35:04 - MIC Value :=^1.0
2025-03-23 13:35:04 - antiBiotic :CIP
2025-03-23 13:35:04 - antiBiotic :Ciprofloxacin
2025-03-23 13:35:04 - MIC Value :=^2.0
2025-03-23 13:35:04 - antiBiotic :LEV
2025-03-23 13:35:04 - antiBiotic :Levofloxacin
2025-03-23 13:35:04 - MIC Value :=^0.5
2025-03-23 13:35:04 - antiBiotic :E
2025-03-23 13:35:04 - antiBiotic :Erythromycin
2025-03-23 13:35:04 - MIC Value :>=^4.0
2025-03-23 13:35:04 - antiBiotic :CM
2025-03-23 13:35:04 - antiBiotic :Clindamycin
2025-03-23 13:35:04 - MIC Value :>=^8.0
2025-03-23 13:35:04 - antiBiotic :LNZ
2025-03-23 13:35:04 - antiBiotic :Linezolid
2025-03-23 13:35:04 - MIC Value :=^1.0
2025-03-23 13:35:04 - antiBiotic :DAP
2025-03-23 13:35:04 - antiBiotic :Daptomycin
2025-03-23 13:35:04 - MIC Value :=^4.0
2025-03-23 13:35:04 - antiBiotic :TEC
2025-03-23 13:35:04 - antiBiotic :Teicoplanin
2025-03-23 13:35:04 - MIC Value :>=^32.0
2025-03-23 13:35:04 - antiBiotic :VA
2025-03-23 13:35:04 - antiBiotic :Vancomycin
2025-03-23 13:35:04 - MIC Value :<=^1.0
2025-03-23 13:35:04 - antiBiotic :TE
2025-03-23 13:35:04 - antiBiotic :Tetracycline
2025-03-23 13:35:04 - MIC Value :=^0.25
2025-03-23 13:35:04 - antiBiotic :TGC
2025-03-23 13:35:04 - antiBiotic :Tigecycline
2025-03-23 13:35:04 - MIC Value :<=^16.0
2025-03-23 13:35:04 - antiBiotic :FT
2025-03-23 13:35:04 - antiBiotic :Nitrofurantoin
2025-03-23 13:35:04 - MIC Value :<=^0.03
2025-03-23 13:35:04 - antiBiotic :RA
2025-03-23 13:35:04 - antiBiotic :Rifampicin
2025-03-23 13:35:04 - MIC Value :<=^10.0
2025-03-23 13:35:04 - antiBiotic :SXT
2025-03-23 13:35:04 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-23 13:37:00 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|URIN^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-23 13:37:00 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250323133700+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-23 13:37:00 - SAMPLE NO :250322MIC00001
2025-03-23 13:37:00 - SAMPLLE TypeURIN
2025-03-23 13:37:00 - Organism type :Staphylococcus aureus
2025-03-23 13:37:00 - MIC Value :>=^0.5
2025-03-23 13:37:00 - antiBiotic :P
2025-03-23 13:37:00 - antiBiotic :Benzylpenicillin
2025-03-23 13:37:00 - MIC Value :>=^4.0
2025-03-23 13:37:00 - antiBiotic :OX1
2025-03-23 13:37:00 - antiBiotic :Oxacillin
2025-03-23 13:37:00 - MIC Value :<=^0.5
2025-03-23 13:37:00 - antiBiotic :GM
2025-03-23 13:37:00 - antiBiotic :Gentamicin
2025-03-23 13:37:00 - MIC Value :=^1.0
2025-03-23 13:37:00 - antiBiotic :CIP
2025-03-23 13:37:00 - antiBiotic :Ciprofloxacin
2025-03-23 13:37:00 - MIC Value :=^2.0
2025-03-23 13:37:00 - antiBiotic :LEV
2025-03-23 13:37:00 - antiBiotic :Levofloxacin
2025-03-23 13:37:00 - MIC Value :=^0.5
2025-03-23 13:37:00 - antiBiotic :E
2025-03-23 13:37:00 - antiBiotic :Erythromycin
2025-03-23 13:37:00 - MIC Value :>=^4.0
2025-03-23 13:37:00 - antiBiotic :CM
2025-03-23 13:37:00 - antiBiotic :Clindamycin
2025-03-23 13:37:00 - MIC Value :>=^8.0
2025-03-23 13:37:00 - antiBiotic :LNZ
2025-03-23 13:37:00 - antiBiotic :Linezolid
2025-03-23 13:37:00 - MIC Value :=^1.0
2025-03-23 13:37:00 - antiBiotic :DAP
2025-03-23 13:37:00 - antiBiotic :Daptomycin
2025-03-23 13:37:00 - MIC Value :=^4.0
2025-03-23 13:37:00 - antiBiotic :TEC
2025-03-23 13:37:00 - antiBiotic :Teicoplanin
2025-03-23 13:37:00 - MIC Value :>=^32.0
2025-03-23 13:37:00 - antiBiotic :VA
2025-03-23 13:37:00 - antiBiotic :Vancomycin
2025-03-23 13:37:00 - MIC Value :<=^1.0
2025-03-23 13:37:00 - antiBiotic :TE
2025-03-23 13:37:00 - antiBiotic :Tetracycline
2025-03-23 13:37:00 - MIC Value :=^0.25
2025-03-23 13:37:00 - antiBiotic :TGC
2025-03-23 13:37:00 - antiBiotic :Tigecycline
2025-03-23 13:37:00 - MIC Value :<=^16.0
2025-03-23 13:37:00 - antiBiotic :FT
2025-03-23 13:37:00 - antiBiotic :Nitrofurantoin
2025-03-23 13:37:00 - MIC Value :<=^0.03
2025-03-23 13:37:00 - antiBiotic :RA
2025-03-23 13:37:00 - antiBiotic :Rifampicin
2025-03-23 13:37:00 - MIC Value :<=^10.0
2025-03-23 13:37:00 - antiBiotic :SXT
2025-03-23 13:37:00 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-23 13:51:50 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|URIN^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-23 13:51:50 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250323135150+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-23 13:51:50 - SAMPLE NO :250322MIC00001
2025-03-23 13:51:50 - SAMPLLE TypeURIN
2025-03-23 13:51:50 - Organism type :Staphylococcus aureus
2025-03-23 13:51:50 - MIC Value :>=^0.5
2025-03-23 13:51:50 - antiBiotic :P
2025-03-23 13:51:50 - antiBiotic :Benzylpenicillin
2025-03-23 13:51:50 - MIC Value :>=^4.0
2025-03-23 13:51:50 - antiBiotic :OX1
2025-03-23 13:51:50 - antiBiotic :Oxacillin
2025-03-23 13:51:50 - MIC Value :<=^0.5
2025-03-23 13:51:50 - antiBiotic :GM
2025-03-23 13:51:50 - antiBiotic :Gentamicin
2025-03-23 13:51:50 - MIC Value :=^1.0
2025-03-23 13:51:50 - antiBiotic :CIP
2025-03-23 13:51:50 - antiBiotic :Ciprofloxacin
2025-03-23 13:51:50 - MIC Value :=^2.0
2025-03-23 13:51:50 - antiBiotic :LEV
2025-03-23 13:51:50 - antiBiotic :Levofloxacin
2025-03-23 13:51:50 - MIC Value :=^0.5
2025-03-23 13:51:50 - antiBiotic :E
2025-03-23 13:51:50 - antiBiotic :Erythromycin
2025-03-23 13:51:50 - MIC Value :>=^4.0
2025-03-23 13:51:50 - antiBiotic :CM
2025-03-23 13:51:50 - antiBiotic :Clindamycin
2025-03-23 13:51:50 - MIC Value :>=^8.0
2025-03-23 13:51:50 - antiBiotic :LNZ
2025-03-23 13:51:50 - antiBiotic :Linezolid
2025-03-23 13:51:50 - MIC Value :=^1.0
2025-03-23 13:51:50 - antiBiotic :DAP
2025-03-23 13:51:50 - antiBiotic :Daptomycin
2025-03-23 13:51:50 - MIC Value :=^4.0
2025-03-23 13:51:50 - antiBiotic :TEC
2025-03-23 13:51:50 - antiBiotic :Teicoplanin
2025-03-23 13:51:50 - MIC Value :>=^32.0
2025-03-23 13:51:50 - antiBiotic :VA
2025-03-23 13:51:50 - antiBiotic :Vancomycin
2025-03-23 13:51:50 - MIC Value :<=^1.0
2025-03-23 13:51:50 - antiBiotic :TE
2025-03-23 13:51:50 - antiBiotic :Tetracycline
2025-03-23 13:51:50 - MIC Value :=^0.25
2025-03-23 13:51:50 - antiBiotic :TGC
2025-03-23 13:51:50 - antiBiotic :Tigecycline
2025-03-23 13:51:50 - MIC Value :<=^16.0
2025-03-23 13:51:50 - antiBiotic :FT
2025-03-23 13:51:50 - antiBiotic :Nitrofurantoin
2025-03-23 13:51:50 - MIC Value :<=^0.03
2025-03-23 13:51:50 - antiBiotic :RA
2025-03-23 13:51:50 - antiBiotic :Rifampicin
2025-03-23 13:51:50 - MIC Value :<=^10.0
2025-03-23 13:51:50 - antiBiotic :SXT
2025-03-23 13:51:50 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-23 13:57:17 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|URIN^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-23 13:57:17 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250323135717+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-23 13:57:17 - SAMPLE NO :250322MIC00001
2025-03-23 13:57:17 - SAMPLLE TypeURIN
2025-03-23 13:57:17 - Organism type :Staphylococcus aureus
2025-03-23 13:57:17 - MIC Value :>=^0.5
2025-03-23 13:57:17 - antiBiotic :P
2025-03-23 13:57:17 - antiBiotic :Benzylpenicillin
2025-03-23 13:57:17 - MIC Value :>=^4.0
2025-03-23 13:57:17 - antiBiotic :OX1
2025-03-23 13:57:17 - antiBiotic :Oxacillin
2025-03-23 13:57:17 - MIC Value :<=^0.5
2025-03-23 13:57:17 - antiBiotic :GM
2025-03-23 13:57:17 - antiBiotic :Gentamicin
2025-03-23 13:57:17 - MIC Value :=^1.0
2025-03-23 13:57:17 - antiBiotic :CIP
2025-03-23 13:57:17 - antiBiotic :Ciprofloxacin
2025-03-23 13:57:17 - MIC Value :=^2.0
2025-03-23 13:57:17 - antiBiotic :LEV
2025-03-23 13:57:17 - antiBiotic :Levofloxacin
2025-03-23 13:57:17 - MIC Value :=^0.5
2025-03-23 13:57:17 - antiBiotic :E
2025-03-23 13:57:17 - antiBiotic :Erythromycin
2025-03-23 13:57:17 - MIC Value :>=^4.0
2025-03-23 13:57:17 - antiBiotic :CM
2025-03-23 13:57:17 - antiBiotic :Clindamycin
2025-03-23 13:57:17 - MIC Value :>=^8.0
2025-03-23 13:57:17 - antiBiotic :LNZ
2025-03-23 13:57:17 - antiBiotic :Linezolid
2025-03-23 13:57:17 - MIC Value :=^1.0
2025-03-23 13:57:17 - antiBiotic :DAP
2025-03-23 13:57:17 - antiBiotic :Daptomycin
2025-03-23 13:57:17 - MIC Value :=^4.0
2025-03-23 13:57:17 - antiBiotic :TEC
2025-03-23 13:57:17 - antiBiotic :Teicoplanin
2025-03-23 13:57:17 - MIC Value :>=^32.0
2025-03-23 13:57:17 - antiBiotic :VA
2025-03-23 13:57:17 - antiBiotic :Vancomycin
2025-03-23 13:57:17 - MIC Value :<=^1.0
2025-03-23 13:57:17 - antiBiotic :TE
2025-03-23 13:57:17 - antiBiotic :Tetracycline
2025-03-23 13:57:17 - MIC Value :=^0.25
2025-03-23 13:57:17 - antiBiotic :TGC
2025-03-23 13:57:17 - antiBiotic :Tigecycline
2025-03-23 13:57:17 - MIC Value :<=^16.0
2025-03-23 13:57:17 - antiBiotic :FT
2025-03-23 13:57:17 - antiBiotic :Nitrofurantoin
2025-03-23 13:57:17 - MIC Value :<=^0.03
2025-03-23 13:57:17 - antiBiotic :RA
2025-03-23 13:57:17 - antiBiotic :Rifampicin
2025-03-23 13:57:17 - MIC Value :<=^10.0
2025-03-23 13:57:17 - antiBiotic :SXT
2025-03-23 13:57:17 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-23 14:10:14 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|URIN^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-23 14:10:14 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250323141014+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-23 14:10:14 - SAMPLE NO :250322MIC00001
2025-03-23 14:10:14 - SAMPLLE TypeURIN
2025-03-23 14:10:14 - Organism type :Staphylococcus aureus
2025-03-23 14:10:14 - MIC Value :>=^0.5
2025-03-23 14:10:14 - antiBiotic :P
2025-03-23 14:10:14 - antiBiotic :Benzylpenicillin
2025-03-23 14:10:14 - MIC Value :>=^4.0
2025-03-23 14:10:14 - antiBiotic :OX1
2025-03-23 14:10:14 - antiBiotic :Oxacillin
2025-03-23 14:10:14 - MIC Value :<=^0.5
2025-03-23 14:10:14 - antiBiotic :GM
2025-03-23 14:10:14 - antiBiotic :Gentamicin
2025-03-23 14:10:14 - MIC Value :=^1.0
2025-03-23 14:10:14 - antiBiotic :CIP
2025-03-23 14:10:14 - antiBiotic :Ciprofloxacin
2025-03-23 14:10:14 - MIC Value :=^2.0
2025-03-23 14:10:14 - antiBiotic :LEV
2025-03-23 14:10:14 - antiBiotic :Levofloxacin
2025-03-23 14:10:14 - MIC Value :=^0.5
2025-03-23 14:10:14 - antiBiotic :E
2025-03-23 14:10:14 - antiBiotic :Erythromycin
2025-03-23 14:10:14 - MIC Value :>=^4.0
2025-03-23 14:10:14 - antiBiotic :CM
2025-03-23 14:10:14 - antiBiotic :Clindamycin
2025-03-23 14:10:14 - MIC Value :>=^8.0
2025-03-23 14:10:14 - antiBiotic :LNZ
2025-03-23 14:10:14 - antiBiotic :Linezolid
2025-03-23 14:10:14 - MIC Value :=^1.0
2025-03-23 14:10:14 - antiBiotic :DAP
2025-03-23 14:10:14 - antiBiotic :Daptomycin
2025-03-23 14:10:14 - MIC Value :=^4.0
2025-03-23 14:10:14 - antiBiotic :TEC
2025-03-23 14:10:14 - antiBiotic :Teicoplanin
2025-03-23 14:10:14 - MIC Value :>=^32.0
2025-03-23 14:10:14 - antiBiotic :VA
2025-03-23 14:10:14 - antiBiotic :Vancomycin
2025-03-23 14:10:14 - MIC Value :<=^1.0
2025-03-23 14:10:14 - antiBiotic :TE
2025-03-23 14:10:14 - antiBiotic :Tetracycline
2025-03-23 14:10:14 - MIC Value :=^0.25
2025-03-23 14:10:14 - antiBiotic :TGC
2025-03-23 14:10:14 - antiBiotic :Tigecycline
2025-03-23 14:10:14 - MIC Value :<=^16.0
2025-03-23 14:10:14 - antiBiotic :FT
2025-03-23 14:10:14 - antiBiotic :Nitrofurantoin
2025-03-23 14:10:14 - MIC Value :<=^0.03
2025-03-23 14:10:14 - antiBiotic :RA
2025-03-23 14:10:14 - antiBiotic :Rifampicin
2025-03-23 14:10:14 - MIC Value :<=^10.0
2025-03-23 14:10:14 - antiBiotic :SXT
2025-03-23 14:10:14 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-23 14:17:59 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|URIN^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-23 14:17:59 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250323141759+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-23 14:17:59 - SAMPLE NO :250322MIC00001
2025-03-23 14:17:59 - SAMPLLE TypeURIN
2025-03-23 14:17:59 - Organism type :Staphylococcus aureus
2025-03-23 14:17:59 - MIC Value :>=^0.5
2025-03-23 14:17:59 - antiBiotic :P
2025-03-23 14:17:59 - antiBiotic :Benzylpenicillin
2025-03-23 14:17:59 - MIC Value :>=^4.0
2025-03-23 14:17:59 - antiBiotic :OX1
2025-03-23 14:17:59 - antiBiotic :Oxacillin
2025-03-23 14:17:59 - MIC Value :<=^0.5
2025-03-23 14:17:59 - antiBiotic :GM
2025-03-23 14:17:59 - antiBiotic :Gentamicin
2025-03-23 14:17:59 - MIC Value :=^1.0
2025-03-23 14:17:59 - antiBiotic :CIP
2025-03-23 14:17:59 - antiBiotic :Ciprofloxacin
2025-03-23 14:17:59 - MIC Value :=^2.0
2025-03-23 14:17:59 - antiBiotic :LEV
2025-03-23 14:17:59 - antiBiotic :Levofloxacin
2025-03-23 14:17:59 - MIC Value :=^0.5
2025-03-23 14:17:59 - antiBiotic :E
2025-03-23 14:17:59 - antiBiotic :Erythromycin
2025-03-23 14:17:59 - MIC Value :>=^4.0
2025-03-23 14:17:59 - antiBiotic :CM
2025-03-23 14:17:59 - antiBiotic :Clindamycin
2025-03-23 14:17:59 - MIC Value :>=^8.0
2025-03-23 14:17:59 - antiBiotic :LNZ
2025-03-23 14:17:59 - antiBiotic :Linezolid
2025-03-23 14:17:59 - MIC Value :=^1.0
2025-03-23 14:17:59 - antiBiotic :DAP
2025-03-23 14:17:59 - antiBiotic :Daptomycin
2025-03-23 14:17:59 - MIC Value :=^4.0
2025-03-23 14:17:59 - antiBiotic :TEC
2025-03-23 14:17:59 - antiBiotic :Teicoplanin
2025-03-23 14:17:59 - MIC Value :>=^32.0
2025-03-23 14:17:59 - antiBiotic :VA
2025-03-23 14:17:59 - antiBiotic :Vancomycin
2025-03-23 14:17:59 - MIC Value :<=^1.0
2025-03-23 14:17:59 - antiBiotic :TE
2025-03-23 14:17:59 - antiBiotic :Tetracycline
2025-03-23 14:17:59 - MIC Value :=^0.25
2025-03-23 14:17:59 - antiBiotic :TGC
2025-03-23 14:17:59 - antiBiotic :Tigecycline
2025-03-23 14:17:59 - MIC Value :<=^16.0
2025-03-23 14:17:59 - antiBiotic :FT
2025-03-23 14:17:59 - antiBiotic :Nitrofurantoin
2025-03-23 14:17:59 - MIC Value :<=^0.03
2025-03-23 14:17:59 - antiBiotic :RA
2025-03-23 14:17:59 - antiBiotic :Rifampicin
2025-03-23 14:17:59 - MIC Value :<=^10.0
2025-03-23 14:17:59 - antiBiotic :SXT
2025-03-23 14:17:59 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-23 14:23:18 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|URIN^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-23 14:23:18 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250323142318+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-23 14:23:18 - SAMPLE NO :250322MIC00001
2025-03-23 14:23:18 - SAMPLLE TypeURIN
2025-03-23 14:23:18 - Organism type :Staphylococcus aureus
2025-03-23 14:23:18 - MIC Value :>=^0.5
2025-03-23 14:23:18 - antiBiotic :P
2025-03-23 14:23:18 - antiBiotic :Benzylpenicillin
2025-03-23 14:23:18 - MIC Value :>=^4.0
2025-03-23 14:23:18 - antiBiotic :OX1
2025-03-23 14:23:18 - antiBiotic :Oxacillin
2025-03-23 14:23:18 - MIC Value :<=^0.5
2025-03-23 14:23:18 - antiBiotic :GM
2025-03-23 14:23:18 - antiBiotic :Gentamicin
2025-03-23 14:23:18 - MIC Value :=^1.0
2025-03-23 14:23:18 - antiBiotic :CIP
2025-03-23 14:23:18 - antiBiotic :Ciprofloxacin
2025-03-23 14:23:18 - MIC Value :=^2.0
2025-03-23 14:23:18 - antiBiotic :LEV
2025-03-23 14:23:18 - antiBiotic :Levofloxacin
2025-03-23 14:23:18 - MIC Value :=^0.5
2025-03-23 14:23:18 - antiBiotic :E
2025-03-23 14:23:18 - antiBiotic :Erythromycin
2025-03-23 14:23:18 - MIC Value :>=^4.0
2025-03-23 14:23:18 - antiBiotic :CM
2025-03-23 14:23:18 - antiBiotic :Clindamycin
2025-03-23 14:23:18 - MIC Value :>=^8.0
2025-03-23 14:23:18 - antiBiotic :LNZ
2025-03-23 14:23:18 - antiBiotic :Linezolid
2025-03-23 14:23:18 - MIC Value :=^1.0
2025-03-23 14:23:18 - antiBiotic :DAP
2025-03-23 14:23:18 - antiBiotic :Daptomycin
2025-03-23 14:23:18 - MIC Value :=^4.0
2025-03-23 14:23:18 - antiBiotic :TEC
2025-03-23 14:23:18 - antiBiotic :Teicoplanin
2025-03-23 14:23:18 - MIC Value :>=^32.0
2025-03-23 14:23:18 - antiBiotic :VA
2025-03-23 14:23:18 - antiBiotic :Vancomycin
2025-03-23 14:23:18 - MIC Value :<=^1.0
2025-03-23 14:23:18 - antiBiotic :TE
2025-03-23 14:23:18 - antiBiotic :Tetracycline
2025-03-23 14:23:18 - MIC Value :=^0.25
2025-03-23 14:23:18 - antiBiotic :TGC
2025-03-23 14:23:18 - antiBiotic :Tigecycline
2025-03-23 14:23:18 - MIC Value :<=^16.0
2025-03-23 14:23:18 - antiBiotic :FT
2025-03-23 14:23:18 - antiBiotic :Nitrofurantoin
2025-03-23 14:23:18 - MIC Value :<=^0.03
2025-03-23 14:23:18 - antiBiotic :RA
2025-03-23 14:23:18 - antiBiotic :Rifampicin
2025-03-23 14:23:18 - MIC Value :<=^10.0
2025-03-23 14:23:18 - antiBiotic :SXT
2025-03-23 14:23:18 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-23 14:25:00 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|URIN^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-23 14:25:00 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250323142500+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-23 14:25:00 - SAMPLE NO :250322MIC00001
2025-03-23 14:25:00 - SAMPLLE TypeURIN
2025-03-23 14:25:00 - Organism type :Staphylococcus aureus
2025-03-23 14:25:00 - MIC Value :>=^0.5
2025-03-23 14:25:00 - antiBiotic :P
2025-03-23 14:25:00 - antiBiotic :Benzylpenicillin
2025-03-23 14:25:00 - MIC Value :>=^4.0
2025-03-23 14:25:00 - antiBiotic :OX1
2025-03-23 14:25:00 - antiBiotic :Oxacillin
2025-03-23 14:25:00 - MIC Value :<=^0.5
2025-03-23 14:25:00 - antiBiotic :GM
2025-03-23 14:25:00 - antiBiotic :Gentamicin
2025-03-23 14:25:00 - MIC Value :=^1.0
2025-03-23 14:25:00 - antiBiotic :CIP
2025-03-23 14:25:00 - antiBiotic :Ciprofloxacin
2025-03-23 14:25:00 - MIC Value :=^2.0
2025-03-23 14:25:00 - antiBiotic :LEV
2025-03-23 14:25:00 - antiBiotic :Levofloxacin
2025-03-23 14:25:00 - MIC Value :=^0.5
2025-03-23 14:25:00 - antiBiotic :E
2025-03-23 14:25:00 - antiBiotic :Erythromycin
2025-03-23 14:25:00 - MIC Value :>=^4.0
2025-03-23 14:25:00 - antiBiotic :CM
2025-03-23 14:25:00 - antiBiotic :Clindamycin
2025-03-23 14:25:00 - MIC Value :>=^8.0
2025-03-23 14:25:00 - antiBiotic :LNZ
2025-03-23 14:25:00 - antiBiotic :Linezolid
2025-03-23 14:25:00 - MIC Value :=^1.0
2025-03-23 14:25:00 - antiBiotic :DAP
2025-03-23 14:25:00 - antiBiotic :Daptomycin
2025-03-23 14:25:00 - MIC Value :=^4.0
2025-03-23 14:25:00 - antiBiotic :TEC
2025-03-23 14:25:00 - antiBiotic :Teicoplanin
2025-03-23 14:25:00 - MIC Value :>=^32.0
2025-03-23 14:25:00 - antiBiotic :VA
2025-03-23 14:25:00 - antiBiotic :Vancomycin
2025-03-23 14:25:00 - MIC Value :<=^1.0
2025-03-23 14:25:00 - antiBiotic :TE
2025-03-23 14:25:00 - antiBiotic :Tetracycline
2025-03-23 14:25:00 - MIC Value :=^0.25
2025-03-23 14:25:00 - antiBiotic :TGC
2025-03-23 14:25:00 - antiBiotic :Tigecycline
2025-03-23 14:25:00 - MIC Value :<=^16.0
2025-03-23 14:25:00 - antiBiotic :FT
2025-03-23 14:25:00 - antiBiotic :Nitrofurantoin
2025-03-23 14:25:00 - MIC Value :<=^0.03
2025-03-23 14:25:00 - antiBiotic :RA
2025-03-23 14:25:00 - antiBiotic :Rifampicin
2025-03-23 14:25:00 - MIC Value :<=^10.0
2025-03-23 14:25:00 - antiBiotic :SXT
2025-03-23 14:25:00 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-23 14:33:15 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|URIN^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-23 14:33:15 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250323143315+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-23 14:33:15 - SAMPLE NO :250322MIC00001
2025-03-23 14:33:15 - SAMPLLE TypeURIN
2025-03-23 14:33:15 - Organism type :Staphylococcus aureus
2025-03-23 14:33:15 - MIC Value :>=^0.5
2025-03-23 14:33:15 - antiBiotic :P
2025-03-23 14:33:15 - antiBiotic :Benzylpenicillin
2025-03-23 14:33:15 - MIC Value :>=^4.0
2025-03-23 14:33:15 - antiBiotic :OX1
2025-03-23 14:33:15 - antiBiotic :Oxacillin
2025-03-23 14:33:15 - MIC Value :<=^0.5
2025-03-23 14:33:15 - antiBiotic :GM
2025-03-23 14:33:15 - antiBiotic :Gentamicin
2025-03-23 14:33:15 - MIC Value :=^1.0
2025-03-23 14:33:15 - antiBiotic :CIP
2025-03-23 14:33:15 - antiBiotic :Ciprofloxacin
2025-03-23 14:33:15 - MIC Value :=^2.0
2025-03-23 14:33:15 - antiBiotic :LEV
2025-03-23 14:33:15 - antiBiotic :Levofloxacin
2025-03-23 14:33:15 - MIC Value :=^0.5
2025-03-23 14:33:15 - antiBiotic :E
2025-03-23 14:33:15 - antiBiotic :Erythromycin
2025-03-23 14:33:15 - MIC Value :>=^4.0
2025-03-23 14:33:15 - antiBiotic :CM
2025-03-23 14:33:15 - antiBiotic :Clindamycin
2025-03-23 14:33:15 - MIC Value :>=^8.0
2025-03-23 14:33:15 - antiBiotic :LNZ
2025-03-23 14:33:15 - antiBiotic :Linezolid
2025-03-23 14:33:15 - MIC Value :=^1.0
2025-03-23 14:33:15 - antiBiotic :DAP
2025-03-23 14:33:15 - antiBiotic :Daptomycin
2025-03-23 14:33:15 - MIC Value :=^4.0
2025-03-23 14:33:15 - antiBiotic :TEC
2025-03-23 14:33:15 - antiBiotic :Teicoplanin
2025-03-23 14:33:15 - MIC Value :>=^32.0
2025-03-23 14:33:15 - antiBiotic :VA
2025-03-23 14:33:15 - antiBiotic :Vancomycin
2025-03-23 14:33:15 - MIC Value :<=^1.0
2025-03-23 14:33:15 - antiBiotic :TE
2025-03-23 14:33:15 - antiBiotic :Tetracycline
2025-03-23 14:33:15 - MIC Value :=^0.25
2025-03-23 14:33:15 - antiBiotic :TGC
2025-03-23 14:33:15 - antiBiotic :Tigecycline
2025-03-23 14:33:15 - MIC Value :<=^16.0
2025-03-23 14:33:15 - antiBiotic :FT
2025-03-23 14:33:15 - antiBiotic :Nitrofurantoin
2025-03-23 14:33:15 - MIC Value :<=^0.03
2025-03-23 14:33:15 - antiBiotic :RA
2025-03-23 14:33:15 - antiBiotic :Rifampicin
2025-03-23 14:33:15 - MIC Value :<=^10.0
2025-03-23 14:33:15 - antiBiotic :SXT
2025-03-23 14:33:15 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-23 15:06:01 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|URIN^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-23 15:06:01 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250323150601+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-23 15:06:01 - SAMPLE NO :250322MIC00001
2025-03-23 15:06:01 - SAMPLLE TypeURIN
2025-03-23 15:06:01 - Organism type :Staphylococcus aureus
2025-03-23 15:06:01 - MIC Value :>=^0.5
2025-03-23 15:06:01 - antiBiotic :P
2025-03-23 15:06:01 - antiBiotic :Benzylpenicillin
2025-03-23 15:06:01 - MIC Value :>=^4.0
2025-03-23 15:06:01 - antiBiotic :OX1
2025-03-23 15:06:01 - antiBiotic :Oxacillin
2025-03-23 15:06:01 - MIC Value :<=^0.5
2025-03-23 15:06:01 - antiBiotic :GM
2025-03-23 15:06:01 - antiBiotic :Gentamicin
2025-03-23 15:06:01 - MIC Value :=^1.0
2025-03-23 15:06:01 - antiBiotic :CIP
2025-03-23 15:06:01 - antiBiotic :Ciprofloxacin
2025-03-23 15:06:01 - MIC Value :=^2.0
2025-03-23 15:06:01 - antiBiotic :LEV
2025-03-23 15:06:01 - antiBiotic :Levofloxacin
2025-03-23 15:06:01 - MIC Value :=^0.5
2025-03-23 15:06:01 - antiBiotic :E
2025-03-23 15:06:01 - antiBiotic :Erythromycin
2025-03-23 15:06:01 - MIC Value :>=^4.0
2025-03-23 15:06:01 - antiBiotic :CM
2025-03-23 15:06:01 - antiBiotic :Clindamycin
2025-03-23 15:06:01 - MIC Value :>=^8.0
2025-03-23 15:06:01 - antiBiotic :LNZ
2025-03-23 15:06:01 - antiBiotic :Linezolid
2025-03-23 15:06:01 - MIC Value :=^1.0
2025-03-23 15:06:01 - antiBiotic :DAP
2025-03-23 15:06:01 - antiBiotic :Daptomycin
2025-03-23 15:06:01 - MIC Value :=^4.0
2025-03-23 15:06:01 - antiBiotic :TEC
2025-03-23 15:06:01 - antiBiotic :Teicoplanin
2025-03-23 15:06:01 - MIC Value :>=^32.0
2025-03-23 15:06:01 - antiBiotic :VA
2025-03-23 15:06:01 - antiBiotic :Vancomycin
2025-03-23 15:06:01 - MIC Value :<=^1.0
2025-03-23 15:06:01 - antiBiotic :TE
2025-03-23 15:06:01 - antiBiotic :Tetracycline
2025-03-23 15:06:01 - MIC Value :=^0.25
2025-03-23 15:06:01 - antiBiotic :TGC
2025-03-23 15:06:01 - antiBiotic :Tigecycline
2025-03-23 15:06:01 - MIC Value :<=^16.0
2025-03-23 15:06:01 - antiBiotic :FT
2025-03-23 15:06:01 - antiBiotic :Nitrofurantoin
2025-03-23 15:06:01 - MIC Value :<=^0.03
2025-03-23 15:06:01 - antiBiotic :RA
2025-03-23 15:06:01 - antiBiotic :Rifampicin
2025-03-23 15:06:01 - MIC Value :<=^10.0
2025-03-23 15:06:01 - antiBiotic :SXT
2025-03-23 15:06:01 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-23 15:10:47 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|URIN^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-23 15:10:47 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250323151047+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-23 15:10:47 - SAMPLE NO :250322MIC00001
2025-03-23 15:10:47 - SAMPLLE TypeURIN
2025-03-23 15:10:47 - Organism type :Staphylococcus aureus
2025-03-23 15:10:47 - MIC Value :>=^0.5
2025-03-23 15:10:47 - antiBiotic :P
2025-03-23 15:10:47 - antiBiotic :Benzylpenicillin
2025-03-23 15:10:47 - MIC Value :>=^4.0
2025-03-23 15:10:47 - antiBiotic :OX1
2025-03-23 15:10:47 - antiBiotic :Oxacillin
2025-03-23 15:10:47 - MIC Value :<=^0.5
2025-03-23 15:10:47 - antiBiotic :GM
2025-03-23 15:10:47 - antiBiotic :Gentamicin
2025-03-23 15:10:47 - MIC Value :=^1.0
2025-03-23 15:10:47 - antiBiotic :CIP
2025-03-23 15:10:47 - antiBiotic :Ciprofloxacin
2025-03-23 15:10:47 - MIC Value :=^2.0
2025-03-23 15:10:47 - antiBiotic :LEV
2025-03-23 15:10:47 - antiBiotic :Levofloxacin
2025-03-23 15:10:47 - MIC Value :=^0.5
2025-03-23 15:10:47 - antiBiotic :E
2025-03-23 15:10:47 - antiBiotic :Erythromycin
2025-03-23 15:10:47 - MIC Value :>=^4.0
2025-03-23 15:10:47 - antiBiotic :CM
2025-03-23 15:10:47 - antiBiotic :Clindamycin
2025-03-23 15:10:47 - MIC Value :>=^8.0
2025-03-23 15:10:47 - antiBiotic :LNZ
2025-03-23 15:10:47 - antiBiotic :Linezolid
2025-03-23 15:10:47 - MIC Value :=^1.0
2025-03-23 15:10:47 - antiBiotic :DAP
2025-03-23 15:10:47 - antiBiotic :Daptomycin
2025-03-23 15:10:47 - MIC Value :=^4.0
2025-03-23 15:10:47 - antiBiotic :TEC
2025-03-23 15:10:47 - antiBiotic :Teicoplanin
2025-03-23 15:10:47 - MIC Value :>=^32.0
2025-03-23 15:10:47 - antiBiotic :VA
2025-03-23 15:10:47 - antiBiotic :Vancomycin
2025-03-23 15:10:47 - MIC Value :<=^1.0
2025-03-23 15:10:47 - antiBiotic :TE
2025-03-23 15:10:47 - antiBiotic :Tetracycline
2025-03-23 15:10:47 - MIC Value :=^0.25
2025-03-23 15:10:47 - antiBiotic :TGC
2025-03-23 15:10:47 - antiBiotic :Tigecycline
2025-03-23 15:10:47 - MIC Value :<=^16.0
2025-03-23 15:10:47 - antiBiotic :FT
2025-03-23 15:10:47 - antiBiotic :Nitrofurantoin
2025-03-23 15:10:47 - MIC Value :<=^0.03
2025-03-23 15:10:47 - antiBiotic :RA
2025-03-23 15:10:47 - antiBiotic :Rifampicin
2025-03-23 15:10:47 - MIC Value :<=^10.0
2025-03-23 15:10:47 - antiBiotic :SXT
2025-03-23 15:10:47 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-23 15:14:00 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|URIN^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-23 15:14:00 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250323151400+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-23 15:14:00 - SAMPLE NO :250322MIC00001
2025-03-23 15:14:00 - SAMPLLE TypeURIN
2025-03-23 15:14:00 - Organism type :Staphylococcus aureus
2025-03-23 15:14:00 - MIC Value :>=^0.5
2025-03-23 15:14:00 - antiBiotic :P
2025-03-23 15:14:00 - antiBiotic :Benzylpenicillin
2025-03-23 15:14:00 - MIC Value :>=^4.0
2025-03-23 15:14:00 - antiBiotic :OX1
2025-03-23 15:14:00 - antiBiotic :Oxacillin
2025-03-23 15:14:00 - MIC Value :<=^0.5
2025-03-23 15:14:00 - antiBiotic :GM
2025-03-23 15:14:00 - antiBiotic :Gentamicin
2025-03-23 15:14:00 - MIC Value :=^1.0
2025-03-23 15:14:00 - antiBiotic :CIP
2025-03-23 15:14:00 - antiBiotic :Ciprofloxacin
2025-03-23 15:14:00 - MIC Value :=^2.0
2025-03-23 15:14:00 - antiBiotic :LEV
2025-03-23 15:14:00 - antiBiotic :Levofloxacin
2025-03-23 15:14:00 - MIC Value :=^0.5
2025-03-23 15:14:00 - antiBiotic :E
2025-03-23 15:14:00 - antiBiotic :Erythromycin
2025-03-23 15:14:00 - MIC Value :>=^4.0
2025-03-23 15:14:00 - antiBiotic :CM
2025-03-23 15:14:00 - antiBiotic :Clindamycin
2025-03-23 15:14:00 - MIC Value :>=^8.0
2025-03-23 15:14:00 - antiBiotic :LNZ
2025-03-23 15:14:00 - antiBiotic :Linezolid
2025-03-23 15:14:00 - MIC Value :=^1.0
2025-03-23 15:14:00 - antiBiotic :DAP
2025-03-23 15:14:00 - antiBiotic :Daptomycin
2025-03-23 15:14:00 - MIC Value :=^4.0
2025-03-23 15:14:00 - antiBiotic :TEC
2025-03-23 15:14:00 - antiBiotic :Teicoplanin
2025-03-23 15:14:00 - MIC Value :>=^32.0
2025-03-23 15:14:00 - antiBiotic :VA
2025-03-23 15:14:00 - antiBiotic :Vancomycin
2025-03-23 15:14:00 - MIC Value :<=^1.0
2025-03-23 15:14:00 - antiBiotic :TE
2025-03-23 15:14:00 - antiBiotic :Tetracycline
2025-03-23 15:14:00 - MIC Value :=^0.25
2025-03-23 15:14:00 - antiBiotic :TGC
2025-03-23 15:14:00 - antiBiotic :Tigecycline
2025-03-23 15:14:00 - MIC Value :<=^16.0
2025-03-23 15:14:00 - antiBiotic :FT
2025-03-23 15:14:00 - antiBiotic :Nitrofurantoin
2025-03-23 15:14:00 - MIC Value :<=^0.03
2025-03-23 15:14:00 - antiBiotic :RA
2025-03-23 15:14:00 - antiBiotic :Rifampicin
2025-03-23 15:14:00 - MIC Value :<=^10.0
2025-03-23 15:14:00 - antiBiotic :SXT
2025-03-23 15:14:00 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-23 15:20:43 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|URIN^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-23 15:20:43 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250323152043+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-23 15:20:43 - SAMPLE NO :250322MIC00001
2025-03-23 15:20:43 - SAMPLLE TypeURIN
2025-03-23 15:20:43 - Organism type :Staphylococcus aureus
2025-03-23 15:20:43 - MIC Value :>=^0.5
2025-03-23 15:20:43 - antiBiotic :P
2025-03-23 15:20:43 - antiBiotic :Benzylpenicillin
2025-03-23 15:20:43 - MIC Value :>=^4.0
2025-03-23 15:20:43 - antiBiotic :OX1
2025-03-23 15:20:43 - antiBiotic :Oxacillin
2025-03-23 15:20:43 - MIC Value :<=^0.5
2025-03-23 15:20:43 - antiBiotic :GM
2025-03-23 15:20:43 - antiBiotic :Gentamicin
2025-03-23 15:20:43 - MIC Value :=^1.0
2025-03-23 15:20:43 - antiBiotic :CIP
2025-03-23 15:20:43 - antiBiotic :Ciprofloxacin
2025-03-23 15:20:43 - MIC Value :=^2.0
2025-03-23 15:20:43 - antiBiotic :LEV
2025-03-23 15:20:43 - antiBiotic :Levofloxacin
2025-03-23 15:20:43 - MIC Value :=^0.5
2025-03-23 15:20:43 - antiBiotic :E
2025-03-23 15:20:43 - antiBiotic :Erythromycin
2025-03-23 15:20:43 - MIC Value :>=^4.0
2025-03-23 15:20:43 - antiBiotic :CM
2025-03-23 15:20:43 - antiBiotic :Clindamycin
2025-03-23 15:20:43 - MIC Value :>=^8.0
2025-03-23 15:20:43 - antiBiotic :LNZ
2025-03-23 15:20:43 - antiBiotic :Linezolid
2025-03-23 15:20:43 - MIC Value :=^1.0
2025-03-23 15:20:43 - antiBiotic :DAP
2025-03-23 15:20:43 - antiBiotic :Daptomycin
2025-03-23 15:20:43 - MIC Value :=^4.0
2025-03-23 15:20:43 - antiBiotic :TEC
2025-03-23 15:20:43 - antiBiotic :Teicoplanin
2025-03-23 15:20:43 - MIC Value :>=^32.0
2025-03-23 15:20:43 - antiBiotic :VA
2025-03-23 15:20:43 - antiBiotic :Vancomycin
2025-03-23 15:20:43 - MIC Value :<=^1.0
2025-03-23 15:20:43 - antiBiotic :TE
2025-03-23 15:20:43 - antiBiotic :Tetracycline
2025-03-23 15:20:43 - MIC Value :=^0.25
2025-03-23 15:20:43 - antiBiotic :TGC
2025-03-23 15:20:43 - antiBiotic :Tigecycline
2025-03-23 15:20:43 - MIC Value :<=^16.0
2025-03-23 15:20:43 - antiBiotic :FT
2025-03-23 15:20:43 - antiBiotic :Nitrofurantoin
2025-03-23 15:20:43 - MIC Value :<=^0.03
2025-03-23 15:20:43 - antiBiotic :RA
2025-03-23 15:20:43 - antiBiotic :Rifampicin
2025-03-23 15:20:43 - MIC Value :<=^10.0
2025-03-23 15:20:43 - antiBiotic :SXT
2025-03-23 15:20:43 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-23 15:23:56 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|URIN^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-23 15:23:56 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250323152356+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-23 15:23:56 - SAMPLE NO :250322MIC00001
2025-03-23 15:23:56 - SAMPLLE TypeURIN
2025-03-23 15:23:56 - Organism type :Staphylococcus aureus
2025-03-23 15:23:56 - MIC Value :>=^0.5
2025-03-23 15:23:56 - antiBiotic :P
2025-03-23 15:23:56 - antiBiotic :Benzylpenicillin
2025-03-23 15:23:56 - MIC Value :>=^4.0
2025-03-23 15:23:56 - antiBiotic :OX1
2025-03-23 15:23:56 - antiBiotic :Oxacillin
2025-03-23 15:23:56 - MIC Value :<=^0.5
2025-03-23 15:23:56 - antiBiotic :GM
2025-03-23 15:23:56 - antiBiotic :Gentamicin
2025-03-23 15:23:56 - MIC Value :=^1.0
2025-03-23 15:23:56 - antiBiotic :CIP
2025-03-23 15:23:56 - antiBiotic :Ciprofloxacin
2025-03-23 15:23:56 - MIC Value :=^2.0
2025-03-23 15:23:56 - antiBiotic :LEV
2025-03-23 15:23:56 - antiBiotic :Levofloxacin
2025-03-23 15:23:56 - MIC Value :=^0.5
2025-03-23 15:23:56 - antiBiotic :E
2025-03-23 15:23:56 - antiBiotic :Erythromycin
2025-03-23 15:23:56 - MIC Value :>=^4.0
2025-03-23 15:23:56 - antiBiotic :CM
2025-03-23 15:23:56 - antiBiotic :Clindamycin
2025-03-23 15:23:56 - MIC Value :>=^8.0
2025-03-23 15:23:56 - antiBiotic :LNZ
2025-03-23 15:23:56 - antiBiotic :Linezolid
2025-03-23 15:23:56 - MIC Value :=^1.0
2025-03-23 15:23:56 - antiBiotic :DAP
2025-03-23 15:23:56 - antiBiotic :Daptomycin
2025-03-23 15:23:56 - MIC Value :=^4.0
2025-03-23 15:23:56 - antiBiotic :TEC
2025-03-23 15:23:56 - antiBiotic :Teicoplanin
2025-03-23 15:23:56 - MIC Value :>=^32.0
2025-03-23 15:23:56 - antiBiotic :VA
2025-03-23 15:23:56 - antiBiotic :Vancomycin
2025-03-23 15:23:56 - MIC Value :<=^1.0
2025-03-23 15:23:56 - antiBiotic :TE
2025-03-23 15:23:56 - antiBiotic :Tetracycline
2025-03-23 15:23:56 - MIC Value :=^0.25
2025-03-23 15:23:56 - antiBiotic :TGC
2025-03-23 15:23:56 - antiBiotic :Tigecycline
2025-03-23 15:23:56 - MIC Value :<=^16.0
2025-03-23 15:23:56 - antiBiotic :FT
2025-03-23 15:23:56 - antiBiotic :Nitrofurantoin
2025-03-23 15:23:56 - MIC Value :<=^0.03
2025-03-23 15:23:56 - antiBiotic :RA
2025-03-23 15:23:56 - antiBiotic :Rifampicin
2025-03-23 15:23:56 - MIC Value :<=^10.0
2025-03-23 15:23:56 - antiBiotic :SXT
2025-03-23 15:23:56 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-23 15:27:27 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|URIN^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-23 15:27:27 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250323152727+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-23 15:27:27 - SAMPLE NO :250322MIC00001
2025-03-23 15:27:27 - SAMPLLE TypeURIN
2025-03-23 15:27:27 - Organism type :Staphylococcus aureus
2025-03-23 15:27:27 - MIC Value :>=^0.5
2025-03-23 15:27:27 - antiBiotic :P
2025-03-23 15:27:27 - antiBiotic :Benzylpenicillin
2025-03-23 15:27:27 - MIC Value :>=^4.0
2025-03-23 15:27:27 - antiBiotic :OX1
2025-03-23 15:27:27 - antiBiotic :Oxacillin
2025-03-23 15:27:27 - MIC Value :<=^0.5
2025-03-23 15:27:27 - antiBiotic :GM
2025-03-23 15:27:27 - antiBiotic :Gentamicin
2025-03-23 15:27:27 - MIC Value :=^1.0
2025-03-23 15:27:27 - antiBiotic :CIP
2025-03-23 15:27:27 - antiBiotic :Ciprofloxacin
2025-03-23 15:27:27 - MIC Value :=^2.0
2025-03-23 15:27:27 - antiBiotic :LEV
2025-03-23 15:27:27 - antiBiotic :Levofloxacin
2025-03-23 15:27:27 - MIC Value :=^0.5
2025-03-23 15:27:27 - antiBiotic :E
2025-03-23 15:27:27 - antiBiotic :Erythromycin
2025-03-23 15:27:27 - MIC Value :>=^4.0
2025-03-23 15:27:27 - antiBiotic :CM
2025-03-23 15:27:27 - antiBiotic :Clindamycin
2025-03-23 15:27:27 - MIC Value :>=^8.0
2025-03-23 15:27:27 - antiBiotic :LNZ
2025-03-23 15:27:27 - antiBiotic :Linezolid
2025-03-23 15:27:27 - MIC Value :=^1.0
2025-03-23 15:27:27 - antiBiotic :DAP
2025-03-23 15:27:27 - antiBiotic :Daptomycin
2025-03-23 15:27:27 - MIC Value :=^4.0
2025-03-23 15:27:27 - antiBiotic :TEC
2025-03-23 15:27:27 - antiBiotic :Teicoplanin
2025-03-23 15:27:27 - MIC Value :>=^32.0
2025-03-23 15:27:27 - antiBiotic :VA
2025-03-23 15:27:27 - antiBiotic :Vancomycin
2025-03-23 15:27:27 - MIC Value :<=^1.0
2025-03-23 15:27:27 - antiBiotic :TE
2025-03-23 15:27:27 - antiBiotic :Tetracycline
2025-03-23 15:27:27 - MIC Value :=^0.25
2025-03-23 15:27:27 - antiBiotic :TGC
2025-03-23 15:27:27 - antiBiotic :Tigecycline
2025-03-23 15:27:27 - MIC Value :<=^16.0
2025-03-23 15:27:27 - antiBiotic :FT
2025-03-23 15:27:27 - antiBiotic :Nitrofurantoin
2025-03-23 15:27:27 - MIC Value :<=^0.03
2025-03-23 15:27:27 - antiBiotic :RA
2025-03-23 15:27:27 - antiBiotic :Rifampicin
2025-03-23 15:27:27 - MIC Value :<=^10.0
2025-03-23 15:27:27 - antiBiotic :SXT
2025-03-23 15:27:27 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-23 15:27:29 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|URIN^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-23 15:27:29 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250323152729+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-23 15:27:29 - SAMPLE NO :250322MIC00001
2025-03-23 15:27:29 - SAMPLLE TypeURIN
2025-03-23 15:27:29 - Organism type :Staphylococcus aureus
2025-03-23 15:27:29 - MIC Value :>=^0.5
2025-03-23 15:27:29 - antiBiotic :P
2025-03-23 15:27:29 - antiBiotic :Benzylpenicillin
2025-03-23 15:27:29 - MIC Value :>=^4.0
2025-03-23 15:27:29 - antiBiotic :OX1
2025-03-23 15:27:29 - antiBiotic :Oxacillin
2025-03-23 15:27:29 - MIC Value :<=^0.5
2025-03-23 15:27:29 - antiBiotic :GM
2025-03-23 15:27:29 - antiBiotic :Gentamicin
2025-03-23 15:27:29 - MIC Value :=^1.0
2025-03-23 15:27:29 - antiBiotic :CIP
2025-03-23 15:27:29 - antiBiotic :Ciprofloxacin
2025-03-23 15:27:29 - MIC Value :=^2.0
2025-03-23 15:27:29 - antiBiotic :LEV
2025-03-23 15:27:29 - antiBiotic :Levofloxacin
2025-03-23 15:27:29 - MIC Value :=^0.5
2025-03-23 15:27:29 - antiBiotic :E
2025-03-23 15:27:29 - antiBiotic :Erythromycin
2025-03-23 15:27:29 - MIC Value :>=^4.0
2025-03-23 15:27:29 - antiBiotic :CM
2025-03-23 15:27:29 - antiBiotic :Clindamycin
2025-03-23 15:27:29 - MIC Value :>=^8.0
2025-03-23 15:27:29 - antiBiotic :LNZ
2025-03-23 15:27:29 - antiBiotic :Linezolid
2025-03-23 15:27:29 - MIC Value :=^1.0
2025-03-23 15:27:29 - antiBiotic :DAP
2025-03-23 15:27:29 - antiBiotic :Daptomycin
2025-03-23 15:27:29 - MIC Value :=^4.0
2025-03-23 15:27:29 - antiBiotic :TEC
2025-03-23 15:27:29 - antiBiotic :Teicoplanin
2025-03-23 15:27:29 - MIC Value :>=^32.0
2025-03-23 15:27:29 - antiBiotic :VA
2025-03-23 15:27:29 - antiBiotic :Vancomycin
2025-03-23 15:27:29 - MIC Value :<=^1.0
2025-03-23 15:27:29 - antiBiotic :TE
2025-03-23 15:27:29 - antiBiotic :Tetracycline
2025-03-23 15:27:29 - MIC Value :=^0.25
2025-03-23 15:27:29 - antiBiotic :TGC
2025-03-23 15:27:29 - antiBiotic :Tigecycline
2025-03-23 15:27:29 - MIC Value :<=^16.0
2025-03-23 15:27:29 - antiBiotic :FT
2025-03-23 15:27:29 - antiBiotic :Nitrofurantoin
2025-03-23 15:27:29 - MIC Value :<=^0.03
2025-03-23 15:27:29 - antiBiotic :RA
2025-03-23 15:27:29 - antiBiotic :Rifampicin
2025-03-23 15:27:29 - MIC Value :<=^10.0
2025-03-23 15:27:29 - antiBiotic :SXT
2025-03-23 15:27:29 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-23 15:29:35 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|URIN^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-23 15:29:35 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250323152935+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-23 15:29:35 - SAMPLE NO :250322MIC00001
2025-03-23 15:29:35 - SAMPLLE TypeURIN
2025-03-23 15:29:35 - Organism type :Staphylococcus aureus
2025-03-23 15:29:35 - MIC Value :>=^0.5
2025-03-23 15:29:35 - antiBiotic :P
2025-03-23 15:29:35 - antiBiotic :Benzylpenicillin
2025-03-23 15:29:35 - MIC Value :>=^4.0
2025-03-23 15:29:35 - antiBiotic :OX1
2025-03-23 15:29:35 - antiBiotic :Oxacillin
2025-03-23 15:29:35 - MIC Value :<=^0.5
2025-03-23 15:29:35 - antiBiotic :GM
2025-03-23 15:29:35 - antiBiotic :Gentamicin
2025-03-23 15:29:35 - MIC Value :=^1.0
2025-03-23 15:29:35 - antiBiotic :CIP
2025-03-23 15:29:35 - antiBiotic :Ciprofloxacin
2025-03-23 15:29:35 - MIC Value :=^2.0
2025-03-23 15:29:35 - antiBiotic :LEV
2025-03-23 15:29:35 - antiBiotic :Levofloxacin
2025-03-23 15:29:35 - MIC Value :=^0.5
2025-03-23 15:29:35 - antiBiotic :E
2025-03-23 15:29:35 - antiBiotic :Erythromycin
2025-03-23 15:29:35 - MIC Value :>=^4.0
2025-03-23 15:29:35 - antiBiotic :CM
2025-03-23 15:29:35 - antiBiotic :Clindamycin
2025-03-23 15:29:35 - MIC Value :>=^8.0
2025-03-23 15:29:35 - antiBiotic :LNZ
2025-03-23 15:29:35 - antiBiotic :Linezolid
2025-03-23 15:29:35 - MIC Value :=^1.0
2025-03-23 15:29:35 - antiBiotic :DAP
2025-03-23 15:29:35 - antiBiotic :Daptomycin
2025-03-23 15:29:35 - MIC Value :=^4.0
2025-03-23 15:29:35 - antiBiotic :TEC
2025-03-23 15:29:35 - antiBiotic :Teicoplanin
2025-03-23 15:29:35 - MIC Value :>=^32.0
2025-03-23 15:29:35 - antiBiotic :VA
2025-03-23 15:29:35 - antiBiotic :Vancomycin
2025-03-23 15:29:35 - MIC Value :<=^1.0
2025-03-23 15:29:35 - antiBiotic :TE
2025-03-23 15:29:35 - antiBiotic :Tetracycline
2025-03-23 15:29:35 - MIC Value :=^0.25
2025-03-23 15:29:35 - antiBiotic :TGC
2025-03-23 15:29:35 - antiBiotic :Tigecycline
2025-03-23 15:29:35 - MIC Value :<=^16.0
2025-03-23 15:29:35 - antiBiotic :FT
2025-03-23 15:29:35 - antiBiotic :Nitrofurantoin
2025-03-23 15:29:35 - MIC Value :<=^0.03
2025-03-23 15:29:35 - antiBiotic :RA
2025-03-23 15:29:35 - antiBiotic :Rifampicin
2025-03-23 15:29:35 - MIC Value :<=^10.0
2025-03-23 15:29:35 - antiBiotic :SXT
2025-03-23 15:29:35 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-23 15:31:18 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|URIN^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-23 15:31:18 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250323153118+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-23 15:31:18 - SAMPLE NO :250322MIC00001
2025-03-23 15:31:18 - SAMPLLE TypeURIN
2025-03-23 15:31:18 - Organism type :Staphylococcus aureus
2025-03-23 15:31:18 - MIC Value :>=^0.5
2025-03-23 15:31:18 - antiBiotic :P
2025-03-23 15:31:18 - antiBiotic :Benzylpenicillin
2025-03-23 15:31:18 - MIC Value :>=^4.0
2025-03-23 15:31:18 - antiBiotic :OX1
2025-03-23 15:31:18 - antiBiotic :Oxacillin
2025-03-23 15:31:18 - MIC Value :<=^0.5
2025-03-23 15:31:18 - antiBiotic :GM
2025-03-23 15:31:18 - antiBiotic :Gentamicin
2025-03-23 15:31:18 - MIC Value :=^1.0
2025-03-23 15:31:18 - antiBiotic :CIP
2025-03-23 15:31:18 - antiBiotic :Ciprofloxacin
2025-03-23 15:31:18 - MIC Value :=^2.0
2025-03-23 15:31:18 - antiBiotic :LEV
2025-03-23 15:31:18 - antiBiotic :Levofloxacin
2025-03-23 15:31:18 - MIC Value :=^0.5
2025-03-23 15:31:18 - antiBiotic :E
2025-03-23 15:31:18 - antiBiotic :Erythromycin
2025-03-23 15:31:18 - MIC Value :>=^4.0
2025-03-23 15:31:18 - antiBiotic :CM
2025-03-23 15:31:18 - antiBiotic :Clindamycin
2025-03-23 15:31:18 - MIC Value :>=^8.0
2025-03-23 15:31:18 - antiBiotic :LNZ
2025-03-23 15:31:18 - antiBiotic :Linezolid
2025-03-23 15:31:18 - MIC Value :=^1.0
2025-03-23 15:31:18 - antiBiotic :DAP
2025-03-23 15:31:18 - antiBiotic :Daptomycin
2025-03-23 15:31:18 - MIC Value :=^4.0
2025-03-23 15:31:18 - antiBiotic :TEC
2025-03-23 15:31:18 - antiBiotic :Teicoplanin
2025-03-23 15:31:18 - MIC Value :>=^32.0
2025-03-23 15:31:18 - antiBiotic :VA
2025-03-23 15:31:18 - antiBiotic :Vancomycin
2025-03-23 15:31:18 - MIC Value :<=^1.0
2025-03-23 15:31:18 - antiBiotic :TE
2025-03-23 15:31:18 - antiBiotic :Tetracycline
2025-03-23 15:31:18 - MIC Value :=^0.25
2025-03-23 15:31:18 - antiBiotic :TGC
2025-03-23 15:31:18 - antiBiotic :Tigecycline
2025-03-23 15:31:18 - MIC Value :<=^16.0
2025-03-23 15:31:18 - antiBiotic :FT
2025-03-23 15:31:18 - antiBiotic :Nitrofurantoin
2025-03-23 15:31:18 - MIC Value :<=^0.03
2025-03-23 15:31:18 - antiBiotic :RA
2025-03-23 15:31:18 - antiBiotic :Rifampicin
2025-03-23 15:31:18 - MIC Value :<=^10.0
2025-03-23 15:31:18 - antiBiotic :SXT
2025-03-23 15:31:18 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-23 15:34:23 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|URIN^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-23 15:34:23 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250323153423+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-23 15:34:23 - SAMPLE NO :250322MIC00001
2025-03-23 15:34:23 - SAMPLLE TypeURIN
2025-03-23 15:34:23 - Organism type :Staphylococcus aureus
2025-03-23 15:34:23 - MIC Value :>=^0.5
2025-03-23 15:34:23 - antiBiotic :P
2025-03-23 15:34:23 - antiBiotic :Benzylpenicillin
2025-03-23 15:34:23 - MIC Value :>=^4.0
2025-03-23 15:34:23 - antiBiotic :OX1
2025-03-23 15:34:23 - antiBiotic :Oxacillin
2025-03-23 15:34:23 - MIC Value :<=^0.5
2025-03-23 15:34:23 - antiBiotic :GM
2025-03-23 15:34:23 - antiBiotic :Gentamicin
2025-03-23 15:34:23 - MIC Value :=^1.0
2025-03-23 15:34:23 - antiBiotic :CIP
2025-03-23 15:34:23 - antiBiotic :Ciprofloxacin
2025-03-23 15:34:23 - MIC Value :=^2.0
2025-03-23 15:34:23 - antiBiotic :LEV
2025-03-23 15:34:23 - antiBiotic :Levofloxacin
2025-03-23 15:34:23 - MIC Value :=^0.5
2025-03-23 15:34:23 - antiBiotic :E
2025-03-23 15:34:23 - antiBiotic :Erythromycin
2025-03-23 15:34:23 - MIC Value :>=^4.0
2025-03-23 15:34:23 - antiBiotic :CM
2025-03-23 15:34:23 - antiBiotic :Clindamycin
2025-03-23 15:34:23 - MIC Value :>=^8.0
2025-03-23 15:34:23 - antiBiotic :LNZ
2025-03-23 15:34:23 - antiBiotic :Linezolid
2025-03-23 15:34:23 - MIC Value :=^1.0
2025-03-23 15:34:23 - antiBiotic :DAP
2025-03-23 15:34:23 - antiBiotic :Daptomycin
2025-03-23 15:34:23 - MIC Value :=^4.0
2025-03-23 15:34:23 - antiBiotic :TEC
2025-03-23 15:34:23 - antiBiotic :Teicoplanin
2025-03-23 15:34:23 - MIC Value :>=^32.0
2025-03-23 15:34:23 - antiBiotic :VA
2025-03-23 15:34:23 - antiBiotic :Vancomycin
2025-03-23 15:34:23 - MIC Value :<=^1.0
2025-03-23 15:34:23 - antiBiotic :TE
2025-03-23 15:34:23 - antiBiotic :Tetracycline
2025-03-23 15:34:23 - MIC Value :=^0.25
2025-03-23 15:34:23 - antiBiotic :TGC
2025-03-23 15:34:23 - antiBiotic :Tigecycline
2025-03-23 15:34:23 - MIC Value :<=^16.0
2025-03-23 15:34:23 - antiBiotic :FT
2025-03-23 15:34:23 - antiBiotic :Nitrofurantoin
2025-03-23 15:34:23 - MIC Value :<=^0.03
2025-03-23 15:34:23 - antiBiotic :RA
2025-03-23 15:34:23 - antiBiotic :Rifampicin
2025-03-23 15:34:23 - MIC Value :<=^10.0
2025-03-23 15:34:23 - antiBiotic :SXT
2025-03-23 15:34:23 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-23 15:38:58 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|URIN^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-23 15:38:58 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250323153858+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-23 15:38:58 - SAMPLE NO :250322MIC00001
2025-03-23 15:38:58 - SAMPLLE TypeURIN
2025-03-23 15:38:58 - Organism type :Staphylococcus aureus
2025-03-23 15:38:58 - MIC Value :>=^0.5
2025-03-23 15:38:58 - antiBiotic :P
2025-03-23 15:38:58 - antiBiotic :Benzylpenicillin
2025-03-23 15:38:58 - MIC Value :>=^4.0
2025-03-23 15:38:58 - antiBiotic :OX1
2025-03-23 15:38:58 - antiBiotic :Oxacillin
2025-03-23 15:38:58 - MIC Value :<=^0.5
2025-03-23 15:38:58 - antiBiotic :GM
2025-03-23 15:38:58 - antiBiotic :Gentamicin
2025-03-23 15:38:58 - MIC Value :=^1.0
2025-03-23 15:38:58 - antiBiotic :CIP
2025-03-23 15:38:58 - antiBiotic :Ciprofloxacin
2025-03-23 15:38:58 - MIC Value :=^2.0
2025-03-23 15:38:58 - antiBiotic :LEV
2025-03-23 15:38:58 - antiBiotic :Levofloxacin
2025-03-23 15:38:58 - MIC Value :=^0.5
2025-03-23 15:38:58 - antiBiotic :E
2025-03-23 15:38:58 - antiBiotic :Erythromycin
2025-03-23 15:38:58 - MIC Value :>=^4.0
2025-03-23 15:38:58 - antiBiotic :CM
2025-03-23 15:38:58 - antiBiotic :Clindamycin
2025-03-23 15:38:58 - MIC Value :>=^8.0
2025-03-23 15:38:58 - antiBiotic :LNZ
2025-03-23 15:38:58 - antiBiotic :Linezolid
2025-03-23 15:38:58 - MIC Value :=^1.0
2025-03-23 15:38:58 - antiBiotic :DAP
2025-03-23 15:38:58 - antiBiotic :Daptomycin
2025-03-23 15:38:58 - MIC Value :=^4.0
2025-03-23 15:38:58 - antiBiotic :TEC
2025-03-23 15:38:58 - antiBiotic :Teicoplanin
2025-03-23 15:38:58 - MIC Value :>=^32.0
2025-03-23 15:38:58 - antiBiotic :VA
2025-03-23 15:38:58 - antiBiotic :Vancomycin
2025-03-23 15:38:58 - MIC Value :<=^1.0
2025-03-23 15:38:58 - antiBiotic :TE
2025-03-23 15:38:58 - antiBiotic :Tetracycline
2025-03-23 15:38:58 - MIC Value :=^0.25
2025-03-23 15:38:58 - antiBiotic :TGC
2025-03-23 15:38:58 - antiBiotic :Tigecycline
2025-03-23 15:38:58 - MIC Value :<=^16.0
2025-03-23 15:38:58 - antiBiotic :FT
2025-03-23 15:38:58 - antiBiotic :Nitrofurantoin
2025-03-23 15:38:58 - MIC Value :<=^0.03
2025-03-23 15:38:58 - antiBiotic :RA
2025-03-23 15:38:58 - antiBiotic :Rifampicin
2025-03-23 15:38:58 - MIC Value :<=^10.0
2025-03-23 15:38:58 - antiBiotic :SXT
2025-03-23 15:38:58 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-23 15:40:34 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|URIN^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-23 15:40:34 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250323154034+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-23 15:40:34 - SAMPLE NO :250322MIC00001
2025-03-23 15:40:34 - SAMPLLE TypeURIN
2025-03-23 15:40:34 - Organism type :Staphylococcus aureus
2025-03-23 15:40:34 - MIC Value :>=^0.5
2025-03-23 15:40:34 - antiBiotic :P
2025-03-23 15:40:34 - antiBiotic :Benzylpenicillin
2025-03-23 15:40:34 - MIC Value :>=^4.0
2025-03-23 15:40:34 - antiBiotic :OX1
2025-03-23 15:40:34 - antiBiotic :Oxacillin
2025-03-23 15:40:34 - MIC Value :<=^0.5
2025-03-23 15:40:34 - antiBiotic :GM
2025-03-23 15:40:34 - antiBiotic :Gentamicin
2025-03-23 15:40:34 - MIC Value :=^1.0
2025-03-23 15:40:34 - antiBiotic :CIP
2025-03-23 15:40:34 - antiBiotic :Ciprofloxacin
2025-03-23 15:40:34 - MIC Value :=^2.0
2025-03-23 15:40:34 - antiBiotic :LEV
2025-03-23 15:40:34 - antiBiotic :Levofloxacin
2025-03-23 15:40:34 - MIC Value :=^0.5
2025-03-23 15:40:34 - antiBiotic :E
2025-03-23 15:40:34 - antiBiotic :Erythromycin
2025-03-23 15:40:34 - MIC Value :>=^4.0
2025-03-23 15:40:34 - antiBiotic :CM
2025-03-23 15:40:34 - antiBiotic :Clindamycin
2025-03-23 15:40:34 - MIC Value :>=^8.0
2025-03-23 15:40:34 - antiBiotic :LNZ
2025-03-23 15:40:34 - antiBiotic :Linezolid
2025-03-23 15:40:34 - MIC Value :=^1.0
2025-03-23 15:40:34 - antiBiotic :DAP
2025-03-23 15:40:34 - antiBiotic :Daptomycin
2025-03-23 15:40:34 - MIC Value :=^4.0
2025-03-23 15:40:34 - antiBiotic :TEC
2025-03-23 15:40:34 - antiBiotic :Teicoplanin
2025-03-23 15:40:34 - MIC Value :>=^32.0
2025-03-23 15:40:34 - antiBiotic :VA
2025-03-23 15:40:34 - antiBiotic :Vancomycin
2025-03-23 15:40:34 - MIC Value :<=^1.0
2025-03-23 15:40:34 - antiBiotic :TE
2025-03-23 15:40:34 - antiBiotic :Tetracycline
2025-03-23 15:40:34 - MIC Value :=^0.25
2025-03-23 15:40:34 - antiBiotic :TGC
2025-03-23 15:40:34 - antiBiotic :Tigecycline
2025-03-23 15:40:34 - MIC Value :<=^16.0
2025-03-23 15:40:34 - antiBiotic :FT
2025-03-23 15:40:34 - antiBiotic :Nitrofurantoin
2025-03-23 15:40:34 - MIC Value :<=^0.03
2025-03-23 15:40:34 - antiBiotic :RA
2025-03-23 15:40:34 - antiBiotic :Rifampicin
2025-03-23 15:40:34 - MIC Value :<=^10.0
2025-03-23 15:40:34 - antiBiotic :SXT
2025-03-23 15:40:34 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-23 15:43:20 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|URIN^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-23 15:43:20 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250323154320+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-23 15:43:20 - SAMPLE NO :250322MIC00001
2025-03-23 15:43:20 - SAMPLLE TypeURIN
2025-03-23 15:43:20 - Organism type :Staphylococcus aureus
2025-03-23 15:43:20 - MIC Value :>=^0.5
2025-03-23 15:43:20 - antiBiotic :P
2025-03-23 15:43:20 - antiBiotic :Benzylpenicillin
2025-03-23 15:43:20 - MIC Value :>=^4.0
2025-03-23 15:43:20 - antiBiotic :OX1
2025-03-23 15:43:20 - antiBiotic :Oxacillin
2025-03-23 15:43:20 - MIC Value :<=^0.5
2025-03-23 15:43:20 - antiBiotic :GM
2025-03-23 15:43:20 - antiBiotic :Gentamicin
2025-03-23 15:43:20 - MIC Value :=^1.0
2025-03-23 15:43:20 - antiBiotic :CIP
2025-03-23 15:43:20 - antiBiotic :Ciprofloxacin
2025-03-23 15:43:20 - MIC Value :=^2.0
2025-03-23 15:43:20 - antiBiotic :LEV
2025-03-23 15:43:20 - antiBiotic :Levofloxacin
2025-03-23 15:43:20 - MIC Value :=^0.5
2025-03-23 15:43:20 - antiBiotic :E
2025-03-23 15:43:20 - antiBiotic :Erythromycin
2025-03-23 15:43:20 - MIC Value :>=^4.0
2025-03-23 15:43:20 - antiBiotic :CM
2025-03-23 15:43:20 - antiBiotic :Clindamycin
2025-03-23 15:43:20 - MIC Value :>=^8.0
2025-03-23 15:43:20 - antiBiotic :LNZ
2025-03-23 15:43:20 - antiBiotic :Linezolid
2025-03-23 15:43:20 - MIC Value :=^1.0
2025-03-23 15:43:20 - antiBiotic :DAP
2025-03-23 15:43:20 - antiBiotic :Daptomycin
2025-03-23 15:43:20 - MIC Value :=^4.0
2025-03-23 15:43:20 - antiBiotic :TEC
2025-03-23 15:43:20 - antiBiotic :Teicoplanin
2025-03-23 15:43:20 - MIC Value :>=^32.0
2025-03-23 15:43:20 - antiBiotic :VA
2025-03-23 15:43:20 - antiBiotic :Vancomycin
2025-03-23 15:43:20 - MIC Value :<=^1.0
2025-03-23 15:43:20 - antiBiotic :TE
2025-03-23 15:43:20 - antiBiotic :Tetracycline
2025-03-23 15:43:20 - MIC Value :=^0.25
2025-03-23 15:43:20 - antiBiotic :TGC
2025-03-23 15:43:20 - antiBiotic :Tigecycline
2025-03-23 15:43:20 - MIC Value :<=^16.0
2025-03-23 15:43:20 - antiBiotic :FT
2025-03-23 15:43:20 - antiBiotic :Nitrofurantoin
2025-03-23 15:43:20 - MIC Value :<=^0.03
2025-03-23 15:43:20 - antiBiotic :RA
2025-03-23 15:43:20 - antiBiotic :Rifampicin
2025-03-23 15:43:20 - MIC Value :<=^10.0
2025-03-23 15:43:20 - antiBiotic :SXT
2025-03-23 15:43:20 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-23 15:46:31 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|URIN^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-23 15:46:31 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250323154631+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-23 15:46:31 - SAMPLE NO :250322MIC00001
2025-03-23 15:46:31 - SAMPLLE TypeURIN
2025-03-23 15:46:31 - Organism type :Staphylococcus aureus
2025-03-23 15:46:31 - MIC Value :>=^0.5
2025-03-23 15:46:31 - antiBiotic :P
2025-03-23 15:46:31 - antiBiotic :Benzylpenicillin
2025-03-23 15:46:31 - MIC Value :>=^4.0
2025-03-23 15:46:31 - antiBiotic :OX1
2025-03-23 15:46:31 - antiBiotic :Oxacillin
2025-03-23 15:46:31 - MIC Value :<=^0.5
2025-03-23 15:46:31 - antiBiotic :GM
2025-03-23 15:46:31 - antiBiotic :Gentamicin
2025-03-23 15:46:31 - MIC Value :=^1.0
2025-03-23 15:46:31 - antiBiotic :CIP
2025-03-23 15:46:31 - antiBiotic :Ciprofloxacin
2025-03-23 15:46:31 - MIC Value :=^2.0
2025-03-23 15:46:31 - antiBiotic :LEV
2025-03-23 15:46:31 - antiBiotic :Levofloxacin
2025-03-23 15:46:31 - MIC Value :=^0.5
2025-03-23 15:46:31 - antiBiotic :E
2025-03-23 15:46:31 - antiBiotic :Erythromycin
2025-03-23 15:46:31 - MIC Value :>=^4.0
2025-03-23 15:46:31 - antiBiotic :CM
2025-03-23 15:46:31 - antiBiotic :Clindamycin
2025-03-23 15:46:31 - MIC Value :>=^8.0
2025-03-23 15:46:31 - antiBiotic :LNZ
2025-03-23 15:46:31 - antiBiotic :Linezolid
2025-03-23 15:46:31 - MIC Value :=^1.0
2025-03-23 15:46:31 - antiBiotic :DAP
2025-03-23 15:46:31 - antiBiotic :Daptomycin
2025-03-23 15:46:31 - MIC Value :=^4.0
2025-03-23 15:46:31 - antiBiotic :TEC
2025-03-23 15:46:31 - antiBiotic :Teicoplanin
2025-03-23 15:46:31 - MIC Value :>=^32.0
2025-03-23 15:46:31 - antiBiotic :VA
2025-03-23 15:46:31 - antiBiotic :Vancomycin
2025-03-23 15:46:31 - MIC Value :<=^1.0
2025-03-23 15:46:31 - antiBiotic :TE
2025-03-23 15:46:31 - antiBiotic :Tetracycline
2025-03-23 15:46:31 - MIC Value :=^0.25
2025-03-23 15:46:31 - antiBiotic :TGC
2025-03-23 15:46:31 - antiBiotic :Tigecycline
2025-03-23 15:46:31 - MIC Value :<=^16.0
2025-03-23 15:46:31 - antiBiotic :FT
2025-03-23 15:46:31 - antiBiotic :Nitrofurantoin
2025-03-23 15:46:31 - MIC Value :<=^0.03
2025-03-23 15:46:31 - antiBiotic :RA
2025-03-23 15:46:31 - antiBiotic :Rifampicin
2025-03-23 15:46:31 - MIC Value :<=^10.0
2025-03-23 15:46:31 - antiBiotic :SXT
2025-03-23 15:46:31 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-23 15:46:49 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|URIN^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-23 15:46:49 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250323154649+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-23 15:46:49 - SAMPLE NO :250322MIC00001
2025-03-23 15:46:49 - SAMPLLE TypeURIN
2025-03-23 15:46:49 - Organism type :Staphylococcus aureus
2025-03-23 15:46:49 - MIC Value :>=^0.5
2025-03-23 15:46:49 - antiBiotic :P
2025-03-23 15:46:49 - antiBiotic :Benzylpenicillin
2025-03-23 15:46:49 - MIC Value :>=^4.0
2025-03-23 15:46:49 - antiBiotic :OX1
2025-03-23 15:46:49 - antiBiotic :Oxacillin
2025-03-23 15:46:49 - MIC Value :<=^0.5
2025-03-23 15:46:49 - antiBiotic :GM
2025-03-23 15:46:49 - antiBiotic :Gentamicin
2025-03-23 15:46:49 - MIC Value :=^1.0
2025-03-23 15:46:49 - antiBiotic :CIP
2025-03-23 15:46:49 - antiBiotic :Ciprofloxacin
2025-03-23 15:46:49 - MIC Value :=^2.0
2025-03-23 15:46:49 - antiBiotic :LEV
2025-03-23 15:46:49 - antiBiotic :Levofloxacin
2025-03-23 15:46:49 - MIC Value :=^0.5
2025-03-23 15:46:49 - antiBiotic :E
2025-03-23 15:46:49 - antiBiotic :Erythromycin
2025-03-23 15:46:49 - MIC Value :>=^4.0
2025-03-23 15:46:49 - antiBiotic :CM
2025-03-23 15:46:49 - antiBiotic :Clindamycin
2025-03-23 15:46:49 - MIC Value :>=^8.0
2025-03-23 15:46:49 - antiBiotic :LNZ
2025-03-23 15:46:49 - antiBiotic :Linezolid
2025-03-23 15:46:49 - MIC Value :=^1.0
2025-03-23 15:46:49 - antiBiotic :DAP
2025-03-23 15:46:49 - antiBiotic :Daptomycin
2025-03-23 15:46:49 - MIC Value :=^4.0
2025-03-23 15:46:49 - antiBiotic :TEC
2025-03-23 15:46:49 - antiBiotic :Teicoplanin
2025-03-23 15:46:49 - MIC Value :>=^32.0
2025-03-23 15:46:49 - antiBiotic :VA
2025-03-23 15:46:49 - antiBiotic :Vancomycin
2025-03-23 15:46:49 - MIC Value :<=^1.0
2025-03-23 15:46:49 - antiBiotic :TE
2025-03-23 15:46:49 - antiBiotic :Tetracycline
2025-03-23 15:46:49 - MIC Value :=^0.25
2025-03-23 15:46:49 - antiBiotic :TGC
2025-03-23 15:46:49 - antiBiotic :Tigecycline
2025-03-23 15:46:49 - MIC Value :<=^16.0
2025-03-23 15:46:49 - antiBiotic :FT
2025-03-23 15:46:49 - antiBiotic :Nitrofurantoin
2025-03-23 15:46:49 - MIC Value :<=^0.03
2025-03-23 15:46:49 - antiBiotic :RA
2025-03-23 15:46:49 - antiBiotic :Rifampicin
2025-03-23 15:46:49 - MIC Value :<=^10.0
2025-03-23 15:46:49 - antiBiotic :SXT
2025-03-23 15:46:49 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-23 15:47:51 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|URIN^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-23 15:47:51 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250323154751+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-23 15:47:51 - SAMPLE NO :250322MIC00001
2025-03-23 15:47:51 - SAMPLLE TypeURIN
2025-03-23 15:47:51 - Organism type :Staphylococcus aureus
2025-03-23 15:47:51 - MIC Value :>=^0.5
2025-03-23 15:47:51 - antiBiotic :P
2025-03-23 15:47:51 - antiBiotic :Benzylpenicillin
2025-03-23 15:47:51 - MIC Value :>=^4.0
2025-03-23 15:47:51 - antiBiotic :OX1
2025-03-23 15:47:51 - antiBiotic :Oxacillin
2025-03-23 15:47:51 - MIC Value :<=^0.5
2025-03-23 15:47:51 - antiBiotic :GM
2025-03-23 15:47:51 - antiBiotic :Gentamicin
2025-03-23 15:47:51 - MIC Value :=^1.0
2025-03-23 15:47:51 - antiBiotic :CIP
2025-03-23 15:47:51 - antiBiotic :Ciprofloxacin
2025-03-23 15:47:51 - MIC Value :=^2.0
2025-03-23 15:47:51 - antiBiotic :LEV
2025-03-23 15:47:51 - antiBiotic :Levofloxacin
2025-03-23 15:47:51 - MIC Value :=^0.5
2025-03-23 15:47:51 - antiBiotic :E
2025-03-23 15:47:51 - antiBiotic :Erythromycin
2025-03-23 15:47:51 - MIC Value :>=^4.0
2025-03-23 15:47:51 - antiBiotic :CM
2025-03-23 15:47:51 - antiBiotic :Clindamycin
2025-03-23 15:47:51 - MIC Value :>=^8.0
2025-03-23 15:47:51 - antiBiotic :LNZ
2025-03-23 15:47:51 - antiBiotic :Linezolid
2025-03-23 15:47:51 - MIC Value :=^1.0
2025-03-23 15:47:51 - antiBiotic :DAP
2025-03-23 15:47:51 - antiBiotic :Daptomycin
2025-03-23 15:47:51 - MIC Value :=^4.0
2025-03-23 15:47:51 - antiBiotic :TEC
2025-03-23 15:47:51 - antiBiotic :Teicoplanin
2025-03-23 15:47:51 - MIC Value :>=^32.0
2025-03-23 15:47:51 - antiBiotic :VA
2025-03-23 15:47:51 - antiBiotic :Vancomycin
2025-03-23 15:47:51 - MIC Value :<=^1.0
2025-03-23 15:47:51 - antiBiotic :TE
2025-03-23 15:47:51 - antiBiotic :Tetracycline
2025-03-23 15:47:51 - MIC Value :=^0.25
2025-03-23 15:47:51 - antiBiotic :TGC
2025-03-23 15:47:51 - antiBiotic :Tigecycline
2025-03-23 15:47:51 - MIC Value :<=^16.0
2025-03-23 15:47:51 - antiBiotic :FT
2025-03-23 15:47:51 - antiBiotic :Nitrofurantoin
2025-03-23 15:47:51 - MIC Value :<=^0.03
2025-03-23 15:47:51 - antiBiotic :RA
2025-03-23 15:47:51 - antiBiotic :Rifampicin
2025-03-23 15:47:51 - MIC Value :<=^10.0
2025-03-23 15:47:51 - antiBiotic :SXT
2025-03-23 15:47:51 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-23 15:48:47 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|URIN^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-23 15:48:47 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250323154847+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-23 15:48:47 - SAMPLE NO :250322MIC00001
2025-03-23 15:48:47 - SAMPLLE TypeURIN
2025-03-23 15:48:47 - Organism type :Staphylococcus aureus
2025-03-23 15:48:47 - MIC Value :>=^0.5
2025-03-23 15:48:47 - antiBiotic :P
2025-03-23 15:48:47 - antiBiotic :Benzylpenicillin
2025-03-23 15:48:47 - MIC Value :>=^4.0
2025-03-23 15:48:47 - antiBiotic :OX1
2025-03-23 15:48:47 - antiBiotic :Oxacillin
2025-03-23 15:48:47 - MIC Value :<=^0.5
2025-03-23 15:48:47 - antiBiotic :GM
2025-03-23 15:48:47 - antiBiotic :Gentamicin
2025-03-23 15:48:47 - MIC Value :=^1.0
2025-03-23 15:48:47 - antiBiotic :CIP
2025-03-23 15:48:47 - antiBiotic :Ciprofloxacin
2025-03-23 15:48:47 - MIC Value :=^2.0
2025-03-23 15:48:47 - antiBiotic :LEV
2025-03-23 15:48:47 - antiBiotic :Levofloxacin
2025-03-23 15:48:47 - MIC Value :=^0.5
2025-03-23 15:48:47 - antiBiotic :E
2025-03-23 15:48:47 - antiBiotic :Erythromycin
2025-03-23 15:48:47 - MIC Value :>=^4.0
2025-03-23 15:48:47 - antiBiotic :CM
2025-03-23 15:48:47 - antiBiotic :Clindamycin
2025-03-23 15:48:47 - MIC Value :>=^8.0
2025-03-23 15:48:47 - antiBiotic :LNZ
2025-03-23 15:48:47 - antiBiotic :Linezolid
2025-03-23 15:48:47 - MIC Value :=^1.0
2025-03-23 15:48:47 - antiBiotic :DAP
2025-03-23 15:48:47 - antiBiotic :Daptomycin
2025-03-23 15:48:47 - MIC Value :=^4.0
2025-03-23 15:48:47 - antiBiotic :TEC
2025-03-23 15:48:47 - antiBiotic :Teicoplanin
2025-03-23 15:48:47 - MIC Value :>=^32.0
2025-03-23 15:48:47 - antiBiotic :VA
2025-03-23 15:48:47 - antiBiotic :Vancomycin
2025-03-23 15:48:47 - MIC Value :<=^1.0
2025-03-23 15:48:47 - antiBiotic :TE
2025-03-23 15:48:47 - antiBiotic :Tetracycline
2025-03-23 15:48:47 - MIC Value :=^0.25
2025-03-23 15:48:47 - antiBiotic :TGC
2025-03-23 15:48:47 - antiBiotic :Tigecycline
2025-03-23 15:48:47 - MIC Value :<=^16.0
2025-03-23 15:48:47 - antiBiotic :FT
2025-03-23 15:48:47 - antiBiotic :Nitrofurantoin
2025-03-23 15:48:47 - MIC Value :<=^0.03
2025-03-23 15:48:47 - antiBiotic :RA
2025-03-23 15:48:47 - antiBiotic :Rifampicin
2025-03-23 15:48:47 - MIC Value :<=^10.0
2025-03-23 15:48:47 - antiBiotic :SXT
2025-03-23 15:48:47 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-23 15:50:08 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|Blood^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-23 15:50:08 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250323155008+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-23 15:50:08 - SAMPLE NO :250322MIC00001
2025-03-23 15:50:08 - SAMPLLE TypeBlood
2025-03-23 15:50:08 - Organism type :Staphylococcus aureus
2025-03-23 15:50:08 - MIC Value :>=^0.5
2025-03-23 15:50:08 - antiBiotic :P
2025-03-23 15:50:08 - antiBiotic :Benzylpenicillin
2025-03-23 15:50:08 - MIC Value :>=^4.0
2025-03-23 15:50:08 - antiBiotic :OX1
2025-03-23 15:50:08 - antiBiotic :Oxacillin
2025-03-23 15:50:08 - MIC Value :<=^0.5
2025-03-23 15:50:08 - antiBiotic :GM
2025-03-23 15:50:08 - antiBiotic :Gentamicin
2025-03-23 15:50:08 - MIC Value :=^1.0
2025-03-23 15:50:08 - antiBiotic :CIP
2025-03-23 15:50:08 - antiBiotic :Ciprofloxacin
2025-03-23 15:50:08 - MIC Value :=^2.0
2025-03-23 15:50:08 - antiBiotic :LEV
2025-03-23 15:50:08 - antiBiotic :Levofloxacin
2025-03-23 15:50:08 - MIC Value :=^0.5
2025-03-23 15:50:08 - antiBiotic :E
2025-03-23 15:50:08 - antiBiotic :Erythromycin
2025-03-23 15:50:08 - MIC Value :>=^4.0
2025-03-23 15:50:08 - antiBiotic :CM
2025-03-23 15:50:08 - antiBiotic :Clindamycin
2025-03-23 15:50:08 - MIC Value :>=^8.0
2025-03-23 15:50:08 - antiBiotic :LNZ
2025-03-23 15:50:08 - antiBiotic :Linezolid
2025-03-23 15:50:08 - MIC Value :=^1.0
2025-03-23 15:50:08 - antiBiotic :DAP
2025-03-23 15:50:08 - antiBiotic :Daptomycin
2025-03-23 15:50:08 - MIC Value :=^4.0
2025-03-23 15:50:08 - antiBiotic :TEC
2025-03-23 15:50:08 - antiBiotic :Teicoplanin
2025-03-23 15:50:08 - MIC Value :>=^32.0
2025-03-23 15:50:08 - antiBiotic :VA
2025-03-23 15:50:08 - antiBiotic :Vancomycin
2025-03-23 15:50:08 - MIC Value :<=^1.0
2025-03-23 15:50:08 - antiBiotic :TE
2025-03-23 15:50:08 - antiBiotic :Tetracycline
2025-03-23 15:50:08 - MIC Value :=^0.25
2025-03-23 15:50:08 - antiBiotic :TGC
2025-03-23 15:50:08 - antiBiotic :Tigecycline
2025-03-23 15:50:08 - MIC Value :<=^16.0
2025-03-23 15:50:08 - antiBiotic :FT
2025-03-23 15:50:08 - antiBiotic :Nitrofurantoin
2025-03-23 15:50:08 - MIC Value :<=^0.03
2025-03-23 15:50:08 - antiBiotic :RA
2025-03-23 15:50:08 - antiBiotic :Rifampicin
2025-03-23 15:50:08 - MIC Value :<=^10.0
2025-03-23 15:50:08 - antiBiotic :SXT
2025-03-23 15:50:08 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-23 15:52:06 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|Blood^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-23 15:52:06 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250323155206+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-23 15:52:06 - SAMPLE NO :250322MIC00001
2025-03-23 15:52:06 - SAMPLLE TypeBlood
2025-03-23 15:52:06 - Organism type :Staphylococcus aureus
2025-03-23 15:52:06 - MIC Value :>=^0.5
2025-03-23 15:52:06 - antiBiotic :P
2025-03-23 15:52:06 - antiBiotic :Benzylpenicillin
2025-03-23 15:52:06 - MIC Value :>=^4.0
2025-03-23 15:52:06 - antiBiotic :OX1
2025-03-23 15:52:06 - antiBiotic :Oxacillin
2025-03-23 15:52:06 - MIC Value :<=^0.5
2025-03-23 15:52:06 - antiBiotic :GM
2025-03-23 15:52:06 - antiBiotic :Gentamicin
2025-03-23 15:52:06 - MIC Value :=^1.0
2025-03-23 15:52:06 - antiBiotic :CIP
2025-03-23 15:52:06 - antiBiotic :Ciprofloxacin
2025-03-23 15:52:06 - MIC Value :=^2.0
2025-03-23 15:52:06 - antiBiotic :LEV
2025-03-23 15:52:06 - antiBiotic :Levofloxacin
2025-03-23 15:52:06 - MIC Value :=^0.5
2025-03-23 15:52:06 - antiBiotic :E
2025-03-23 15:52:06 - antiBiotic :Erythromycin
2025-03-23 15:52:06 - MIC Value :>=^4.0
2025-03-23 15:52:06 - antiBiotic :CM
2025-03-23 15:52:06 - antiBiotic :Clindamycin
2025-03-23 15:52:06 - MIC Value :>=^8.0
2025-03-23 15:52:06 - antiBiotic :LNZ
2025-03-23 15:52:06 - antiBiotic :Linezolid
2025-03-23 15:52:06 - MIC Value :=^1.0
2025-03-23 15:52:06 - antiBiotic :DAP
2025-03-23 15:52:06 - antiBiotic :Daptomycin
2025-03-23 15:52:06 - MIC Value :=^4.0
2025-03-23 15:52:06 - antiBiotic :TEC
2025-03-23 15:52:06 - antiBiotic :Teicoplanin
2025-03-23 15:52:06 - MIC Value :>=^32.0
2025-03-23 15:52:06 - antiBiotic :VA
2025-03-23 15:52:06 - antiBiotic :Vancomycin
2025-03-23 15:52:06 - MIC Value :<=^1.0
2025-03-23 15:52:06 - antiBiotic :TE
2025-03-23 15:52:06 - antiBiotic :Tetracycline
2025-03-23 15:52:06 - MIC Value :=^0.25
2025-03-23 15:52:06 - antiBiotic :TGC
2025-03-23 15:52:06 - antiBiotic :Tigecycline
2025-03-23 15:52:06 - MIC Value :<=^16.0
2025-03-23 15:52:06 - antiBiotic :FT
2025-03-23 15:52:06 - antiBiotic :Nitrofurantoin
2025-03-23 15:52:06 - MIC Value :<=^0.03
2025-03-23 15:52:06 - antiBiotic :RA
2025-03-23 15:52:06 - antiBiotic :Rifampicin
2025-03-23 15:52:06 - MIC Value :<=^10.0
2025-03-23 15:52:06 - antiBiotic :SXT
2025-03-23 15:52:06 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-23 15:59:03 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|Blood^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-23 15:59:03 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250323155903+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-23 15:59:03 - SAMPLE NO :250322MIC00001
2025-03-23 15:59:03 - SAMPLLE TypeBlood
2025-03-23 15:59:03 - Organism type :Staphylococcus aureus
2025-03-23 15:59:03 - MIC Value :>=^0.5
2025-03-23 15:59:03 - antiBiotic :P
2025-03-23 15:59:03 - antiBiotic :Benzylpenicillin
2025-03-23 15:59:03 - MIC Value :>=^4.0
2025-03-23 15:59:03 - antiBiotic :OX1
2025-03-23 15:59:03 - antiBiotic :Oxacillin
2025-03-23 15:59:03 - MIC Value :<=^0.5
2025-03-23 15:59:03 - antiBiotic :GM
2025-03-23 15:59:03 - antiBiotic :Gentamicin
2025-03-23 15:59:03 - MIC Value :=^1.0
2025-03-23 15:59:03 - antiBiotic :CIP
2025-03-23 15:59:03 - antiBiotic :Ciprofloxacin
2025-03-23 15:59:03 - MIC Value :=^2.0
2025-03-23 15:59:03 - antiBiotic :LEV
2025-03-23 15:59:03 - antiBiotic :Levofloxacin
2025-03-23 15:59:03 - MIC Value :=^0.5
2025-03-23 15:59:03 - antiBiotic :E
2025-03-23 15:59:03 - antiBiotic :Erythromycin
2025-03-23 15:59:03 - MIC Value :>=^4.0
2025-03-23 15:59:03 - antiBiotic :CM
2025-03-23 15:59:03 - antiBiotic :Clindamycin
2025-03-23 15:59:03 - MIC Value :>=^8.0
2025-03-23 15:59:03 - antiBiotic :LNZ
2025-03-23 15:59:03 - antiBiotic :Linezolid
2025-03-23 15:59:03 - MIC Value :=^1.0
2025-03-23 15:59:03 - antiBiotic :DAP
2025-03-23 15:59:03 - antiBiotic :Daptomycin
2025-03-23 15:59:03 - MIC Value :=^4.0
2025-03-23 15:59:03 - antiBiotic :TEC
2025-03-23 15:59:03 - antiBiotic :Teicoplanin
2025-03-23 15:59:03 - MIC Value :>=^32.0
2025-03-23 15:59:03 - antiBiotic :VA
2025-03-23 15:59:03 - antiBiotic :Vancomycin
2025-03-23 15:59:03 - MIC Value :<=^1.0
2025-03-23 15:59:03 - antiBiotic :TE
2025-03-23 15:59:03 - antiBiotic :Tetracycline
2025-03-23 15:59:03 - MIC Value :=^0.25
2025-03-23 15:59:03 - antiBiotic :TGC
2025-03-23 15:59:03 - antiBiotic :Tigecycline
2025-03-23 15:59:03 - MIC Value :<=^16.0
2025-03-23 15:59:03 - antiBiotic :FT
2025-03-23 15:59:03 - antiBiotic :Nitrofurantoin
2025-03-23 15:59:03 - MIC Value :<=^0.03
2025-03-23 15:59:03 - antiBiotic :RA
2025-03-23 15:59:03 - antiBiotic :Rifampicin
2025-03-23 15:59:03 - MIC Value :<=^10.0
2025-03-23 15:59:03 - antiBiotic :SXT
2025-03-23 15:59:03 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-24 10:01:37 - Data sends to Mestria is started  for sample no ::  250322MIC00001
2025-03-24 10:01:38 - Response from API: [{"patFirstName":"Test Usr One    ","patType":"Special","patLastName":null,"patMiddleName":"-","patGender":"M","patientBirthDate":"-","patCrno":"939152100000382","patSampleNo":"250322MIC00001","patSampleType":"1002","patSampleCollectionDate":"2025-03-22","hisOrderId":"250322MIC000006","reqDno":"939151002225032210000201"}]
2025-03-24 10:01:38 - Save Patient Details API called for PACS 
2025-03-24 10:01:38 - Update Status API called
2025-03-24 10:01:38 - Response Body:  Status Updated
2025-03-24 10:01:38 - Data sends to Mestria is started ::  
2025-03-24 10:01:38 - Query  : SELECT hrgstr_fname,hrgstr_mname, hrgstr_lname, patient_gender, hrgnum_puk,hivnum_sample_no,hivnum_sample_type,  pat_sample_collection_date FROM  patient_org_test_details WHERE org_test_status = 0 and hivnum_sample_no=?
2025-03-24 10:01:38 - Query  : SELECT hrgstr_fname,hrgstr_mname, hrgstr_lname, patient_gender, hrgnum_puk,hivnum_sample_no,hivnum_sample_type,  pat_sample_collection_date FROM  patient_org_test_details WHERE org_test_status = 0
2025-03-24 10:01:38 - HL 7 :  MSH|^~\&|LIS|LAB|myla|BMX|20250324100138||OML^O33^OML_O33|MSG-20241007-101200-0377|P|2.5.1|||NE|AL||UNICODE UTF-8 PID|||939152100000382||Test Usr One    ^.^^^^^nill|CDAC TEST2|19681025|M|||nill^^nill^^nill^nill|||||S|PV1||E|GW-NEW CUBICAL WARD-J^8-FCGW-J-29^^ AIIMS^^^^^8-FCGW-J-29^||||^||||||||||||250322MIC00001SPM|1|250322MIC00001||BC^Blood Culture^99BMx|||^^|^^|||P^Patient^||||||20250324100138|SAC||||24008676 ORC|NW||||||||20250324100138TQ1|||||||||R^^OBR|1|714647||SU^SU^99BMx||||||^^||||||^|123456780
2025-03-24 10:01:40 - Error: Error connecting to server: Connection refused: connect
2025-03-24 10:01:40 - Stack Trace: java.lang.Exception: Error connecting to server: Connection refused: connect
	at Server.ServerConnector.sendToServer(ServerConnector.java:51)
	at Server.AIIMSLAB$6.doInBackground(AIIMSLAB.java:1834)
	at Server.AIIMSLAB$6.doInBackground(AIIMSLAB.java:1)
	at javax.swing.SwingWorker$1.call(SwingWorker.java:295)
	at java.util.concurrent.FutureTask.run(FutureTask.java:266)
	at javax.swing.SwingWorker.run(SwingWorker.java:334)
	at java.util.concurrent.ThreadPoolExecutor.runWorker(ThreadPoolExecutor.java:1149)
	at java.util.concurrent.ThreadPoolExecutor$Worker.run(ThreadPoolExecutor.java:624)
	at java.lang.Thread.run(Thread.java:750)

2025-03-24 10:10:34 - Data sends to Mestria is started  for sample no ::  250322MIC00001
2025-03-24 10:10:34 - Response from API: [{"patFirstName":"Test Usr One    ","patType":"Special","patAge":"62 Yr             ","patLastName":null,"patMiddleName":"-","patGender":"M","patientBirthDate":"-","patCrno":"939152100000382","patSampleNo":"250322MIC00001","patSampleType":"1002","patSampleCollectionDate":"2025-03-22","hisOrderId":"250322MIC000006","reqDno":"939151002225032210000201"}]
2025-03-24 10:10:34 - Save Patient Details API called for PACS 
2025-03-24 10:10:34 - Query  : SELECT hrgstr_fname,hrgstr_mname, hrgstr_lname, patient_gender, hrgnum_puk,hivnum_sample_no,hivnum_sample_type,  pat_sample_collection_date FROM  patient_org_test_details WHERE org_test_status = 0 and hivnum_sample_no=?
2025-03-24 10:11:26 - Data sends to Mestria is started  for sample no ::  250322MIC00001
2025-03-24 10:11:26 - Response from API: [{"patFirstName":"Test Usr One    ","patType":"Special","patAge":"62 Yr             ","patLastName":null,"patMiddleName":"-","patGender":"M","patientBirthDate":"-","patCrno":"939152100000382","patSampleNo":"250322MIC00001","patSampleType":"1002","patSampleCollectionDate":"2025-03-22","hisOrderId":"250322MIC000006","reqDno":"939151002225032210000201"}]
2025-03-24 10:11:26 - Save Patient Details API called for PACS 
2025-03-24 10:11:26 - Update Status API called
2025-03-24 10:11:26 - Response Body:  Status Updated
2025-03-24 10:11:26 - Data sends to Mestria is started ::  
2025-03-24 10:11:26 - Query  : SELECT hrgstr_fname,hrgstr_mname, hrgstr_lname, patient_gender, hrgnum_puk,hivnum_sample_no,hivnum_sample_type,  pat_sample_collection_date FROM  patient_org_test_details WHERE org_test_status = 0
2025-03-24 10:11:26 - Query  : SELECT hrgstr_fname,hrgstr_mname, hrgstr_lname, patient_gender, hrgnum_puk,hivnum_sample_no,hivnum_sample_type,  pat_sample_collection_date FROM  patient_org_test_details WHERE org_test_status = 0 and hivnum_sample_no=?
2025-03-24 10:11:26 - HL 7 :  MSH|^~\&|LIS|LAB|myla|BMX|20250324101126||OML^O33^OML_O33|MSG-20241007-101200-0377|P|2.5.1|||NE|AL||UNICODE UTF-8 PID|||939152100000382||Test Usr One    ^.^^^^^nill|CDAC TEST2|19681025|M|||nill^^nill^^nill^nill|||||S|PV1||E|GW-NEW CUBICAL WARD-J^8-FCGW-J-29^^ AIIMS^^^^^8-FCGW-J-29^||||^||||||||||||250322MIC00001SPM|1|250322MIC00001||BC^Blood Culture^99BMx|||^^|^^|||P^Patient^||||||20250324101126|SAC||||24008676 ORC|NW||||||||20250324101126TQ1|||||||||R^^OBR|1|714647||SU^SU^99BMx||||||^^||||||^|123456780
2025-03-24 10:11:28 - Error: Error connecting to server: Connection refused: connect
2025-03-24 10:11:28 - Stack Trace: java.lang.Exception: Error connecting to server: Connection refused: connect
	at Server.ServerConnector.sendToServer(ServerConnector.java:51)
	at Server.AIIMSLAB$6.doInBackground(AIIMSLAB.java:1834)
	at Server.AIIMSLAB$6.doInBackground(AIIMSLAB.java:1)
	at javax.swing.SwingWorker$1.call(SwingWorker.java:295)
	at java.util.concurrent.FutureTask.run(FutureTask.java:266)
	at javax.swing.SwingWorker.run(SwingWorker.java:334)
	at java.util.concurrent.ThreadPoolExecutor.runWorker(ThreadPoolExecutor.java:1149)
	at java.util.concurrent.ThreadPoolExecutor$Worker.run(ThreadPoolExecutor.java:624)
	at java.lang.Thread.run(Thread.java:750)

2025-03-24 10:12:30 - Data sends to Mestria is started  for sample no ::  250322MIC00001
2025-03-24 10:12:30 - Response from API: [{"patFirstName":"Test Usr One    ","patType":"Special","patAge":"62 Yr             ","patLastName":null,"patMiddleName":"-","patGender":"M","patientBirthDate":"-","patCrno":"939152100000382","patSampleNo":"250322MIC00001","patSampleType":"1002","patSampleCollectionDate":"2025-03-22","hisOrderId":"250322MIC000006","reqDno":"939151002225032210000201"}]
2025-03-24 10:12:30 - Save Patient Details API called for PACS 
2025-03-24 10:12:30 - Update Status API called
2025-03-24 10:12:30 - Response Body:  Status Updated
2025-03-24 10:12:30 - Data sends to Mestria is started ::  
2025-03-24 10:12:30 - Query  : SELECT hrgstr_fname,hrgstr_mname, hrgstr_lname, patient_gender, hrgnum_puk,hivnum_sample_no,hivnum_sample_type,  pat_sample_collection_date FROM  patient_org_test_details WHERE org_test_status = 0
2025-03-24 10:12:30 - Query  : SELECT hrgstr_fname,hrgstr_mname, hrgstr_lname, patient_gender, hrgnum_puk,hivnum_sample_no,hivnum_sample_type,  pat_sample_collection_date FROM  patient_org_test_details WHERE org_test_status = 0 and hivnum_sample_no=?
2025-03-24 10:12:30 - HL 7 :  MSH|^~\&|LIS|LAB|myla|BMX|20250324101230||OML^O33^OML_O33|MSG-20241007-101200-0377|P|2.5.1|||NE|AL||UNICODE UTF-8 PID|||939152100000382||Test Usr One    ^.^^^^^nill|CDAC TEST2|19681025|M|||nill^^nill^^nill^nill|||||S|PV1||E|GW-NEW CUBICAL WARD-J^8-FCGW-J-29^^ AIIMS^^^^^8-FCGW-J-29^||||^||||||||||||250322MIC00001SPM|1|250322MIC00001||BC^Blood Culture^99BMx|||^^|^^|||P^Patient^||||||20250324101230|SAC||||24008676 ORC|NW||||||||20250324101230TQ1|||||||||R^^OBR|1|714647||SU^SU^99BMx||||||^^||||||^|123456780
2025-03-24 10:12:32 - Error: Error connecting to server: Connection refused: connect
2025-03-24 10:12:32 - Stack Trace: java.lang.Exception: Error connecting to server: Connection refused: connect
	at Server.ServerConnector.sendToServer(ServerConnector.java:51)
	at Server.AIIMSLAB$6.doInBackground(AIIMSLAB.java:1834)
	at Server.AIIMSLAB$6.doInBackground(AIIMSLAB.java:1)
	at javax.swing.SwingWorker$1.call(SwingWorker.java:295)
	at java.util.concurrent.FutureTask.run(FutureTask.java:266)
	at javax.swing.SwingWorker.run(SwingWorker.java:334)
	at java.util.concurrent.ThreadPoolExecutor.runWorker(ThreadPoolExecutor.java:1149)
	at java.util.concurrent.ThreadPoolExecutor$Worker.run(ThreadPoolExecutor.java:624)
	at java.lang.Thread.run(Thread.java:750)

2025-03-24 10:13:25 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|Blood^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-24 10:13:25 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250324101325+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-24 10:13:25 - SAMPLE NO :250322MIC00001
2025-03-24 10:13:25 - SAMPLLE TypeBlood
2025-03-24 10:13:25 - Organism type :Staphylococcus aureus
2025-03-24 10:13:25 - MIC Value :>=^0.5
2025-03-24 10:13:25 - antiBiotic :P
2025-03-24 10:13:25 - antiBiotic :Benzylpenicillin
2025-03-24 10:13:25 - MIC Value :>=^4.0
2025-03-24 10:13:25 - antiBiotic :OX1
2025-03-24 10:13:25 - antiBiotic :Oxacillin
2025-03-24 10:13:25 - MIC Value :<=^0.5
2025-03-24 10:13:25 - antiBiotic :GM
2025-03-24 10:13:25 - antiBiotic :Gentamicin
2025-03-24 10:13:25 - MIC Value :=^1.0
2025-03-24 10:13:25 - antiBiotic :CIP
2025-03-24 10:13:25 - antiBiotic :Ciprofloxacin
2025-03-24 10:13:25 - MIC Value :=^2.0
2025-03-24 10:13:25 - antiBiotic :LEV
2025-03-24 10:13:25 - antiBiotic :Levofloxacin
2025-03-24 10:13:25 - MIC Value :=^0.5
2025-03-24 10:13:25 - antiBiotic :E
2025-03-24 10:13:25 - antiBiotic :Erythromycin
2025-03-24 10:13:25 - MIC Value :>=^4.0
2025-03-24 10:13:25 - antiBiotic :CM
2025-03-24 10:13:25 - antiBiotic :Clindamycin
2025-03-24 10:13:25 - MIC Value :>=^8.0
2025-03-24 10:13:25 - antiBiotic :LNZ
2025-03-24 10:13:25 - antiBiotic :Linezolid
2025-03-24 10:13:25 - MIC Value :=^1.0
2025-03-24 10:13:25 - antiBiotic :DAP
2025-03-24 10:13:25 - antiBiotic :Daptomycin
2025-03-24 10:13:25 - MIC Value :=^4.0
2025-03-24 10:13:25 - antiBiotic :TEC
2025-03-24 10:13:25 - antiBiotic :Teicoplanin
2025-03-24 10:13:25 - MIC Value :>=^32.0
2025-03-24 10:13:25 - antiBiotic :VA
2025-03-24 10:13:25 - antiBiotic :Vancomycin
2025-03-24 10:13:25 - MIC Value :<=^1.0
2025-03-24 10:13:25 - antiBiotic :TE
2025-03-24 10:13:25 - antiBiotic :Tetracycline
2025-03-24 10:13:25 - MIC Value :=^0.25
2025-03-24 10:13:25 - antiBiotic :TGC
2025-03-24 10:13:25 - antiBiotic :Tigecycline
2025-03-24 10:13:25 - MIC Value :<=^16.0
2025-03-24 10:13:25 - antiBiotic :FT
2025-03-24 10:13:25 - antiBiotic :Nitrofurantoin
2025-03-24 10:13:25 - MIC Value :<=^0.03
2025-03-24 10:13:25 - antiBiotic :RA
2025-03-24 10:13:25 - antiBiotic :Rifampicin
2025-03-24 10:13:25 - MIC Value :<=^10.0
2025-03-24 10:13:25 - antiBiotic :SXT
2025-03-24 10:13:25 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-24 10:15:07 - Start PACS HL7 Result parsing : 
2025-03-24 10:15:08 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|Blood^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-24 10:15:08 - Sent ACK response: MSH|^~\&|HIS_APP|HIS_FACILITY|PACS_APP|PACS_FACILITY|20250324101508+0530||ACK^O01|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.3MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|Result Recived
2025-03-24 10:15:08 - CR NO. :  250322MIC00001
2025-03-24 10:15:20 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|Blood^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-24 10:15:20 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250324101520+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-24 10:15:20 - SAMPLE NO :250322MIC00001
2025-03-24 10:15:20 - SAMPLLE TypeBlood
2025-03-24 10:15:20 - Organism type :Staphylococcus aureus
2025-03-24 10:15:20 - MIC Value :>=^0.5
2025-03-24 10:15:20 - antiBiotic :P
2025-03-24 10:15:20 - antiBiotic :Benzylpenicillin
2025-03-24 10:15:20 - MIC Value :>=^4.0
2025-03-24 10:15:20 - antiBiotic :OX1
2025-03-24 10:15:20 - antiBiotic :Oxacillin
2025-03-24 10:15:20 - MIC Value :<=^0.5
2025-03-24 10:15:20 - antiBiotic :GM
2025-03-24 10:15:20 - antiBiotic :Gentamicin
2025-03-24 10:15:20 - MIC Value :=^1.0
2025-03-24 10:15:20 - antiBiotic :CIP
2025-03-24 10:15:20 - antiBiotic :Ciprofloxacin
2025-03-24 10:15:20 - MIC Value :=^2.0
2025-03-24 10:15:20 - antiBiotic :LEV
2025-03-24 10:15:20 - antiBiotic :Levofloxacin
2025-03-24 10:15:20 - MIC Value :=^0.5
2025-03-24 10:15:20 - antiBiotic :E
2025-03-24 10:15:20 - antiBiotic :Erythromycin
2025-03-24 10:15:20 - MIC Value :>=^4.0
2025-03-24 10:15:20 - antiBiotic :CM
2025-03-24 10:15:20 - antiBiotic :Clindamycin
2025-03-24 10:15:20 - MIC Value :>=^8.0
2025-03-24 10:15:20 - antiBiotic :LNZ
2025-03-24 10:15:20 - antiBiotic :Linezolid
2025-03-24 10:15:20 - MIC Value :=^1.0
2025-03-24 10:15:20 - antiBiotic :DAP
2025-03-24 10:15:20 - antiBiotic :Daptomycin
2025-03-24 10:15:20 - MIC Value :=^4.0
2025-03-24 10:15:20 - antiBiotic :TEC
2025-03-24 10:15:20 - antiBiotic :Teicoplanin
2025-03-24 10:15:20 - MIC Value :>=^32.0
2025-03-24 10:15:20 - antiBiotic :VA
2025-03-24 10:15:20 - antiBiotic :Vancomycin
2025-03-24 10:15:20 - MIC Value :<=^1.0
2025-03-24 10:15:20 - antiBiotic :TE
2025-03-24 10:15:20 - antiBiotic :Tetracycline
2025-03-24 10:15:20 - MIC Value :=^0.25
2025-03-24 10:15:20 - antiBiotic :TGC
2025-03-24 10:15:20 - antiBiotic :Tigecycline
2025-03-24 10:15:20 - MIC Value :<=^16.0
2025-03-24 10:15:20 - antiBiotic :FT
2025-03-24 10:15:20 - antiBiotic :Nitrofurantoin
2025-03-24 10:15:20 - MIC Value :<=^0.03
2025-03-24 10:15:20 - antiBiotic :RA
2025-03-24 10:15:20 - antiBiotic :Rifampicin
2025-03-24 10:15:20 - MIC Value :<=^10.0
2025-03-24 10:15:20 - antiBiotic :SXT
2025-03-24 10:15:20 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-24 10:16:28 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|Blood^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-24 10:16:28 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250324101628+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-24 10:16:28 - SAMPLE NO :250322MIC00001
2025-03-24 10:16:28 - SAMPLLE TypeBlood
2025-03-24 10:16:28 - Organism type :Staphylococcus aureus
2025-03-24 10:16:28 - MIC Value :>=^0.5
2025-03-24 10:16:28 - antiBiotic :P
2025-03-24 10:16:28 - antiBiotic :Benzylpenicillin
2025-03-24 10:16:28 - MIC Value :>=^4.0
2025-03-24 10:16:28 - antiBiotic :OX1
2025-03-24 10:16:28 - antiBiotic :Oxacillin
2025-03-24 10:16:28 - MIC Value :<=^0.5
2025-03-24 10:16:28 - antiBiotic :GM
2025-03-24 10:16:28 - antiBiotic :Gentamicin
2025-03-24 10:16:28 - MIC Value :=^1.0
2025-03-24 10:16:28 - antiBiotic :CIP
2025-03-24 10:16:28 - antiBiotic :Ciprofloxacin
2025-03-24 10:16:28 - MIC Value :=^2.0
2025-03-24 10:16:28 - antiBiotic :LEV
2025-03-24 10:16:28 - antiBiotic :Levofloxacin
2025-03-24 10:16:28 - MIC Value :=^0.5
2025-03-24 10:16:28 - antiBiotic :E
2025-03-24 10:16:28 - antiBiotic :Erythromycin
2025-03-24 10:16:28 - MIC Value :>=^4.0
2025-03-24 10:16:28 - antiBiotic :CM
2025-03-24 10:16:28 - antiBiotic :Clindamycin
2025-03-24 10:16:28 - MIC Value :>=^8.0
2025-03-24 10:16:28 - antiBiotic :LNZ
2025-03-24 10:16:28 - antiBiotic :Linezolid
2025-03-24 10:16:28 - MIC Value :=^1.0
2025-03-24 10:16:28 - antiBiotic :DAP
2025-03-24 10:16:28 - antiBiotic :Daptomycin
2025-03-24 10:16:28 - MIC Value :=^4.0
2025-03-24 10:16:28 - antiBiotic :TEC
2025-03-24 10:16:28 - antiBiotic :Teicoplanin
2025-03-24 10:16:28 - MIC Value :>=^32.0
2025-03-24 10:16:28 - antiBiotic :VA
2025-03-24 10:16:28 - antiBiotic :Vancomycin
2025-03-24 10:16:28 - MIC Value :<=^1.0
2025-03-24 10:16:28 - antiBiotic :TE
2025-03-24 10:16:28 - antiBiotic :Tetracycline
2025-03-24 10:16:28 - MIC Value :=^0.25
2025-03-24 10:16:28 - antiBiotic :TGC
2025-03-24 10:16:28 - antiBiotic :Tigecycline
2025-03-24 10:16:28 - MIC Value :<=^16.0
2025-03-24 10:16:28 - antiBiotic :FT
2025-03-24 10:16:28 - antiBiotic :Nitrofurantoin
2025-03-24 10:16:28 - MIC Value :<=^0.03
2025-03-24 10:16:28 - antiBiotic :RA
2025-03-24 10:16:28 - antiBiotic :Rifampicin
2025-03-24 10:16:28 - MIC Value :<=^10.0
2025-03-24 10:16:28 - antiBiotic :SXT
2025-03-24 10:16:28 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-24 10:17:18 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|Blood^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-24 10:17:18 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250324101718+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-24 10:17:18 - SAMPLE NO :250322MIC00001
2025-03-24 10:17:18 - SAMPLLE TypeBlood
2025-03-24 10:17:18 - Organism type :Staphylococcus aureus
2025-03-24 10:17:18 - MIC Value :>=^0.5
2025-03-24 10:17:18 - antiBiotic :P
2025-03-24 10:17:18 - antiBiotic :Benzylpenicillin
2025-03-24 10:17:18 - MIC Value :>=^4.0
2025-03-24 10:17:18 - antiBiotic :OX1
2025-03-24 10:17:18 - antiBiotic :Oxacillin
2025-03-24 10:17:18 - MIC Value :<=^0.5
2025-03-24 10:17:18 - antiBiotic :GM
2025-03-24 10:17:18 - antiBiotic :Gentamicin
2025-03-24 10:17:18 - MIC Value :=^1.0
2025-03-24 10:17:18 - antiBiotic :CIP
2025-03-24 10:17:18 - antiBiotic :Ciprofloxacin
2025-03-24 10:17:18 - MIC Value :=^2.0
2025-03-24 10:17:18 - antiBiotic :LEV
2025-03-24 10:17:18 - antiBiotic :Levofloxacin
2025-03-24 10:17:18 - MIC Value :=^0.5
2025-03-24 10:17:18 - antiBiotic :E
2025-03-24 10:17:18 - antiBiotic :Erythromycin
2025-03-24 10:17:18 - MIC Value :>=^4.0
2025-03-24 10:17:18 - antiBiotic :CM
2025-03-24 10:17:18 - antiBiotic :Clindamycin
2025-03-24 10:17:18 - MIC Value :>=^8.0
2025-03-24 10:17:18 - antiBiotic :LNZ
2025-03-24 10:17:18 - antiBiotic :Linezolid
2025-03-24 10:17:18 - MIC Value :=^1.0
2025-03-24 10:17:18 - antiBiotic :DAP
2025-03-24 10:17:18 - antiBiotic :Daptomycin
2025-03-24 10:17:18 - MIC Value :=^4.0
2025-03-24 10:17:18 - antiBiotic :TEC
2025-03-24 10:17:18 - antiBiotic :Teicoplanin
2025-03-24 10:17:18 - MIC Value :>=^32.0
2025-03-24 10:17:18 - antiBiotic :VA
2025-03-24 10:17:18 - antiBiotic :Vancomycin
2025-03-24 10:17:18 - MIC Value :<=^1.0
2025-03-24 10:17:18 - antiBiotic :TE
2025-03-24 10:17:18 - antiBiotic :Tetracycline
2025-03-24 10:17:18 - MIC Value :=^0.25
2025-03-24 10:17:18 - antiBiotic :TGC
2025-03-24 10:17:18 - antiBiotic :Tigecycline
2025-03-24 10:17:18 - MIC Value :<=^16.0
2025-03-24 10:17:18 - antiBiotic :FT
2025-03-24 10:17:18 - antiBiotic :Nitrofurantoin
2025-03-24 10:17:18 - MIC Value :<=^0.03
2025-03-24 10:17:18 - antiBiotic :RA
2025-03-24 10:17:18 - antiBiotic :Rifampicin
2025-03-24 10:17:18 - MIC Value :<=^10.0
2025-03-24 10:17:18 - antiBiotic :SXT
2025-03-24 10:17:18 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-24 10:19:37 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|Blood^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-24 10:19:37 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250324101937+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-24 10:19:37 - SAMPLE NO :250322MIC00001
2025-03-24 10:19:37 - SAMPLLE TypeBlood
2025-03-24 10:19:37 - Organism type :Staphylococcus aureus
2025-03-24 10:19:37 - MIC Value :>=^0.5
2025-03-24 10:19:37 - antiBiotic :P
2025-03-24 10:19:37 - antiBiotic :Benzylpenicillin
2025-03-24 10:19:37 - MIC Value :>=^4.0
2025-03-24 10:19:37 - antiBiotic :OX1
2025-03-24 10:19:37 - antiBiotic :Oxacillin
2025-03-24 10:19:37 - MIC Value :<=^0.5
2025-03-24 10:19:37 - antiBiotic :GM
2025-03-24 10:19:37 - antiBiotic :Gentamicin
2025-03-24 10:19:37 - MIC Value :=^1.0
2025-03-24 10:19:37 - antiBiotic :CIP
2025-03-24 10:19:37 - antiBiotic :Ciprofloxacin
2025-03-24 10:19:37 - MIC Value :=^2.0
2025-03-24 10:19:37 - antiBiotic :LEV
2025-03-24 10:19:37 - antiBiotic :Levofloxacin
2025-03-24 10:19:37 - MIC Value :=^0.5
2025-03-24 10:19:37 - antiBiotic :E
2025-03-24 10:19:37 - antiBiotic :Erythromycin
2025-03-24 10:19:37 - MIC Value :>=^4.0
2025-03-24 10:19:37 - antiBiotic :CM
2025-03-24 10:19:37 - antiBiotic :Clindamycin
2025-03-24 10:19:37 - MIC Value :>=^8.0
2025-03-24 10:19:37 - antiBiotic :LNZ
2025-03-24 10:19:37 - antiBiotic :Linezolid
2025-03-24 10:19:37 - MIC Value :=^1.0
2025-03-24 10:19:37 - antiBiotic :DAP
2025-03-24 10:19:37 - antiBiotic :Daptomycin
2025-03-24 10:19:37 - MIC Value :=^4.0
2025-03-24 10:19:37 - antiBiotic :TEC
2025-03-24 10:19:37 - antiBiotic :Teicoplanin
2025-03-24 10:19:37 - MIC Value :>=^32.0
2025-03-24 10:19:37 - antiBiotic :VA
2025-03-24 10:19:37 - antiBiotic :Vancomycin
2025-03-24 10:19:37 - MIC Value :<=^1.0
2025-03-24 10:19:37 - antiBiotic :TE
2025-03-24 10:19:37 - antiBiotic :Tetracycline
2025-03-24 10:19:37 - MIC Value :=^0.25
2025-03-24 10:19:37 - antiBiotic :TGC
2025-03-24 10:19:37 - antiBiotic :Tigecycline
2025-03-24 10:19:37 - MIC Value :<=^16.0
2025-03-24 10:19:37 - antiBiotic :FT
2025-03-24 10:19:37 - antiBiotic :Nitrofurantoin
2025-03-24 10:19:37 - MIC Value :<=^0.03
2025-03-24 10:19:37 - antiBiotic :RA
2025-03-24 10:19:37 - antiBiotic :Rifampicin
2025-03-24 10:19:37 - MIC Value :<=^10.0
2025-03-24 10:19:37 - antiBiotic :SXT
2025-03-24 10:19:37 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-24 10:32:50 - Data sends to Mestria is started  for sample no ::  250322MIC00001
2025-03-24 10:32:50 - API call failed. Response code: 500
2025-03-24 10:32:51 - Query  : SELECT hrgstr_fname,hrgstr_mname, hrgstr_lname, patient_gender, hrgnum_puk,hivnum_sample_no,hivnum_sample_type,  pat_sample_collection_date FROM  patient_org_test_details WHERE org_test_status = 0 and hivnum_sample_no=?
2025-03-24 10:33:41 - Data sends to Mestria is started  for sample no ::  250322MIC00001
2025-03-24 10:33:41 - Response from API: [{"patFirstName":"Test Usr One    ","patType":"Special","patAge":"62 Yr             ","testcode":"10193","depcode":"102","labcode":"null","patLastName":null,"patMiddleName":"-","patGender":"M","patientBirthDate":"-","patCrno":"939152100000382","patSampleNo":"250322MIC00001","patSampleType":"1002","patSampleCollectionDate":"2025-03-22","hisOrderId":"250322MIC000006","reqDno":"939151002225032210000201"}]
2025-03-24 10:33:41 - Save Patient Details API called for PACS 
2025-03-24 10:33:41 - Query  : SELECT hrgstr_fname,hrgstr_mname, hrgstr_lname, patient_gender, hrgnum_puk,hivnum_sample_no,hivnum_sample_type,  pat_sample_collection_date FROM  patient_org_test_details WHERE org_test_status = 0 and hivnum_sample_no=?
2025-03-24 10:35:39 - Data sends to Mestria is started  for sample no ::  250322MIC00001
2025-03-24 10:35:39 - Response from API: [{"patFirstName":"Test Usr One    ","patType":"Special","patAge":"62 Yr             ","testcode":"10193","depcode":"102","labcode":"10022","patLastName":null,"patMiddleName":"-","patGender":"M","patientBirthDate":"-","patCrno":"939152100000382","patSampleNo":"250322MIC00001","patSampleType":"1002","patSampleCollectionDate":"2025-03-22","hisOrderId":"250322MIC000006","reqDno":"939151002225032210000201"}]
2025-03-24 10:35:39 - Save Patient Details API called for PACS 
2025-03-24 10:35:39 - Query  : SELECT hrgstr_fname,hrgstr_mname, hrgstr_lname, patient_gender, hrgnum_puk,hivnum_sample_no,hivnum_sample_type,  pat_sample_collection_date FROM  patient_org_test_details WHERE org_test_status = 0 and hivnum_sample_no=?
2025-03-24 10:36:22 - Data sends to Mestria is started  for sample no ::  250322MIC00001
2025-03-24 10:36:22 - Response from API: [{"patFirstName":"Test Usr One    ","patType":"Special","patAge":"62 Yr             ","testcode":"10193","depcode":"102","labcode":"10022","patLastName":null,"patMiddleName":"-","patGender":"M","patientBirthDate":"-","patCrno":"939152100000382","patSampleNo":"250322MIC00001","patSampleType":"1002","patSampleCollectionDate":"2025-03-22","hisOrderId":"250322MIC000006","reqDno":"939151002225032210000201"}]
2025-03-24 10:36:22 - Save Patient Details API called for PACS 
2025-03-24 10:36:23 - Update Status API called
2025-03-24 10:36:23 - Response Body:  Status Updated
2025-03-24 10:36:23 - Data sends to Mestria is started ::  
2025-03-24 10:36:23 - Query  : SELECT hrgstr_fname,hrgstr_mname, hrgstr_lname, patient_gender, hrgnum_puk,hivnum_sample_no,hivnum_sample_type,  pat_sample_collection_date FROM  patient_org_test_details WHERE org_test_status = 0 and hivnum_sample_no=?
2025-03-24 10:36:23 - Query  : SELECT hrgstr_fname,hrgstr_mname, hrgstr_lname, patient_gender, hrgnum_puk,hivnum_sample_no,hivnum_sample_type,  pat_sample_collection_date FROM  patient_org_test_details WHERE org_test_status = 0
2025-03-24 10:36:23 - HL 7 :  MSH|^~\&|LIS|LAB|myla|BMX|20250324103623||OML^O33^OML_O33|MSG-20241007-101200-0377|P|2.5.1|||NE|AL||UNICODE UTF-8 PID|||939152100000382||Test Usr One    ^.^^^^^nill|CDAC TEST2|19681025|M|||nill^^nill^^nill^nill|||||S|PV1||E|GW-NEW CUBICAL WARD-J^8-FCGW-J-29^^ AIIMS^^^^^8-FCGW-J-29^||||^||||||||||||250322MIC00001SPM|1|250322MIC00001||BC^Blood Culture^99BMx|||^^|^^|||P^Patient^||||||20250324103623|SAC||||24008676 ORC|NW||||||||20250324103623TQ1|||||||||R^^OBR|1|714647||SU^SU^99BMx||||||^^||||||^|123456780
2025-03-24 10:36:25 - Error: Error connecting to server: Connection refused: connect
2025-03-24 10:36:25 - Stack Trace: java.lang.Exception: Error connecting to server: Connection refused: connect
	at Server.ServerConnector.sendToServer(ServerConnector.java:51)
	at Server.AIIMSLAB$6.doInBackground(AIIMSLAB.java:1838)
	at Server.AIIMSLAB$6.doInBackground(AIIMSLAB.java:1)
	at javax.swing.SwingWorker$1.call(SwingWorker.java:295)
	at java.util.concurrent.FutureTask.run(FutureTask.java:266)
	at javax.swing.SwingWorker.run(SwingWorker.java:334)
	at java.util.concurrent.ThreadPoolExecutor.runWorker(ThreadPoolExecutor.java:1149)
	at java.util.concurrent.ThreadPoolExecutor$Worker.run(ThreadPoolExecutor.java:624)
	at java.lang.Thread.run(Thread.java:750)

2025-03-24 10:40:34 - Data sends to Mestria is started  for sample no ::  250322MIC00001
2025-03-24 10:40:34 - Response from API: [{"patFirstName":"Test Usr One    ","patType":"Special","patAge":"62 Yr             ","testcode":"10193","depcode":"102","labcode":"10022","patLastName":null,"patMiddleName":"-","patGender":"M","patientBirthDate":"-","patCrno":"939152100000382","patSampleNo":"250322MIC00001","patSampleType":"1002","patSampleCollectionDate":"2025-03-22","hisOrderId":"250322MIC000006","reqDno":"939151002225032210000201"}]
2025-03-24 10:40:34 - Save Patient Details API called for PACS 
2025-03-24 10:40:34 - Query  : SELECT hrgstr_fname,hrgstr_mname, hrgstr_lname, patient_gender, hrgnum_puk,hivnum_sample_no,hivnum_sample_type,  pat_sample_collection_date FROM  patient_org_test_details WHERE org_test_status = 0 and hivnum_sample_no=?
2025-03-24 10:40:47 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|Blood^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-24 10:40:47 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250324104047+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-24 10:40:47 - SAMPLE NO :250322MIC00001
2025-03-24 10:40:47 - SAMPLLE TypeBlood
2025-03-24 10:40:47 - Organism type :Staphylococcus aureus
2025-03-24 10:40:47 - MIC Value :>=^0.5
2025-03-24 10:40:47 - antiBiotic :P
2025-03-24 10:40:47 - antiBiotic :Benzylpenicillin
2025-03-24 10:40:47 - MIC Value :>=^4.0
2025-03-24 10:40:47 - antiBiotic :OX1
2025-03-24 10:40:47 - antiBiotic :Oxacillin
2025-03-24 10:40:47 - MIC Value :<=^0.5
2025-03-24 10:40:47 - antiBiotic :GM
2025-03-24 10:40:47 - antiBiotic :Gentamicin
2025-03-24 10:40:47 - MIC Value :=^1.0
2025-03-24 10:40:47 - antiBiotic :CIP
2025-03-24 10:40:47 - antiBiotic :Ciprofloxacin
2025-03-24 10:40:47 - MIC Value :=^2.0
2025-03-24 10:40:47 - antiBiotic :LEV
2025-03-24 10:40:47 - antiBiotic :Levofloxacin
2025-03-24 10:40:47 - MIC Value :=^0.5
2025-03-24 10:40:47 - antiBiotic :E
2025-03-24 10:40:47 - antiBiotic :Erythromycin
2025-03-24 10:40:47 - MIC Value :>=^4.0
2025-03-24 10:40:47 - antiBiotic :CM
2025-03-24 10:40:47 - antiBiotic :Clindamycin
2025-03-24 10:40:47 - MIC Value :>=^8.0
2025-03-24 10:40:47 - antiBiotic :LNZ
2025-03-24 10:40:47 - antiBiotic :Linezolid
2025-03-24 10:40:47 - MIC Value :=^1.0
2025-03-24 10:40:47 - antiBiotic :DAP
2025-03-24 10:40:47 - antiBiotic :Daptomycin
2025-03-24 10:40:47 - MIC Value :=^4.0
2025-03-24 10:40:47 - antiBiotic :TEC
2025-03-24 10:40:47 - antiBiotic :Teicoplanin
2025-03-24 10:40:47 - MIC Value :>=^32.0
2025-03-24 10:40:47 - antiBiotic :VA
2025-03-24 10:40:47 - antiBiotic :Vancomycin
2025-03-24 10:40:47 - MIC Value :<=^1.0
2025-03-24 10:40:47 - antiBiotic :TE
2025-03-24 10:40:47 - antiBiotic :Tetracycline
2025-03-24 10:40:47 - MIC Value :=^0.25
2025-03-24 10:40:47 - antiBiotic :TGC
2025-03-24 10:40:47 - antiBiotic :Tigecycline
2025-03-24 10:40:47 - MIC Value :<=^16.0
2025-03-24 10:40:47 - antiBiotic :FT
2025-03-24 10:40:47 - antiBiotic :Nitrofurantoin
2025-03-24 10:40:47 - MIC Value :<=^0.03
2025-03-24 10:40:47 - antiBiotic :RA
2025-03-24 10:40:47 - antiBiotic :Rifampicin
2025-03-24 10:40:47 - MIC Value :<=^10.0
2025-03-24 10:40:47 - antiBiotic :SXT
2025-03-24 10:40:47 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-24 10:41:34 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|Blood^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-24 10:41:34 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250324104134+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-24 10:41:34 - SAMPLE NO :250322MIC00001
2025-03-24 10:41:34 - SAMPLLE TypeBlood
2025-03-24 10:41:34 - Organism type :Staphylococcus aureus
2025-03-24 10:41:34 - MIC Value :>=^0.5
2025-03-24 10:41:34 - antiBiotic :P
2025-03-24 10:41:34 - antiBiotic :Benzylpenicillin
2025-03-24 10:41:34 - MIC Value :>=^4.0
2025-03-24 10:41:34 - antiBiotic :OX1
2025-03-24 10:41:34 - antiBiotic :Oxacillin
2025-03-24 10:41:34 - MIC Value :<=^0.5
2025-03-24 10:41:34 - antiBiotic :GM
2025-03-24 10:41:34 - antiBiotic :Gentamicin
2025-03-24 10:41:34 - MIC Value :=^1.0
2025-03-24 10:41:34 - antiBiotic :CIP
2025-03-24 10:41:34 - antiBiotic :Ciprofloxacin
2025-03-24 10:41:34 - MIC Value :=^2.0
2025-03-24 10:41:34 - antiBiotic :LEV
2025-03-24 10:41:34 - antiBiotic :Levofloxacin
2025-03-24 10:41:34 - MIC Value :=^0.5
2025-03-24 10:41:34 - antiBiotic :E
2025-03-24 10:41:34 - antiBiotic :Erythromycin
2025-03-24 10:41:34 - MIC Value :>=^4.0
2025-03-24 10:41:34 - antiBiotic :CM
2025-03-24 10:41:34 - antiBiotic :Clindamycin
2025-03-24 10:41:34 - MIC Value :>=^8.0
2025-03-24 10:41:34 - antiBiotic :LNZ
2025-03-24 10:41:34 - antiBiotic :Linezolid
2025-03-24 10:41:34 - MIC Value :=^1.0
2025-03-24 10:41:34 - antiBiotic :DAP
2025-03-24 10:41:34 - antiBiotic :Daptomycin
2025-03-24 10:41:34 - MIC Value :=^4.0
2025-03-24 10:41:34 - antiBiotic :TEC
2025-03-24 10:41:34 - antiBiotic :Teicoplanin
2025-03-24 10:41:34 - MIC Value :>=^32.0
2025-03-24 10:41:34 - antiBiotic :VA
2025-03-24 10:41:34 - antiBiotic :Vancomycin
2025-03-24 10:41:34 - MIC Value :<=^1.0
2025-03-24 10:41:34 - antiBiotic :TE
2025-03-24 10:41:34 - antiBiotic :Tetracycline
2025-03-24 10:41:34 - MIC Value :=^0.25
2025-03-24 10:41:34 - antiBiotic :TGC
2025-03-24 10:41:34 - antiBiotic :Tigecycline
2025-03-24 10:41:34 - MIC Value :<=^16.0
2025-03-24 10:41:34 - antiBiotic :FT
2025-03-24 10:41:34 - antiBiotic :Nitrofurantoin
2025-03-24 10:41:34 - MIC Value :<=^0.03
2025-03-24 10:41:34 - antiBiotic :RA
2025-03-24 10:41:34 - antiBiotic :Rifampicin
2025-03-24 10:41:34 - MIC Value :<=^10.0
2025-03-24 10:41:34 - antiBiotic :SXT
2025-03-24 10:41:34 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-24 10:48:30 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|Blood^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-24 10:48:30 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250324104830+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-24 10:48:30 - SAMPLE NO :250322MIC00001
2025-03-24 10:48:30 - SAMPLLE TypeBlood
2025-03-24 10:48:30 - Organism type :Staphylococcus aureus
2025-03-24 10:48:30 - MIC Value :>=^0.5
2025-03-24 10:48:30 - antiBiotic :P
2025-03-24 10:48:30 - antiBiotic :Benzylpenicillin
2025-03-24 10:48:30 - MIC Value :>=^4.0
2025-03-24 10:48:30 - antiBiotic :OX1
2025-03-24 10:48:30 - antiBiotic :Oxacillin
2025-03-24 10:48:30 - MIC Value :<=^0.5
2025-03-24 10:48:30 - antiBiotic :GM
2025-03-24 10:48:30 - antiBiotic :Gentamicin
2025-03-24 10:48:30 - MIC Value :=^1.0
2025-03-24 10:48:30 - antiBiotic :CIP
2025-03-24 10:48:30 - antiBiotic :Ciprofloxacin
2025-03-24 10:48:30 - MIC Value :=^2.0
2025-03-24 10:48:30 - antiBiotic :LEV
2025-03-24 10:48:30 - antiBiotic :Levofloxacin
2025-03-24 10:48:30 - MIC Value :=^0.5
2025-03-24 10:48:30 - antiBiotic :E
2025-03-24 10:48:30 - antiBiotic :Erythromycin
2025-03-24 10:48:30 - MIC Value :>=^4.0
2025-03-24 10:48:30 - antiBiotic :CM
2025-03-24 10:48:30 - antiBiotic :Clindamycin
2025-03-24 10:48:30 - MIC Value :>=^8.0
2025-03-24 10:48:30 - antiBiotic :LNZ
2025-03-24 10:48:30 - antiBiotic :Linezolid
2025-03-24 10:48:30 - MIC Value :=^1.0
2025-03-24 10:48:30 - antiBiotic :DAP
2025-03-24 10:48:30 - antiBiotic :Daptomycin
2025-03-24 10:48:30 - MIC Value :=^4.0
2025-03-24 10:48:30 - antiBiotic :TEC
2025-03-24 10:48:30 - antiBiotic :Teicoplanin
2025-03-24 10:48:30 - MIC Value :>=^32.0
2025-03-24 10:48:30 - antiBiotic :VA
2025-03-24 10:48:30 - antiBiotic :Vancomycin
2025-03-24 10:48:30 - MIC Value :<=^1.0
2025-03-24 10:48:30 - antiBiotic :TE
2025-03-24 10:48:30 - antiBiotic :Tetracycline
2025-03-24 10:48:30 - MIC Value :=^0.25
2025-03-24 10:48:30 - antiBiotic :TGC
2025-03-24 10:48:30 - antiBiotic :Tigecycline
2025-03-24 10:48:30 - MIC Value :<=^16.0
2025-03-24 10:48:30 - antiBiotic :FT
2025-03-24 10:48:30 - antiBiotic :Nitrofurantoin
2025-03-24 10:48:30 - MIC Value :<=^0.03
2025-03-24 10:48:30 - antiBiotic :RA
2025-03-24 10:48:30 - antiBiotic :Rifampicin
2025-03-24 10:48:30 - MIC Value :<=^10.0
2025-03-24 10:48:30 - antiBiotic :SXT
2025-03-24 10:48:30 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-24 10:53:51 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|Blood^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-24 10:53:51 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250324105351+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-24 10:53:51 - SAMPLE NO :250322MIC00001
2025-03-24 10:53:51 - SAMPLLE TypeBlood
2025-03-24 10:53:51 - Organism type :Staphylococcus aureus
2025-03-24 10:53:51 - MIC Value :>=^0.5
2025-03-24 10:53:51 - antiBiotic :P
2025-03-24 10:53:51 - antiBiotic :Benzylpenicillin
2025-03-24 10:53:51 - MIC Value :>=^4.0
2025-03-24 10:53:51 - antiBiotic :OX1
2025-03-24 10:53:51 - antiBiotic :Oxacillin
2025-03-24 10:53:51 - MIC Value :<=^0.5
2025-03-24 10:53:51 - antiBiotic :GM
2025-03-24 10:53:51 - antiBiotic :Gentamicin
2025-03-24 10:53:51 - MIC Value :=^1.0
2025-03-24 10:53:51 - antiBiotic :CIP
2025-03-24 10:53:51 - antiBiotic :Ciprofloxacin
2025-03-24 10:53:51 - MIC Value :=^2.0
2025-03-24 10:53:51 - antiBiotic :LEV
2025-03-24 10:53:51 - antiBiotic :Levofloxacin
2025-03-24 10:53:51 - MIC Value :=^0.5
2025-03-24 10:53:51 - antiBiotic :E
2025-03-24 10:53:51 - antiBiotic :Erythromycin
2025-03-24 10:53:51 - MIC Value :>=^4.0
2025-03-24 10:53:51 - antiBiotic :CM
2025-03-24 10:53:51 - antiBiotic :Clindamycin
2025-03-24 10:53:51 - MIC Value :>=^8.0
2025-03-24 10:53:51 - antiBiotic :LNZ
2025-03-24 10:53:51 - antiBiotic :Linezolid
2025-03-24 10:53:51 - MIC Value :=^1.0
2025-03-24 10:53:51 - antiBiotic :DAP
2025-03-24 10:53:51 - antiBiotic :Daptomycin
2025-03-24 10:53:51 - MIC Value :=^4.0
2025-03-24 10:53:51 - antiBiotic :TEC
2025-03-24 10:53:51 - antiBiotic :Teicoplanin
2025-03-24 10:53:51 - MIC Value :>=^32.0
2025-03-24 10:53:51 - antiBiotic :VA
2025-03-24 10:53:51 - antiBiotic :Vancomycin
2025-03-24 10:53:51 - MIC Value :<=^1.0
2025-03-24 10:53:51 - antiBiotic :TE
2025-03-24 10:53:51 - antiBiotic :Tetracycline
2025-03-24 10:53:51 - MIC Value :=^0.25
2025-03-24 10:53:51 - antiBiotic :TGC
2025-03-24 10:53:51 - antiBiotic :Tigecycline
2025-03-24 10:53:51 - MIC Value :<=^16.0
2025-03-24 10:53:51 - antiBiotic :FT
2025-03-24 10:53:51 - antiBiotic :Nitrofurantoin
2025-03-24 10:53:51 - MIC Value :<=^0.03
2025-03-24 10:53:51 - antiBiotic :RA
2025-03-24 10:53:51 - antiBiotic :Rifampicin
2025-03-24 10:53:51 - MIC Value :<=^10.0
2025-03-24 10:53:51 - antiBiotic :SXT
2025-03-24 10:53:51 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-24 11:08:06 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|Blood^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-24 11:08:06 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250324110806+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-24 11:08:06 - SAMPLE NO :250322MIC00001
2025-03-24 11:08:06 - SAMPLLE TypeBlood
2025-03-24 11:08:06 - Organism type :Staphylococcus aureus
2025-03-24 11:08:06 - MIC Value :>=^0.5
2025-03-24 11:08:06 - antiBiotic :P
2025-03-24 11:08:06 - antiBiotic :Benzylpenicillin
2025-03-24 11:08:06 - MIC Value :>=^4.0
2025-03-24 11:08:06 - antiBiotic :OX1
2025-03-24 11:08:06 - antiBiotic :Oxacillin
2025-03-24 11:08:06 - MIC Value :<=^0.5
2025-03-24 11:08:06 - antiBiotic :GM
2025-03-24 11:08:06 - antiBiotic :Gentamicin
2025-03-24 11:08:06 - MIC Value :=^1.0
2025-03-24 11:08:06 - antiBiotic :CIP
2025-03-24 11:08:06 - antiBiotic :Ciprofloxacin
2025-03-24 11:08:06 - MIC Value :=^2.0
2025-03-24 11:08:06 - antiBiotic :LEV
2025-03-24 11:08:06 - antiBiotic :Levofloxacin
2025-03-24 11:08:06 - MIC Value :=^0.5
2025-03-24 11:08:06 - antiBiotic :E
2025-03-24 11:08:06 - antiBiotic :Erythromycin
2025-03-24 11:08:06 - MIC Value :>=^4.0
2025-03-24 11:08:06 - antiBiotic :CM
2025-03-24 11:08:06 - antiBiotic :Clindamycin
2025-03-24 11:08:06 - MIC Value :>=^8.0
2025-03-24 11:08:06 - antiBiotic :LNZ
2025-03-24 11:08:06 - antiBiotic :Linezolid
2025-03-24 11:08:06 - MIC Value :=^1.0
2025-03-24 11:08:06 - antiBiotic :DAP
2025-03-24 11:08:06 - antiBiotic :Daptomycin
2025-03-24 11:08:06 - MIC Value :=^4.0
2025-03-24 11:08:06 - antiBiotic :TEC
2025-03-24 11:08:06 - antiBiotic :Teicoplanin
2025-03-24 11:08:06 - MIC Value :>=^32.0
2025-03-24 11:08:06 - antiBiotic :VA
2025-03-24 11:08:06 - antiBiotic :Vancomycin
2025-03-24 11:08:06 - MIC Value :<=^1.0
2025-03-24 11:08:06 - antiBiotic :TE
2025-03-24 11:08:06 - antiBiotic :Tetracycline
2025-03-24 11:08:06 - MIC Value :=^0.25
2025-03-24 11:08:06 - antiBiotic :TGC
2025-03-24 11:08:06 - antiBiotic :Tigecycline
2025-03-24 11:08:06 - MIC Value :<=^16.0
2025-03-24 11:08:06 - antiBiotic :FT
2025-03-24 11:08:06 - antiBiotic :Nitrofurantoin
2025-03-24 11:08:06 - MIC Value :<=^0.03
2025-03-24 11:08:06 - antiBiotic :RA
2025-03-24 11:08:06 - antiBiotic :Rifampicin
2025-03-24 11:08:06 - MIC Value :<=^10.0
2025-03-24 11:08:06 - antiBiotic :SXT
2025-03-24 11:08:06 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-24 11:11:04 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|Blood^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-24 11:11:04 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250324111104+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-24 11:11:04 - SAMPLE NO :250322MIC00001
2025-03-24 11:11:04 - SAMPLLE TypeBlood
2025-03-24 11:11:04 - Organism type :Staphylococcus aureus
2025-03-24 11:11:04 - MIC Value :>=^0.5
2025-03-24 11:11:04 - antiBiotic :P
2025-03-24 11:11:04 - antiBiotic :Benzylpenicillin
2025-03-24 11:11:04 - MIC Value :>=^4.0
2025-03-24 11:11:04 - antiBiotic :OX1
2025-03-24 11:11:04 - antiBiotic :Oxacillin
2025-03-24 11:11:04 - MIC Value :<=^0.5
2025-03-24 11:11:04 - antiBiotic :GM
2025-03-24 11:11:04 - antiBiotic :Gentamicin
2025-03-24 11:11:04 - MIC Value :=^1.0
2025-03-24 11:11:04 - antiBiotic :CIP
2025-03-24 11:11:04 - antiBiotic :Ciprofloxacin
2025-03-24 11:11:04 - MIC Value :=^2.0
2025-03-24 11:11:04 - antiBiotic :LEV
2025-03-24 11:11:04 - antiBiotic :Levofloxacin
2025-03-24 11:11:04 - MIC Value :=^0.5
2025-03-24 11:11:04 - antiBiotic :E
2025-03-24 11:11:04 - antiBiotic :Erythromycin
2025-03-24 11:11:04 - MIC Value :>=^4.0
2025-03-24 11:11:04 - antiBiotic :CM
2025-03-24 11:11:04 - antiBiotic :Clindamycin
2025-03-24 11:11:04 - MIC Value :>=^8.0
2025-03-24 11:11:04 - antiBiotic :LNZ
2025-03-24 11:11:04 - antiBiotic :Linezolid
2025-03-24 11:11:04 - MIC Value :=^1.0
2025-03-24 11:11:04 - antiBiotic :DAP
2025-03-24 11:11:04 - antiBiotic :Daptomycin
2025-03-24 11:11:04 - MIC Value :=^4.0
2025-03-24 11:11:04 - antiBiotic :TEC
2025-03-24 11:11:04 - antiBiotic :Teicoplanin
2025-03-24 11:11:04 - MIC Value :>=^32.0
2025-03-24 11:11:04 - antiBiotic :VA
2025-03-24 11:11:04 - antiBiotic :Vancomycin
2025-03-24 11:11:04 - MIC Value :<=^1.0
2025-03-24 11:11:04 - antiBiotic :TE
2025-03-24 11:11:04 - antiBiotic :Tetracycline
2025-03-24 11:11:04 - MIC Value :=^0.25
2025-03-24 11:11:04 - antiBiotic :TGC
2025-03-24 11:11:04 - antiBiotic :Tigecycline
2025-03-24 11:11:04 - MIC Value :<=^16.0
2025-03-24 11:11:04 - antiBiotic :FT
2025-03-24 11:11:04 - antiBiotic :Nitrofurantoin
2025-03-24 11:11:04 - MIC Value :<=^0.03
2025-03-24 11:11:04 - antiBiotic :RA
2025-03-24 11:11:04 - antiBiotic :Rifampicin
2025-03-24 11:11:04 - MIC Value :<=^10.0
2025-03-24 11:11:04 - antiBiotic :SXT
2025-03-24 11:11:04 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-24 11:11:45 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|Blood^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-24 11:11:45 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250324111145+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-24 11:11:45 - SAMPLE NO :250322MIC00001
2025-03-24 11:11:45 - SAMPLLE TypeBlood
2025-03-24 11:11:45 - Organism type :Staphylococcus aureus
2025-03-24 11:11:45 - MIC Value :>=^0.5
2025-03-24 11:11:45 - antiBiotic :P
2025-03-24 11:11:45 - antiBiotic :Benzylpenicillin
2025-03-24 11:11:45 - MIC Value :>=^4.0
2025-03-24 11:11:45 - antiBiotic :OX1
2025-03-24 11:11:45 - antiBiotic :Oxacillin
2025-03-24 11:11:45 - MIC Value :<=^0.5
2025-03-24 11:11:45 - antiBiotic :GM
2025-03-24 11:11:45 - antiBiotic :Gentamicin
2025-03-24 11:11:45 - MIC Value :=^1.0
2025-03-24 11:11:45 - antiBiotic :CIP
2025-03-24 11:11:45 - antiBiotic :Ciprofloxacin
2025-03-24 11:11:45 - MIC Value :=^2.0
2025-03-24 11:11:45 - antiBiotic :LEV
2025-03-24 11:11:45 - antiBiotic :Levofloxacin
2025-03-24 11:11:45 - MIC Value :=^0.5
2025-03-24 11:11:45 - antiBiotic :E
2025-03-24 11:11:45 - antiBiotic :Erythromycin
2025-03-24 11:11:45 - MIC Value :>=^4.0
2025-03-24 11:11:45 - antiBiotic :CM
2025-03-24 11:11:45 - antiBiotic :Clindamycin
2025-03-24 11:11:45 - MIC Value :>=^8.0
2025-03-24 11:11:45 - antiBiotic :LNZ
2025-03-24 11:11:45 - antiBiotic :Linezolid
2025-03-24 11:11:45 - MIC Value :=^1.0
2025-03-24 11:11:45 - antiBiotic :DAP
2025-03-24 11:11:45 - antiBiotic :Daptomycin
2025-03-24 11:11:45 - MIC Value :=^4.0
2025-03-24 11:11:45 - antiBiotic :TEC
2025-03-24 11:11:45 - antiBiotic :Teicoplanin
2025-03-24 11:11:45 - MIC Value :>=^32.0
2025-03-24 11:11:45 - antiBiotic :VA
2025-03-24 11:11:45 - antiBiotic :Vancomycin
2025-03-24 11:11:45 - MIC Value :<=^1.0
2025-03-24 11:11:45 - antiBiotic :TE
2025-03-24 11:11:45 - antiBiotic :Tetracycline
2025-03-24 11:11:45 - MIC Value :=^0.25
2025-03-24 11:11:45 - antiBiotic :TGC
2025-03-24 11:11:45 - antiBiotic :Tigecycline
2025-03-24 11:11:45 - MIC Value :<=^16.0
2025-03-24 11:11:45 - antiBiotic :FT
2025-03-24 11:11:45 - antiBiotic :Nitrofurantoin
2025-03-24 11:11:45 - MIC Value :<=^0.03
2025-03-24 11:11:45 - antiBiotic :RA
2025-03-24 11:11:45 - antiBiotic :Rifampicin
2025-03-24 11:11:45 - MIC Value :<=^10.0
2025-03-24 11:11:45 - antiBiotic :SXT
2025-03-24 11:11:45 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-24 11:14:38 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|Blood^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-24 11:14:38 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250324111438+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-24 11:14:38 - SAMPLE NO :250322MIC00001
2025-03-24 11:14:38 - SAMPLLE TypeBlood
2025-03-24 11:14:38 - Organism type :Staphylococcus aureus
2025-03-24 11:14:38 - MIC Value :>=^0.5
2025-03-24 11:14:38 - antiBiotic :P
2025-03-24 11:14:38 - antiBiotic :Benzylpenicillin
2025-03-24 11:14:38 - MIC Value :>=^4.0
2025-03-24 11:14:38 - antiBiotic :OX1
2025-03-24 11:14:38 - antiBiotic :Oxacillin
2025-03-24 11:14:38 - MIC Value :<=^0.5
2025-03-24 11:14:38 - antiBiotic :GM
2025-03-24 11:14:38 - antiBiotic :Gentamicin
2025-03-24 11:14:38 - MIC Value :=^1.0
2025-03-24 11:14:38 - antiBiotic :CIP
2025-03-24 11:14:38 - antiBiotic :Ciprofloxacin
2025-03-24 11:14:38 - MIC Value :=^2.0
2025-03-24 11:14:38 - antiBiotic :LEV
2025-03-24 11:14:38 - antiBiotic :Levofloxacin
2025-03-24 11:14:38 - MIC Value :=^0.5
2025-03-24 11:14:38 - antiBiotic :E
2025-03-24 11:14:38 - antiBiotic :Erythromycin
2025-03-24 11:14:38 - MIC Value :>=^4.0
2025-03-24 11:14:38 - antiBiotic :CM
2025-03-24 11:14:38 - antiBiotic :Clindamycin
2025-03-24 11:14:38 - MIC Value :>=^8.0
2025-03-24 11:14:38 - antiBiotic :LNZ
2025-03-24 11:14:38 - antiBiotic :Linezolid
2025-03-24 11:14:38 - MIC Value :=^1.0
2025-03-24 11:14:38 - antiBiotic :DAP
2025-03-24 11:14:38 - antiBiotic :Daptomycin
2025-03-24 11:14:38 - MIC Value :=^4.0
2025-03-24 11:14:38 - antiBiotic :TEC
2025-03-24 11:14:38 - antiBiotic :Teicoplanin
2025-03-24 11:14:38 - MIC Value :>=^32.0
2025-03-24 11:14:38 - antiBiotic :VA
2025-03-24 11:14:38 - antiBiotic :Vancomycin
2025-03-24 11:14:38 - MIC Value :<=^1.0
2025-03-24 11:14:38 - antiBiotic :TE
2025-03-24 11:14:38 - antiBiotic :Tetracycline
2025-03-24 11:14:38 - MIC Value :=^0.25
2025-03-24 11:14:38 - antiBiotic :TGC
2025-03-24 11:14:38 - antiBiotic :Tigecycline
2025-03-24 11:14:38 - MIC Value :<=^16.0
2025-03-24 11:14:38 - antiBiotic :FT
2025-03-24 11:14:38 - antiBiotic :Nitrofurantoin
2025-03-24 11:14:38 - MIC Value :<=^0.03
2025-03-24 11:14:38 - antiBiotic :RA
2025-03-24 11:14:38 - antiBiotic :Rifampicin
2025-03-24 11:14:38 - MIC Value :<=^10.0
2025-03-24 11:14:38 - antiBiotic :SXT
2025-03-24 11:14:38 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-24 11:16:02 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|Blood^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-24 11:16:02 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250324111602+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-24 11:16:02 - SAMPLE NO :250322MIC00001
2025-03-24 11:16:02 - SAMPLLE TypeBlood
2025-03-24 11:16:02 - Organism type :Staphylococcus aureus
2025-03-24 11:16:02 - MIC Value :>=^0.5
2025-03-24 11:16:02 - antiBiotic :P
2025-03-24 11:16:02 - antiBiotic :Benzylpenicillin
2025-03-24 11:16:02 - MIC Value :>=^4.0
2025-03-24 11:16:02 - antiBiotic :OX1
2025-03-24 11:16:02 - antiBiotic :Oxacillin
2025-03-24 11:16:02 - MIC Value :<=^0.5
2025-03-24 11:16:02 - antiBiotic :GM
2025-03-24 11:16:02 - antiBiotic :Gentamicin
2025-03-24 11:16:02 - MIC Value :=^1.0
2025-03-24 11:16:02 - antiBiotic :CIP
2025-03-24 11:16:02 - antiBiotic :Ciprofloxacin
2025-03-24 11:16:02 - MIC Value :=^2.0
2025-03-24 11:16:02 - antiBiotic :LEV
2025-03-24 11:16:02 - antiBiotic :Levofloxacin
2025-03-24 11:16:02 - MIC Value :=^0.5
2025-03-24 11:16:02 - antiBiotic :E
2025-03-24 11:16:02 - antiBiotic :Erythromycin
2025-03-24 11:16:02 - MIC Value :>=^4.0
2025-03-24 11:16:02 - antiBiotic :CM
2025-03-24 11:16:02 - antiBiotic :Clindamycin
2025-03-24 11:16:02 - MIC Value :>=^8.0
2025-03-24 11:16:02 - antiBiotic :LNZ
2025-03-24 11:16:02 - antiBiotic :Linezolid
2025-03-24 11:16:02 - MIC Value :=^1.0
2025-03-24 11:16:02 - antiBiotic :DAP
2025-03-24 11:16:02 - antiBiotic :Daptomycin
2025-03-24 11:16:02 - MIC Value :=^4.0
2025-03-24 11:16:02 - antiBiotic :TEC
2025-03-24 11:16:02 - antiBiotic :Teicoplanin
2025-03-24 11:16:02 - MIC Value :>=^32.0
2025-03-24 11:16:02 - antiBiotic :VA
2025-03-24 11:16:02 - antiBiotic :Vancomycin
2025-03-24 11:16:02 - MIC Value :<=^1.0
2025-03-24 11:16:02 - antiBiotic :TE
2025-03-24 11:16:02 - antiBiotic :Tetracycline
2025-03-24 11:16:02 - MIC Value :=^0.25
2025-03-24 11:16:02 - antiBiotic :TGC
2025-03-24 11:16:02 - antiBiotic :Tigecycline
2025-03-24 11:16:02 - MIC Value :<=^16.0
2025-03-24 11:16:02 - antiBiotic :FT
2025-03-24 11:16:02 - antiBiotic :Nitrofurantoin
2025-03-24 11:16:02 - MIC Value :<=^0.03
2025-03-24 11:16:02 - antiBiotic :RA
2025-03-24 11:16:02 - antiBiotic :Rifampicin
2025-03-24 11:16:02 - MIC Value :<=^10.0
2025-03-24 11:16:02 - antiBiotic :SXT
2025-03-24 11:16:02 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-24 11:16:31 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|Blood^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-24 11:16:31 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250324111631+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-24 11:16:31 - SAMPLE NO :250322MIC00001
2025-03-24 11:16:31 - SAMPLLE TypeBlood
2025-03-24 11:16:31 - Organism type :Staphylococcus aureus
2025-03-24 11:16:31 - MIC Value :>=^0.5
2025-03-24 11:16:31 - antiBiotic :P
2025-03-24 11:16:31 - antiBiotic :Benzylpenicillin
2025-03-24 11:16:31 - MIC Value :>=^4.0
2025-03-24 11:16:31 - antiBiotic :OX1
2025-03-24 11:16:31 - antiBiotic :Oxacillin
2025-03-24 11:16:31 - MIC Value :<=^0.5
2025-03-24 11:16:31 - antiBiotic :GM
2025-03-24 11:16:31 - antiBiotic :Gentamicin
2025-03-24 11:16:31 - MIC Value :=^1.0
2025-03-24 11:16:31 - antiBiotic :CIP
2025-03-24 11:16:31 - antiBiotic :Ciprofloxacin
2025-03-24 11:16:31 - MIC Value :=^2.0
2025-03-24 11:16:31 - antiBiotic :LEV
2025-03-24 11:16:31 - antiBiotic :Levofloxacin
2025-03-24 11:16:31 - MIC Value :=^0.5
2025-03-24 11:16:31 - antiBiotic :E
2025-03-24 11:16:31 - antiBiotic :Erythromycin
2025-03-24 11:16:31 - MIC Value :>=^4.0
2025-03-24 11:16:31 - antiBiotic :CM
2025-03-24 11:16:31 - antiBiotic :Clindamycin
2025-03-24 11:16:31 - MIC Value :>=^8.0
2025-03-24 11:16:31 - antiBiotic :LNZ
2025-03-24 11:16:31 - antiBiotic :Linezolid
2025-03-24 11:16:31 - MIC Value :=^1.0
2025-03-24 11:16:31 - antiBiotic :DAP
2025-03-24 11:16:31 - antiBiotic :Daptomycin
2025-03-24 11:16:31 - MIC Value :=^4.0
2025-03-24 11:16:31 - antiBiotic :TEC
2025-03-24 11:16:31 - antiBiotic :Teicoplanin
2025-03-24 11:16:31 - MIC Value :>=^32.0
2025-03-24 11:16:31 - antiBiotic :VA
2025-03-24 11:16:31 - antiBiotic :Vancomycin
2025-03-24 11:16:31 - MIC Value :<=^1.0
2025-03-24 11:16:31 - antiBiotic :TE
2025-03-24 11:16:31 - antiBiotic :Tetracycline
2025-03-24 11:16:31 - MIC Value :=^0.25
2025-03-24 11:16:31 - antiBiotic :TGC
2025-03-24 11:16:31 - antiBiotic :Tigecycline
2025-03-24 11:16:31 - MIC Value :<=^16.0
2025-03-24 11:16:31 - antiBiotic :FT
2025-03-24 11:16:31 - antiBiotic :Nitrofurantoin
2025-03-24 11:16:31 - MIC Value :<=^0.03
2025-03-24 11:16:31 - antiBiotic :RA
2025-03-24 11:16:31 - antiBiotic :Rifampicin
2025-03-24 11:16:31 - MIC Value :<=^10.0
2025-03-24 11:16:31 - antiBiotic :SXT
2025-03-24 11:16:31 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-24 11:19:08 - Data sends to Mestria is started  for sample no ::  250322MIC00001
2025-03-24 11:19:08 - Response from API: [{"patFirstName":"Test Usr One    ","patType":"Special","patAge":"62 Yr             ","testcode":"10193","depcode":"102","labcode":"10022","patLastName":null,"patMiddleName":"-","patGender":"M","patientBirthDate":"-","patCrno":"939152100000382","patSampleNo":"250322MIC00001","patSampleType":"1002","patSampleCollectionDate":"2025-03-22","hisOrderId":"250322MIC000006","reqDno":"939151002225032210000201"}]
2025-03-24 11:19:08 - Save Patient Details API called for PACS 
2025-03-24 11:19:09 - Update Status API called
2025-03-24 11:19:09 - Response Body:  Status Updated
2025-03-24 11:19:09 - Data sends to Mestria is started ::  
2025-03-24 11:19:09 - Query  : SELECT hrgstr_fname,hrgstr_mname, hrgstr_lname, patient_gender, hrgnum_puk,hivnum_sample_no,hivnum_sample_type,  pat_sample_collection_date FROM  patient_org_test_details WHERE org_test_status = 0 and hivnum_sample_no=?
2025-03-24 11:19:09 - Query  : SELECT hrgstr_fname,hrgstr_mname, hrgstr_lname, patient_gender, hrgnum_puk,hivnum_sample_no,hivnum_sample_type,  pat_sample_collection_date FROM  patient_org_test_details WHERE org_test_status = 0
2025-03-24 11:19:09 - HL 7 :  MSH|^~\&|LIS|LAB|myla|BMX|20250324111909||OML^O33^OML_O33|MSG-20241007-101200-0377|P|2.5.1|||NE|AL||UNICODE UTF-8 PID|||939152100000382||Test Usr One    ^.^^^^^nill|CDAC TEST2|19681025|M|||nill^^nill^^nill^nill|||||S|PV1||E|GW-NEW CUBICAL WARD-J^8-FCGW-J-29^^ AIIMS^^^^^8-FCGW-J-29^||||^||||||||||||250322MIC00001SPM|1|250322MIC00001||BC^Blood Culture^99BMx|||^^|^^|||P^Patient^||||||20250324111909|SAC||||24008676 ORC|NW||||||||20250324111909TQ1|||||||||R^^OBR|1|714647||SU^SU^99BMx||||||^^||||||^|123456780
2025-03-24 11:19:11 - Error: Error connecting to server: Connection refused: connect
2025-03-24 11:19:11 - Stack Trace: java.lang.Exception: Error connecting to server: Connection refused: connect
	at Server.ServerConnector.sendToServer(ServerConnector.java:51)
	at Server.AIIMSLAB$6.doInBackground(AIIMSLAB.java:1851)
	at Server.AIIMSLAB$6.doInBackground(AIIMSLAB.java:1)
	at javax.swing.SwingWorker$1.call(SwingWorker.java:295)
	at java.util.concurrent.FutureTask.run(FutureTask.java:266)
	at javax.swing.SwingWorker.run(SwingWorker.java:334)
	at java.util.concurrent.ThreadPoolExecutor.runWorker(ThreadPoolExecutor.java:1149)
	at java.util.concurrent.ThreadPoolExecutor$Worker.run(ThreadPoolExecutor.java:624)
	at java.lang.Thread.run(Thread.java:750)

2025-03-24 11:19:27 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|Blood^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-24 11:19:27 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250324111927+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-24 11:19:27 - SAMPLE NO :250322MIC00001
2025-03-24 11:19:27 - SAMPLLE TypeBlood
2025-03-24 11:19:27 - Organism type :Staphylococcus aureus
2025-03-24 11:19:27 - MIC Value :>=^0.5
2025-03-24 11:19:27 - antiBiotic :P
2025-03-24 11:19:27 - antiBiotic :Benzylpenicillin
2025-03-24 11:19:27 - MIC Value :>=^4.0
2025-03-24 11:19:27 - antiBiotic :OX1
2025-03-24 11:19:27 - antiBiotic :Oxacillin
2025-03-24 11:19:27 - MIC Value :<=^0.5
2025-03-24 11:19:27 - antiBiotic :GM
2025-03-24 11:19:27 - antiBiotic :Gentamicin
2025-03-24 11:19:27 - MIC Value :=^1.0
2025-03-24 11:19:27 - antiBiotic :CIP
2025-03-24 11:19:27 - antiBiotic :Ciprofloxacin
2025-03-24 11:19:27 - MIC Value :=^2.0
2025-03-24 11:19:27 - antiBiotic :LEV
2025-03-24 11:19:27 - antiBiotic :Levofloxacin
2025-03-24 11:19:27 - MIC Value :=^0.5
2025-03-24 11:19:27 - antiBiotic :E
2025-03-24 11:19:27 - antiBiotic :Erythromycin
2025-03-24 11:19:27 - MIC Value :>=^4.0
2025-03-24 11:19:27 - antiBiotic :CM
2025-03-24 11:19:27 - antiBiotic :Clindamycin
2025-03-24 11:19:27 - MIC Value :>=^8.0
2025-03-24 11:19:27 - antiBiotic :LNZ
2025-03-24 11:19:27 - antiBiotic :Linezolid
2025-03-24 11:19:27 - MIC Value :=^1.0
2025-03-24 11:19:27 - antiBiotic :DAP
2025-03-24 11:19:27 - antiBiotic :Daptomycin
2025-03-24 11:19:27 - MIC Value :=^4.0
2025-03-24 11:19:27 - antiBiotic :TEC
2025-03-24 11:19:27 - antiBiotic :Teicoplanin
2025-03-24 11:19:27 - MIC Value :>=^32.0
2025-03-24 11:19:27 - antiBiotic :VA
2025-03-24 11:19:27 - antiBiotic :Vancomycin
2025-03-24 11:19:27 - MIC Value :<=^1.0
2025-03-24 11:19:27 - antiBiotic :TE
2025-03-24 11:19:27 - antiBiotic :Tetracycline
2025-03-24 11:19:27 - MIC Value :=^0.25
2025-03-24 11:19:27 - antiBiotic :TGC
2025-03-24 11:19:27 - antiBiotic :Tigecycline
2025-03-24 11:19:27 - MIC Value :<=^16.0
2025-03-24 11:19:27 - antiBiotic :FT
2025-03-24 11:19:27 - antiBiotic :Nitrofurantoin
2025-03-24 11:19:27 - MIC Value :<=^0.03
2025-03-24 11:19:27 - antiBiotic :RA
2025-03-24 11:19:27 - antiBiotic :Rifampicin
2025-03-24 11:19:27 - MIC Value :<=^10.0
2025-03-24 11:19:27 - antiBiotic :SXT
2025-03-24 11:19:27 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-24 11:20:39 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|Blood^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-24 11:20:39 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250324112039+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-24 11:20:39 - SAMPLE NO :250322MIC00001
2025-03-24 11:20:39 - SAMPLLE TypeBlood
2025-03-24 11:20:39 - Organism type :Staphylococcus aureus
2025-03-24 11:20:39 - MIC Value :>=^0.5
2025-03-24 11:20:39 - antiBiotic :P
2025-03-24 11:20:39 - antiBiotic :Benzylpenicillin
2025-03-24 11:20:39 - MIC Value :>=^4.0
2025-03-24 11:20:39 - antiBiotic :OX1
2025-03-24 11:20:39 - antiBiotic :Oxacillin
2025-03-24 11:20:39 - MIC Value :<=^0.5
2025-03-24 11:20:39 - antiBiotic :GM
2025-03-24 11:20:39 - antiBiotic :Gentamicin
2025-03-24 11:20:39 - MIC Value :=^1.0
2025-03-24 11:20:39 - antiBiotic :CIP
2025-03-24 11:20:39 - antiBiotic :Ciprofloxacin
2025-03-24 11:20:39 - MIC Value :=^2.0
2025-03-24 11:20:39 - antiBiotic :LEV
2025-03-24 11:20:39 - antiBiotic :Levofloxacin
2025-03-24 11:20:39 - MIC Value :=^0.5
2025-03-24 11:20:39 - antiBiotic :E
2025-03-24 11:20:39 - antiBiotic :Erythromycin
2025-03-24 11:20:39 - MIC Value :>=^4.0
2025-03-24 11:20:39 - antiBiotic :CM
2025-03-24 11:20:39 - antiBiotic :Clindamycin
2025-03-24 11:20:39 - MIC Value :>=^8.0
2025-03-24 11:20:39 - antiBiotic :LNZ
2025-03-24 11:20:39 - antiBiotic :Linezolid
2025-03-24 11:20:39 - MIC Value :=^1.0
2025-03-24 11:20:39 - antiBiotic :DAP
2025-03-24 11:20:39 - antiBiotic :Daptomycin
2025-03-24 11:20:39 - MIC Value :=^4.0
2025-03-24 11:20:39 - antiBiotic :TEC
2025-03-24 11:20:39 - antiBiotic :Teicoplanin
2025-03-24 11:20:39 - MIC Value :>=^32.0
2025-03-24 11:20:39 - antiBiotic :VA
2025-03-24 11:20:39 - antiBiotic :Vancomycin
2025-03-24 11:20:39 - MIC Value :<=^1.0
2025-03-24 11:20:39 - antiBiotic :TE
2025-03-24 11:20:39 - antiBiotic :Tetracycline
2025-03-24 11:20:39 - MIC Value :=^0.25
2025-03-24 11:20:39 - antiBiotic :TGC
2025-03-24 11:20:39 - antiBiotic :Tigecycline
2025-03-24 11:20:39 - MIC Value :<=^16.0
2025-03-24 11:20:39 - antiBiotic :FT
2025-03-24 11:20:39 - antiBiotic :Nitrofurantoin
2025-03-24 11:20:39 - MIC Value :<=^0.03
2025-03-24 11:20:39 - antiBiotic :RA
2025-03-24 11:20:39 - antiBiotic :Rifampicin
2025-03-24 11:20:39 - MIC Value :<=^10.0
2025-03-24 11:20:39 - antiBiotic :SXT
2025-03-24 11:20:39 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-24 11:35:41 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|Blood^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-24 11:35:41 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250324113541+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-24 11:35:41 - SAMPLE NO :250322MIC00001
2025-03-24 11:35:41 - SAMPLLE TypeBlood
2025-03-24 11:35:41 - Organism type :Staphylococcus aureus
2025-03-24 11:35:41 - MIC Value :>=^0.5
2025-03-24 11:35:41 - antiBiotic :P
2025-03-24 11:35:41 - antiBiotic :Benzylpenicillin
2025-03-24 11:35:41 - MIC Value :>=^4.0
2025-03-24 11:35:41 - antiBiotic :OX1
2025-03-24 11:35:41 - antiBiotic :Oxacillin
2025-03-24 11:35:41 - MIC Value :<=^0.5
2025-03-24 11:35:41 - antiBiotic :GM
2025-03-24 11:35:41 - antiBiotic :Gentamicin
2025-03-24 11:35:41 - MIC Value :=^1.0
2025-03-24 11:35:41 - antiBiotic :CIP
2025-03-24 11:35:41 - antiBiotic :Ciprofloxacin
2025-03-24 11:35:41 - MIC Value :=^2.0
2025-03-24 11:35:41 - antiBiotic :LEV
2025-03-24 11:35:41 - antiBiotic :Levofloxacin
2025-03-24 11:35:41 - MIC Value :=^0.5
2025-03-24 11:35:41 - antiBiotic :E
2025-03-24 11:35:41 - antiBiotic :Erythromycin
2025-03-24 11:35:41 - MIC Value :>=^4.0
2025-03-24 11:35:41 - antiBiotic :CM
2025-03-24 11:35:41 - antiBiotic :Clindamycin
2025-03-24 11:35:41 - MIC Value :>=^8.0
2025-03-24 11:35:41 - antiBiotic :LNZ
2025-03-24 11:35:41 - antiBiotic :Linezolid
2025-03-24 11:35:41 - MIC Value :=^1.0
2025-03-24 11:35:41 - antiBiotic :DAP
2025-03-24 11:35:41 - antiBiotic :Daptomycin
2025-03-24 11:35:41 - MIC Value :=^4.0
2025-03-24 11:35:41 - antiBiotic :TEC
2025-03-24 11:35:41 - antiBiotic :Teicoplanin
2025-03-24 11:35:41 - MIC Value :>=^32.0
2025-03-24 11:35:41 - antiBiotic :VA
2025-03-24 11:35:41 - antiBiotic :Vancomycin
2025-03-24 11:35:41 - MIC Value :<=^1.0
2025-03-24 11:35:41 - antiBiotic :TE
2025-03-24 11:35:41 - antiBiotic :Tetracycline
2025-03-24 11:35:41 - MIC Value :=^0.25
2025-03-24 11:35:41 - antiBiotic :TGC
2025-03-24 11:35:41 - antiBiotic :Tigecycline
2025-03-24 11:35:41 - MIC Value :<=^16.0
2025-03-24 11:35:41 - antiBiotic :FT
2025-03-24 11:35:41 - antiBiotic :Nitrofurantoin
2025-03-24 11:35:41 - MIC Value :<=^0.03
2025-03-24 11:35:41 - antiBiotic :RA
2025-03-24 11:35:41 - antiBiotic :Rifampicin
2025-03-24 11:35:41 - MIC Value :<=^10.0
2025-03-24 11:35:41 - antiBiotic :SXT
2025-03-24 11:35:41 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-24 11:43:18 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|Blood^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-24 11:43:18 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250324114318+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-24 11:43:18 - SAMPLE NO :250322MIC00001
2025-03-24 11:43:18 - SAMPLLE TypeBlood
2025-03-24 11:43:18 - Organism type :Staphylococcus aureus
2025-03-24 11:43:18 - MIC Value :>=^0.5
2025-03-24 11:43:18 - antiBiotic :P
2025-03-24 11:43:18 - antiBiotic :Benzylpenicillin
2025-03-24 11:43:18 - MIC Value :>=^4.0
2025-03-24 11:43:18 - antiBiotic :OX1
2025-03-24 11:43:18 - antiBiotic :Oxacillin
2025-03-24 11:43:18 - MIC Value :<=^0.5
2025-03-24 11:43:18 - antiBiotic :GM
2025-03-24 11:43:18 - antiBiotic :Gentamicin
2025-03-24 11:43:18 - MIC Value :=^1.0
2025-03-24 11:43:18 - antiBiotic :CIP
2025-03-24 11:43:18 - antiBiotic :Ciprofloxacin
2025-03-24 11:43:18 - MIC Value :=^2.0
2025-03-24 11:43:18 - antiBiotic :LEV
2025-03-24 11:43:18 - antiBiotic :Levofloxacin
2025-03-24 11:43:18 - MIC Value :=^0.5
2025-03-24 11:43:18 - antiBiotic :E
2025-03-24 11:43:18 - antiBiotic :Erythromycin
2025-03-24 11:43:18 - MIC Value :>=^4.0
2025-03-24 11:43:18 - antiBiotic :CM
2025-03-24 11:43:18 - antiBiotic :Clindamycin
2025-03-24 11:43:18 - MIC Value :>=^8.0
2025-03-24 11:43:18 - antiBiotic :LNZ
2025-03-24 11:43:18 - antiBiotic :Linezolid
2025-03-24 11:43:18 - MIC Value :=^1.0
2025-03-24 11:43:18 - antiBiotic :DAP
2025-03-24 11:43:18 - antiBiotic :Daptomycin
2025-03-24 11:43:18 - MIC Value :=^4.0
2025-03-24 11:43:18 - antiBiotic :TEC
2025-03-24 11:43:18 - antiBiotic :Teicoplanin
2025-03-24 11:43:18 - MIC Value :>=^32.0
2025-03-24 11:43:18 - antiBiotic :VA
2025-03-24 11:43:18 - antiBiotic :Vancomycin
2025-03-24 11:43:18 - MIC Value :<=^1.0
2025-03-24 11:43:18 - antiBiotic :TE
2025-03-24 11:43:18 - antiBiotic :Tetracycline
2025-03-24 11:43:18 - MIC Value :=^0.25
2025-03-24 11:43:18 - antiBiotic :TGC
2025-03-24 11:43:18 - antiBiotic :Tigecycline
2025-03-24 11:43:18 - MIC Value :<=^16.0
2025-03-24 11:43:18 - antiBiotic :FT
2025-03-24 11:43:18 - antiBiotic :Nitrofurantoin
2025-03-24 11:43:18 - MIC Value :<=^0.03
2025-03-24 11:43:18 - antiBiotic :RA
2025-03-24 11:43:18 - antiBiotic :Rifampicin
2025-03-24 11:43:18 - MIC Value :<=^10.0
2025-03-24 11:43:18 - antiBiotic :SXT
2025-03-24 11:43:18 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-24 11:43:32 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|Blood^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-24 11:43:32 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250324114332+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-24 11:43:32 - SAMPLE NO :250322MIC00001
2025-03-24 11:43:32 - SAMPLLE TypeBlood
2025-03-24 11:43:32 - Organism type :Staphylococcus aureus
2025-03-24 11:43:32 - MIC Value :>=^0.5
2025-03-24 11:43:32 - antiBiotic :P
2025-03-24 11:43:32 - antiBiotic :Benzylpenicillin
2025-03-24 11:43:32 - MIC Value :>=^4.0
2025-03-24 11:43:32 - antiBiotic :OX1
2025-03-24 11:43:32 - antiBiotic :Oxacillin
2025-03-24 11:43:32 - MIC Value :<=^0.5
2025-03-24 11:43:32 - antiBiotic :GM
2025-03-24 11:43:32 - antiBiotic :Gentamicin
2025-03-24 11:43:32 - MIC Value :=^1.0
2025-03-24 11:43:32 - antiBiotic :CIP
2025-03-24 11:43:32 - antiBiotic :Ciprofloxacin
2025-03-24 11:43:32 - MIC Value :=^2.0
2025-03-24 11:43:32 - antiBiotic :LEV
2025-03-24 11:43:32 - antiBiotic :Levofloxacin
2025-03-24 11:43:32 - MIC Value :=^0.5
2025-03-24 11:43:32 - antiBiotic :E
2025-03-24 11:43:32 - antiBiotic :Erythromycin
2025-03-24 11:43:32 - MIC Value :>=^4.0
2025-03-24 11:43:32 - antiBiotic :CM
2025-03-24 11:43:32 - antiBiotic :Clindamycin
2025-03-24 11:43:32 - MIC Value :>=^8.0
2025-03-24 11:43:32 - antiBiotic :LNZ
2025-03-24 11:43:32 - antiBiotic :Linezolid
2025-03-24 11:43:32 - MIC Value :=^1.0
2025-03-24 11:43:32 - antiBiotic :DAP
2025-03-24 11:43:32 - antiBiotic :Daptomycin
2025-03-24 11:43:32 - MIC Value :=^4.0
2025-03-24 11:43:32 - antiBiotic :TEC
2025-03-24 11:43:32 - antiBiotic :Teicoplanin
2025-03-24 11:43:32 - MIC Value :>=^32.0
2025-03-24 11:43:32 - antiBiotic :VA
2025-03-24 11:43:32 - antiBiotic :Vancomycin
2025-03-24 11:43:32 - MIC Value :<=^1.0
2025-03-24 11:43:32 - antiBiotic :TE
2025-03-24 11:43:32 - antiBiotic :Tetracycline
2025-03-24 11:43:32 - MIC Value :=^0.25
2025-03-24 11:43:32 - antiBiotic :TGC
2025-03-24 11:43:32 - antiBiotic :Tigecycline
2025-03-24 11:43:32 - MIC Value :<=^16.0
2025-03-24 11:43:32 - antiBiotic :FT
2025-03-24 11:43:32 - antiBiotic :Nitrofurantoin
2025-03-24 11:43:32 - MIC Value :<=^0.03
2025-03-24 11:43:32 - antiBiotic :RA
2025-03-24 11:43:32 - antiBiotic :Rifampicin
2025-03-24 11:43:32 - MIC Value :<=^10.0
2025-03-24 11:43:32 - antiBiotic :SXT
2025-03-24 11:43:32 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-24 11:50:37 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|Blood^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-24 11:50:37 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250324115037+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-24 11:50:37 - SAMPLE NO :250322MIC00001
2025-03-24 11:50:37 - SAMPLLE TypeBlood
2025-03-24 11:50:37 - Organism type :Staphylococcus aureus
2025-03-24 11:50:37 - MIC Value :>=^0.5
2025-03-24 11:50:37 - antiBiotic :P
2025-03-24 11:50:37 - antiBiotic :Benzylpenicillin
2025-03-24 11:50:37 - MIC Value :>=^4.0
2025-03-24 11:50:37 - antiBiotic :OX1
2025-03-24 11:50:37 - antiBiotic :Oxacillin
2025-03-24 11:50:37 - MIC Value :<=^0.5
2025-03-24 11:50:37 - antiBiotic :GM
2025-03-24 11:50:37 - antiBiotic :Gentamicin
2025-03-24 11:50:37 - MIC Value :=^1.0
2025-03-24 11:50:37 - antiBiotic :CIP
2025-03-24 11:50:37 - antiBiotic :Ciprofloxacin
2025-03-24 11:50:37 - MIC Value :=^2.0
2025-03-24 11:50:37 - antiBiotic :LEV
2025-03-24 11:50:37 - antiBiotic :Levofloxacin
2025-03-24 11:50:37 - MIC Value :=^0.5
2025-03-24 11:50:37 - antiBiotic :E
2025-03-24 11:50:37 - antiBiotic :Erythromycin
2025-03-24 11:50:37 - MIC Value :>=^4.0
2025-03-24 11:50:37 - antiBiotic :CM
2025-03-24 11:50:37 - antiBiotic :Clindamycin
2025-03-24 11:50:37 - MIC Value :>=^8.0
2025-03-24 11:50:37 - antiBiotic :LNZ
2025-03-24 11:50:37 - antiBiotic :Linezolid
2025-03-24 11:50:37 - MIC Value :=^1.0
2025-03-24 11:50:37 - antiBiotic :DAP
2025-03-24 11:50:37 - antiBiotic :Daptomycin
2025-03-24 11:50:37 - MIC Value :=^4.0
2025-03-24 11:50:37 - antiBiotic :TEC
2025-03-24 11:50:37 - antiBiotic :Teicoplanin
2025-03-24 11:50:37 - MIC Value :>=^32.0
2025-03-24 11:50:37 - antiBiotic :VA
2025-03-24 11:50:37 - antiBiotic :Vancomycin
2025-03-24 11:50:37 - MIC Value :<=^1.0
2025-03-24 11:50:37 - antiBiotic :TE
2025-03-24 11:50:37 - antiBiotic :Tetracycline
2025-03-24 11:50:37 - MIC Value :=^0.25
2025-03-24 11:50:37 - antiBiotic :TGC
2025-03-24 11:50:37 - antiBiotic :Tigecycline
2025-03-24 11:50:37 - MIC Value :<=^16.0
2025-03-24 11:50:37 - antiBiotic :FT
2025-03-24 11:50:37 - antiBiotic :Nitrofurantoin
2025-03-24 11:50:37 - MIC Value :<=^0.03
2025-03-24 11:50:37 - antiBiotic :RA
2025-03-24 11:50:37 - antiBiotic :Rifampicin
2025-03-24 11:50:37 - MIC Value :<=^10.0
2025-03-24 11:50:37 - antiBiotic :SXT
2025-03-24 11:50:37 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-24 11:50:39 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|Blood^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-24 11:50:39 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250324115039+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-24 11:50:39 - SAMPLE NO :250322MIC00001
2025-03-24 11:50:39 - SAMPLLE TypeBlood
2025-03-24 11:50:39 - Organism type :Staphylococcus aureus
2025-03-24 11:50:39 - MIC Value :>=^0.5
2025-03-24 11:50:39 - antiBiotic :P
2025-03-24 11:50:39 - antiBiotic :Benzylpenicillin
2025-03-24 11:50:39 - MIC Value :>=^4.0
2025-03-24 11:50:39 - antiBiotic :OX1
2025-03-24 11:50:39 - antiBiotic :Oxacillin
2025-03-24 11:50:39 - MIC Value :<=^0.5
2025-03-24 11:50:39 - antiBiotic :GM
2025-03-24 11:50:39 - antiBiotic :Gentamicin
2025-03-24 11:50:39 - MIC Value :=^1.0
2025-03-24 11:50:39 - antiBiotic :CIP
2025-03-24 11:50:39 - antiBiotic :Ciprofloxacin
2025-03-24 11:50:39 - MIC Value :=^2.0
2025-03-24 11:50:39 - antiBiotic :LEV
2025-03-24 11:50:39 - antiBiotic :Levofloxacin
2025-03-24 11:50:39 - MIC Value :=^0.5
2025-03-24 11:50:39 - antiBiotic :E
2025-03-24 11:50:39 - antiBiotic :Erythromycin
2025-03-24 11:50:39 - MIC Value :>=^4.0
2025-03-24 11:50:39 - antiBiotic :CM
2025-03-24 11:50:39 - antiBiotic :Clindamycin
2025-03-24 11:50:39 - MIC Value :>=^8.0
2025-03-24 11:50:39 - antiBiotic :LNZ
2025-03-24 11:50:39 - antiBiotic :Linezolid
2025-03-24 11:50:39 - MIC Value :=^1.0
2025-03-24 11:50:39 - antiBiotic :DAP
2025-03-24 11:50:39 - antiBiotic :Daptomycin
2025-03-24 11:50:39 - MIC Value :=^4.0
2025-03-24 11:50:39 - antiBiotic :TEC
2025-03-24 11:50:39 - antiBiotic :Teicoplanin
2025-03-24 11:50:39 - MIC Value :>=^32.0
2025-03-24 11:50:39 - antiBiotic :VA
2025-03-24 11:50:39 - antiBiotic :Vancomycin
2025-03-24 11:50:39 - MIC Value :<=^1.0
2025-03-24 11:50:39 - antiBiotic :TE
2025-03-24 11:50:39 - antiBiotic :Tetracycline
2025-03-24 11:50:39 - MIC Value :=^0.25
2025-03-24 11:50:39 - antiBiotic :TGC
2025-03-24 11:50:39 - antiBiotic :Tigecycline
2025-03-24 11:50:39 - MIC Value :<=^16.0
2025-03-24 11:50:39 - antiBiotic :FT
2025-03-24 11:50:39 - antiBiotic :Nitrofurantoin
2025-03-24 11:50:39 - MIC Value :<=^0.03
2025-03-24 11:50:39 - antiBiotic :RA
2025-03-24 11:50:39 - antiBiotic :Rifampicin
2025-03-24 11:50:39 - MIC Value :<=^10.0
2025-03-24 11:50:39 - antiBiotic :SXT
2025-03-24 11:50:39 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-24 11:50:44 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|Blood^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-24 11:50:44 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250324115044+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-24 11:50:44 - SAMPLE NO :250322MIC00001
2025-03-24 11:50:44 - SAMPLLE TypeBlood
2025-03-24 11:50:44 - Organism type :Staphylococcus aureus
2025-03-24 11:50:44 - MIC Value :>=^0.5
2025-03-24 11:50:44 - antiBiotic :P
2025-03-24 11:50:44 - antiBiotic :Benzylpenicillin
2025-03-24 11:50:44 - MIC Value :>=^4.0
2025-03-24 11:50:44 - antiBiotic :OX1
2025-03-24 11:50:44 - antiBiotic :Oxacillin
2025-03-24 11:50:44 - MIC Value :<=^0.5
2025-03-24 11:50:44 - antiBiotic :GM
2025-03-24 11:50:44 - antiBiotic :Gentamicin
2025-03-24 11:50:44 - MIC Value :=^1.0
2025-03-24 11:50:44 - antiBiotic :CIP
2025-03-24 11:50:44 - antiBiotic :Ciprofloxacin
2025-03-24 11:50:44 - MIC Value :=^2.0
2025-03-24 11:50:44 - antiBiotic :LEV
2025-03-24 11:50:44 - antiBiotic :Levofloxacin
2025-03-24 11:50:44 - MIC Value :=^0.5
2025-03-24 11:50:44 - antiBiotic :E
2025-03-24 11:50:44 - antiBiotic :Erythromycin
2025-03-24 11:50:44 - MIC Value :>=^4.0
2025-03-24 11:50:44 - antiBiotic :CM
2025-03-24 11:50:44 - antiBiotic :Clindamycin
2025-03-24 11:50:44 - MIC Value :>=^8.0
2025-03-24 11:50:44 - antiBiotic :LNZ
2025-03-24 11:50:44 - antiBiotic :Linezolid
2025-03-24 11:50:44 - MIC Value :=^1.0
2025-03-24 11:50:44 - antiBiotic :DAP
2025-03-24 11:50:44 - antiBiotic :Daptomycin
2025-03-24 11:50:44 - MIC Value :=^4.0
2025-03-24 11:50:44 - antiBiotic :TEC
2025-03-24 11:50:44 - antiBiotic :Teicoplanin
2025-03-24 11:50:44 - MIC Value :>=^32.0
2025-03-24 11:50:44 - antiBiotic :VA
2025-03-24 11:50:44 - antiBiotic :Vancomycin
2025-03-24 11:50:44 - MIC Value :<=^1.0
2025-03-24 11:50:44 - antiBiotic :TE
2025-03-24 11:50:44 - antiBiotic :Tetracycline
2025-03-24 11:50:44 - MIC Value :=^0.25
2025-03-24 11:50:44 - antiBiotic :TGC
2025-03-24 11:50:44 - antiBiotic :Tigecycline
2025-03-24 11:50:44 - MIC Value :<=^16.0
2025-03-24 11:50:44 - antiBiotic :FT
2025-03-24 11:50:44 - antiBiotic :Nitrofurantoin
2025-03-24 11:50:44 - MIC Value :<=^0.03
2025-03-24 11:50:44 - antiBiotic :RA
2025-03-24 11:50:44 - antiBiotic :Rifampicin
2025-03-24 11:50:44 - MIC Value :<=^10.0
2025-03-24 11:50:44 - antiBiotic :SXT
2025-03-24 11:50:44 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-24 11:52:37 - Received : MSH|^~\&|myla|BMX|HL72LIS|LIS|20250109123017+0530||OUL^R22^OUL_R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1|||NE|AL||UNICODE UTF-8
PID|1||250322MIC00001||CDAC TEST^.||19681025|M
PV1|1|U|||||||||||||||||0252581
SPM|1|1|250322MIC00001|Blood^URIN|||||||P^Patient||||||20250108160410
SAC|1||1|250322MIC00001
OBR|1|714647||AST-P628^AST-P628^99BMx
ORC|SC||||CM
OBX|1|CE|ID^Bacteria identified in isolate^99BMx|1|MAU^Staphylococcus aureus^99BMx|||""|99.0||""|||||""||""|""||||||||||SCI
OBX|2|CE|OXSF^Cefoxitin Screen^99BMx^18888-8^cefOXitin [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|3|SN|P^Benzylpenicillin^99BMx^6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^0.5|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|4|SN|OX1^Oxacillin^99BMx^383-0^Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|5|SN|GM^Gentamicin^99BMx^267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|6|SN|CIP^Ciprofloxacin^99BMx^185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|7|SN|LEV^Levofloxacin^99BMx^20396-8^levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^2.0|mg/mL^microgram per milliliter^UCUM||I^Intermediate^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|8|CE|ICR^Inducible Clindamycin Resistance^99BMx^61188-9^Clindamycin.induced [Susceptibility]^LN|1|""|||Neg^Negative^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|9|SN|E^Erythromycin^99BMx^233-7^Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.5|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|10|SN|CM^Clindamycin^99BMx^193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^4.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|11|SN|LNZ^Linezolid^99BMx^29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^8.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
NTE|1|Z|This drug is flagged to be suppressed from reporting.|ar^Suppressed drug^99BMx
OBX|12|SN|DAP^Daptomycin^99BMx^35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|13|SN|TEC^Teicoplanin^99BMx^484-6^Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^4.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|14|SN|VA^Vancomycin^99BMx^524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|>=^32.0|mg/mL^microgram per milliliter^UCUM||R^Resistant^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|15|SN|TE^Tetracycline^99BMx^496-0^Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^1.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|16|SN|TGC^Tigecycline^99BMx^42355-8^Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|=^0.25|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|17|SN|FT^Nitrofurantoin^99BMx^363-2^Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^16.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|18|SN|RA^Rifampicin^99BMx^428-3^rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^0.03|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
OBX|19|SN|SXT^Trimethoprim/Sulfamethoxazole^99BMx^516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|<=^10.0|mg/mL^microgram per milliliter^UCUM||S^Susceptible^HL70078|||F|||||""||Vitek2^biomerieux~000016FE032E^biomerieux~AIIMS BHOPAL^biomerieux~|20250109100236||||||||||RSLT
INV|AST-P628^^99BMx|NA^Not Applicable^HL70383|VITEK2-AST-CARD^^99BMx|5382728503750704||||||||20250516||||5382728503
NTE|1|Z|Vancomycin resistance in staphylococcus aureus is very uncommon. Please check the Vitek suspension solution sterility and purity of the colony. Repeat the test if deemed necessary.|nd^User Comment^99BMx
2025-03-24 11:52:37 - Sent ACK response: MSH|^~\&|HL72LIS||LIS|BMX|myla|20250324115237+0530+0530||ACK^R22|e9a56648-1d8c-4bb8-96cf-1cb124c380f6|P|2.5.1MSA|AA|e9a56648-1d8c-4bb8-96cf-1cb124c380f6
2025-03-24 11:52:37 - SAMPLE NO :250322MIC00001
2025-03-24 11:52:37 - SAMPLLE TypeBlood
2025-03-24 11:52:37 - Organism type :Staphylococcus aureus
2025-03-24 11:52:37 - MIC Value :>=^0.5
2025-03-24 11:52:37 - antiBiotic :P
2025-03-24 11:52:37 - antiBiotic :Benzylpenicillin
2025-03-24 11:52:37 - MIC Value :>=^4.0
2025-03-24 11:52:37 - antiBiotic :OX1
2025-03-24 11:52:37 - antiBiotic :Oxacillin
2025-03-24 11:52:37 - MIC Value :<=^0.5
2025-03-24 11:52:37 - antiBiotic :GM
2025-03-24 11:52:37 - antiBiotic :Gentamicin
2025-03-24 11:52:37 - MIC Value :=^1.0
2025-03-24 11:52:37 - antiBiotic :CIP
2025-03-24 11:52:37 - antiBiotic :Ciprofloxacin
2025-03-24 11:52:37 - MIC Value :=^2.0
2025-03-24 11:52:37 - antiBiotic :LEV
2025-03-24 11:52:37 - antiBiotic :Levofloxacin
2025-03-24 11:52:37 - MIC Value :=^0.5
2025-03-24 11:52:37 - antiBiotic :E
2025-03-24 11:52:37 - antiBiotic :Erythromycin
2025-03-24 11:52:37 - MIC Value :>=^4.0
2025-03-24 11:52:37 - antiBiotic :CM
2025-03-24 11:52:37 - antiBiotic :Clindamycin
2025-03-24 11:52:37 - MIC Value :>=^8.0
2025-03-24 11:52:37 - antiBiotic :LNZ
2025-03-24 11:52:37 - antiBiotic :Linezolid
2025-03-24 11:52:37 - MIC Value :=^1.0
2025-03-24 11:52:37 - antiBiotic :DAP
2025-03-24 11:52:37 - antiBiotic :Daptomycin
2025-03-24 11:52:37 - MIC Value :=^4.0
2025-03-24 11:52:37 - antiBiotic :TEC
2025-03-24 11:52:37 - antiBiotic :Teicoplanin
2025-03-24 11:52:37 - MIC Value :>=^32.0
2025-03-24 11:52:37 - antiBiotic :VA
2025-03-24 11:52:37 - antiBiotic :Vancomycin
2025-03-24 11:52:37 - MIC Value :<=^1.0
2025-03-24 11:52:37 - antiBiotic :TE
2025-03-24 11:52:37 - antiBiotic :Tetracycline
2025-03-24 11:52:37 - MIC Value :=^0.25
2025-03-24 11:52:37 - antiBiotic :TGC
2025-03-24 11:52:37 - antiBiotic :Tigecycline
2025-03-24 11:52:37 - MIC Value :<=^16.0
2025-03-24 11:52:37 - antiBiotic :FT
2025-03-24 11:52:37 - antiBiotic :Nitrofurantoin
2025-03-24 11:52:37 - MIC Value :<=^0.03
2025-03-24 11:52:37 - antiBiotic :RA
2025-03-24 11:52:37 - antiBiotic :Rifampicin
2025-03-24 11:52:37 - MIC Value :<=^10.0
2025-03-24 11:52:37 - antiBiotic :SXT
2025-03-24 11:52:37 - antiBiotic :Trimethoprim/Sulfamethoxazole
2025-03-24 12:28:12 - Data sends to Mestria is started  for sample no ::  250322MIC00001
2025-03-24 12:28:14 - Stack Trace: java.net.ConnectException: Connection refused: connect
	at java.net.DualStackPlainSocketImpl.connect0(Native Method)
	at java.net.DualStackPlainSocketImpl.socketConnect(DualStackPlainSocketImpl.java:79)
	at java.net.AbstractPlainSocketImpl.doConnect(AbstractPlainSocketImpl.java:350)
	at java.net.AbstractPlainSocketImpl.connectToAddress(AbstractPlainSocketImpl.java:206)
	at java.net.AbstractPlainSocketImpl.connect(AbstractPlainSocketImpl.java:188)
	at java.net.PlainSocketImpl.connect(PlainSocketImpl.java:172)
	at java.net.SocksSocketImpl.connect(SocksSocketImpl.java:392)
	at java.net.Socket.connect(Socket.java:607)
	at java.net.Socket.connect(Socket.java:556)
	at sun.net.NetworkClient.doConnect(NetworkClient.java:180)
	at sun.net.www.http.HttpClient.openServer(HttpClient.java:463)
	at sun.net.www.http.HttpClient.openServer(HttpClient.java:558)
	at sun.net.www.http.HttpClient.<init>(HttpClient.java:242)
	at sun.net.www.http.HttpClient.New(HttpClient.java:339)
	at sun.net.www.http.HttpClient.New(HttpClient.java:357)
	at sun.net.www.protocol.http.HttpURLConnection.getNewHttpClient(HttpURLConnection.java:1228)
	at sun.net.www.protocol.http.HttpURLConnection.plainConnect0(HttpURLConnection.java:1162)
	at sun.net.www.protocol.http.HttpURLConnection.plainConnect(HttpURLConnection.java:1056)
	at sun.net.www.protocol.http.HttpURLConnection.connect(HttpURLConnection.java:990)
	at sun.net.www.protocol.http.HttpURLConnection.getInputStream0(HttpURLConnection.java:1572)
	at sun.net.www.protocol.http.HttpURLConnection.getInputStream(HttpURLConnection.java:1500)
	at java.net.HttpURLConnection.getResponseCode(HttpURLConnection.java:480)
	at Server.AIIMSLAB$7.doInBackground(AIIMSLAB.java:1919)
	at Server.AIIMSLAB$7.doInBackground(AIIMSLAB.java:1)
	at javax.swing.SwingWorker$1.call(SwingWorker.java:295)
	at java.util.concurrent.FutureTask.run(FutureTask.java:266)
	at javax.swing.SwingWorker.run(SwingWorker.java:334)
	at java.util.concurrent.ThreadPoolExecutor.runWorker(ThreadPoolExecutor.java:1149)
	at java.util.concurrent.ThreadPoolExecutor$Worker.run(ThreadPoolExecutor.java:624)
	at java.lang.Thread.run(Thread.java:750)

2025-03-24 12:28:14 - Query  : SELECT hrgstr_fname,hrgstr_mname, hrgstr_lname, patient_gender, hrgnum_puk,hivnum_sample_no,hivnum_sample_type,  pat_sample_collection_date FROM  patient_org_test_details WHERE org_test_status = 0 and hivnum_sample_no=?
2025-03-24 12:28:25 - Data sends to Mestria is started  for sample no ::  250322MIC00001
2025-03-24 12:28:27 - Stack Trace: java.net.ConnectException: Connection refused: connect
	at java.net.DualStackPlainSocketImpl.connect0(Native Method)
	at java.net.DualStackPlainSocketImpl.socketConnect(DualStackPlainSocketImpl.java:79)
	at java.net.AbstractPlainSocketImpl.doConnect(AbstractPlainSocketImpl.java:350)
	at java.net.AbstractPlainSocketImpl.connectToAddress(AbstractPlainSocketImpl.java:206)
	at java.net.AbstractPlainSocketImpl.connect(AbstractPlainSocketImpl.java:188)
	at java.net.PlainSocketImpl.connect(PlainSocketImpl.java:172)
	at java.net.SocksSocketImpl.connect(SocksSocketImpl.java:392)
	at java.net.Socket.connect(Socket.java:607)
	at java.net.Socket.connect(Socket.java:556)
	at sun.net.NetworkClient.doConnect(NetworkClient.java:180)
	at sun.net.www.http.HttpClient.openServer(HttpClient.java:463)
	at sun.net.www.http.HttpClient.openServer(HttpClient.java:558)
	at sun.net.www.http.HttpClient.<init>(HttpClient.java:242)
	at sun.net.www.http.HttpClient.New(HttpClient.java:339)
	at sun.net.www.http.HttpClient.New(HttpClient.java:357)
	at sun.net.www.protocol.http.HttpURLConnection.getNewHttpClient(HttpURLConnection.java:1228)
	at sun.net.www.protocol.http.HttpURLConnection.plainConnect0(HttpURLConnection.java:1162)
	at sun.net.www.protocol.http.HttpURLConnection.plainConnect(HttpURLConnection.java:1056)
	at sun.net.www.protocol.http.HttpURLConnection.connect(HttpURLConnection.java:990)
	at sun.net.www.protocol.http.HttpURLConnection.getInputStream0(HttpURLConnection.java:1572)
	at sun.net.www.protocol.http.HttpURLConnection.getInputStream(HttpURLConnection.java:1500)
	at java.net.HttpURLConnection.getResponseCode(HttpURLConnection.java:480)
	at Server.AIIMSLAB$7.doInBackground(AIIMSLAB.java:1919)
	at Server.AIIMSLAB$7.doInBackground(AIIMSLAB.java:1)
	at javax.swing.SwingWorker$1.call(SwingWorker.java:295)
	at java.util.concurrent.FutureTask.run(FutureTask.java:266)
	at javax.swing.SwingWorker.run(SwingWorker.java:334)
	at java.util.concurrent.ThreadPoolExecutor.runWorker(ThreadPoolExecutor.java:1149)
	at java.util.concurrent.ThreadPoolExecutor$Worker.run(ThreadPoolExecutor.java:624)
	at java.lang.Thread.run(Thread.java:750)

2025-03-24 12:28:27 - Query  : SELECT hrgstr_fname,hrgstr_mname, hrgstr_lname, patient_gender, hrgnum_puk,hivnum_sample_no,hivnum_sample_type,  pat_sample_collection_date FROM  patient_org_test_details WHERE org_test_status = 0 and hivnum_sample_no=?
2025-03-24 12:47:07 - Data sends to Mestria is started  for sample no ::  250322MIC00000
2025-03-24 12:47:07 - Response from API: [{"patFirstName":"Test Usr One    ","patType":"Special","patAge":"62 Yr             ","testcode":"10193","depcode":"102","labcode":"10022","patLastName":null,"patMiddleName":"-","patGender":"M","patientBirthDate":"-","patCrno":"939152100000382","patSampleNo":"250322MIC00000","patSampleType":"1002","patSampleCollectionDate":"2025-03-22","hisOrderId":"250322MIC000005","reqDno":"939151002225032210000101"}]
2025-03-24 12:47:07 - Save Patient Details API called for PACS 
2025-03-24 12:47:09 - Query  : SELECT hrgstr_fname,hrgstr_mname, hrgstr_lname, patient_gender, hrgnum_puk,hivnum_sample_no,hivnum_sample_type,  pat_sample_collection_date FROM  patient_org_test_details WHERE org_test_status = 0 and hivnum_sample_no=?
2025-03-24 12:48:33 - Data sends to Mestria is started  for sample no ::  250322MIC00000
2025-03-24 12:48:33 - Response from API: [{"patFirstName":"Test Usr One    ","patType":"Special","patAge":"62 Yr             ","testcode":"10193","depcode":"102","labcode":"10022","patLastName":null,"patMiddleName":"-","patGender":"M","patientBirthDate":"-","patCrno":"939152100000382","patSampleNo":"250322MIC00000","patSampleType":"1002","patSampleCollectionDate":"2025-03-22","hisOrderId":"250322MIC000005","reqDno":"939151002225032210000101"}]
2025-03-24 12:48:33 - Save Patient Details API called for PACS 
2025-03-24 12:48:33 - Update Status API called
2025-03-24 12:48:34 - Response Body:  Status Updated
2025-03-24 12:48:34 - Data sends to Mestria is started ::  
2025-03-24 12:48:34 - Query  : SELECT hrgstr_fname,hrgstr_mname, hrgstr_lname, patient_gender, hrgnum_puk,hivnum_sample_no,hivnum_sample_type,  pat_sample_collection_date FROM  patient_org_test_details WHERE org_test_status = 0
2025-03-24 12:48:34 - Query  : SELECT hrgstr_fname,hrgstr_mname, hrgstr_lname, patient_gender, hrgnum_puk,hivnum_sample_no,hivnum_sample_type,  pat_sample_collection_date FROM  patient_org_test_details WHERE org_test_status = 0 and hivnum_sample_no=?
2025-03-24 12:48:34 - HL 7 :  MSH|^~\&|LIS|LAB|myla|BMX|20250324124834||OML^O33^OML_O33|MSG-20241007-101200-0377|P|2.5.1|||NE|AL||UNICODE UTF-8 PID|||939152100000382||Test Usr One    ^.^^^^^nill|CDAC TEST2|19681025|M|||nill^^nill^^nill^nill|||||S|PV1||E|GW-NEW CUBICAL WARD-J^8-FCGW-J-29^^ AIIMS^^^^^8-FCGW-J-29^||||^||||||||||||250322MIC00001SPM|1|250322MIC00001||BC^Blood Culture^99BMx|||^^|^^|||P^Patient^||||||20250324124834|SAC||||24008676 ORC|NW||||||||20250324124834TQ1|||||||||R^^OBR|1|714647||SU^SU^99BMx||||||^^||||||^|123456780
2025-03-24 12:48:36 - Error: Error connecting to server: Connection refused: connect
2025-03-24 12:48:36 - Stack Trace: java.lang.Exception: Error connecting to server: Connection refused: connect
	at Server.ServerConnector.sendToServer(ServerConnector.java:51)
	at Server.AIIMSLAB$6.doInBackground(AIIMSLAB.java:1856)
	at Server.AIIMSLAB$6.doInBackground(AIIMSLAB.java:1)
	at javax.swing.SwingWorker$1.call(SwingWorker.java:295)
	at java.util.concurrent.FutureTask.run(FutureTask.java:266)
	at javax.swing.SwingWorker.run(SwingWorker.java:334)
	at java.util.concurrent.ThreadPoolExecutor.runWorker(ThreadPoolExecutor.java:1149)
	at java.util.concurrent.ThreadPoolExecutor$Worker.run(ThreadPoolExecutor.java:624)
	at java.lang.Thread.run(Thread.java:750)

2025-03-24 12:54:09 - Data sends to Mestria is started  for sample no ::  250322MIC00000
2025-03-24 12:54:09 - Response from API: [{"patFirstName":"Test Usr One    ","patType":"Special","patAge":"62 Yr             ","testcode":"10193","depcode":"102","labcode":"10022","patLastName":null,"patMiddleName":"-","patGender":"M","patientBirthDate":"-","patCrno":"939152100000382","patSampleNo":"250322MIC00000","patSampleType":"1002","patSampleCollectionDate":"2025-03-22","hisOrderId":"250322MIC000005","reqDno":"939151002225032210000101"}]
2025-03-24 12:54:09 - Save Patient Details API called for PACS 
2025-03-24 12:54:09 - Update Status API called
2025-03-24 12:54:09 - Response Body:  Status Updated
2025-03-24 12:54:09 - Data sends to Mestria is started ::  
2025-03-24 12:54:09 - Query  : SELECT hrgstr_fname,hrgstr_mname, hrgstr_lname, patient_gender, hrgnum_puk,hivnum_sample_no,hivnum_sample_type,  pat_sample_collection_date FROM  patient_org_test_details WHERE org_test_status = 0
2025-03-24 12:54:09 - Query  : SELECT hrgstr_fname,hrgstr_mname, hrgstr_lname, patient_gender, hrgnum_puk,hivnum_sample_no,hivnum_sample_type,  pat_sample_collection_date FROM  patient_org_test_details WHERE org_test_status = 0 and hivnum_sample_no=?
2025-03-24 12:54:09 - HL 7 :  MSH|^~\&|LIS|LAB|myla|BMX|20250324125409||OML^O33^OML_O33|MSG-20241007-101200-0377|P|2.5.1|||NE|AL||UNICODE UTF-8 PID|||939152100000382||Test Usr One    ^.^^^^^nill|CDAC TEST2|19681025|M|||nill^^nill^^nill^nill|||||S|PV1||E|GW-NEW CUBICAL WARD-J^8-FCGW-J-29^^ AIIMS^^^^^8-FCGW-J-29^||||^||||||||||||250322MIC00000SPM|1|250322MIC00000||BC^Blood Culture^99BMx|||^^|^^|||P^Patient^||||||20250324125409|SAC||||24008676 ORC|NW||||||||20250324125409TQ1|||||||||R^^OBR|1|714647||SU^SU^99BMx||||||^^||||||^|123456780
2025-03-24 12:54:11 - Error: Error connecting to server: Connection refused: connect
2025-03-24 12:54:11 - Stack Trace: java.lang.Exception: Error connecting to server: Connection refused: connect
	at Server.ServerConnector.sendToServer(ServerConnector.java:51)
	at Server.AIIMSLAB$6.doInBackground(AIIMSLAB.java:1856)
	at Server.AIIMSLAB$6.doInBackground(AIIMSLAB.java:1)
	at javax.swing.SwingWorker$1.call(SwingWorker.java:295)
	at java.util.concurrent.FutureTask.run(FutureTask.java:266)
	at javax.swing.SwingWorker.run(SwingWorker.java:334)
	at java.util.concurrent.ThreadPoolExecutor.runWorker(ThreadPoolExecutor.java:1149)
	at java.util.concurrent.ThreadPoolExecutor$Worker.run(ThreadPoolExecutor.java:624)
	at java.lang.Thread.run(Thread.java:750)

2025-03-24 12:55:16 - Data sends to Mestria is started  for sample no ::  250322MIC00000
2025-03-24 12:55:17 - Response from API: [{"patFirstName":"Test Usr One    ","patType":"Special","patAge":"62 Yr             ","testcode":"10193","depcode":"102","labcode":"10022","patLastName":null,"patMiddleName":"-","patGender":"M","patientBirthDate":"-","patCrno":"939152100000382","patSampleNo":"250322MIC00000","patSampleType":"1002","patSampleCollectionDate":"2025-03-22","hisOrderId":"250322MIC000005","reqDno":"939151002225032210000101"}]
2025-03-24 12:55:17 - Save Patient Details API called for PACS 
2025-03-24 12:55:17 - Update Status API called
2025-03-24 12:55:17 - Response Body:  Status Updated
2025-03-24 12:55:17 - Data sends to Mestria is started ::  
2025-03-24 12:55:17 - Query  : SELECT hrgstr_fname,hrgstr_mname, hrgstr_lname, patient_gender, hrgnum_puk,hivnum_sample_no,hivnum_sample_type,  pat_sample_collection_date FROM  patient_org_test_details WHERE org_test_status = 0 and hivnum_sample_no=?
2025-03-24 12:55:17 - Query  : SELECT hrgstr_fname,hrgstr_mname, hrgstr_lname, patient_gender, hrgnum_puk,hivnum_sample_no,hivnum_sample_type,  pat_sample_collection_date FROM  patient_org_test_details WHERE org_test_status = 0
2025-03-24 12:55:17 - HL 7 :  MSH|^~\&|LIS|LAB|myla|BMX|20250324125517||OML^O33^OML_O33|MSG-20241007-101200-0377|P|2.5.1|||NE|AL||UNICODE UTF-8 PID|||939152100000382||Test Usr One    ^.^^^^^nill|CDAC TEST2|19681025|M|||nill^^nill^^nill^nill|||||S|PV1||E|GW-NEW CUBICAL WARD-J^8-FCGW-J-29^^ AIIMS^^^^^8-FCGW-J-29^||||^||||||||||||250322MIC00000SPM|1|250322MIC00000||BC^Blood Culture^99BMx|||^^|^^|||P^Patient^||||||20250324125517|SAC||||24008676 ORC|NW||||||||20250324125517TQ1|||||||||R^^OBR|1|714647||SU^SU^99BMx||||||^^||||||^|123456780
2025-03-24 12:55:19 - Error: Error connecting to server: Connection refused: connect
2025-03-24 12:55:19 - Stack Trace: java.lang.Exception: Error connecting to server: Connection refused: connect
	at Server.ServerConnector.sendToServer(ServerConnector.java:51)
	at Server.AIIMSLAB$6.doInBackground(AIIMSLAB.java:1856)
	at Server.AIIMSLAB$6.doInBackground(AIIMSLAB.java:1)
	at javax.swing.SwingWorker$1.call(SwingWorker.java:295)
	at java.util.concurrent.FutureTask.run(FutureTask.java:266)
	at javax.swing.SwingWorker.run(SwingWorker.java:334)
	at java.util.concurrent.ThreadPoolExecutor.runWorker(ThreadPoolExecutor.java:1149)
	at java.util.concurrent.ThreadPoolExecutor$Worker.run(ThreadPoolExecutor.java:624)
	at java.lang.Thread.run(Thread.java:750)

2025-03-24 12:55:51 - Data sends to Mestria is started  for sample no ::  250322MIC00001
2025-03-24 12:55:51 - Response from API: [{"patFirstName":"Test Usr One    ","patType":"Special","patAge":"62 Yr             ","testcode":"10193","depcode":"102","labcode":"10022","patLastName":null,"patMiddleName":"-","patGender":"M","patientBirthDate":"-","patCrno":"939152100000382","patSampleNo":"250322MIC00001","patSampleType":"1002","patSampleCollectionDate":"2025-03-22","hisOrderId":"250322MIC000006","reqDno":"939151002225032210000201"}]
2025-03-24 12:55:51 - Save Patient Details API called for PACS 
2025-03-24 12:55:51 - Query  : SELECT hrgstr_fname,hrgstr_mname, hrgstr_lname, patient_gender, hrgnum_puk,hivnum_sample_no,hivnum_sample_type,  pat_sample_collection_date FROM  patient_org_test_details WHERE org_test_status = 0 and hivnum_sample_no=?
2025-03-24 12:56:51 - Data sends to Mestria is started  for sample no ::  250322MIC00001
2025-03-24 12:56:51 - Response from API: [{"patFirstName":"Test Usr One    ","patType":"Special","patAge":"62 Yr             ","testcode":"10193","depcode":"102","labcode":"10022","patLastName":null,"patMiddleName":"-","patGender":"M","patientBirthDate":"-","patCrno":"939152100000382","patSampleNo":"250322MIC00001","patSampleType":"1002","patSampleCollectionDate":"2025-03-22","hisOrderId":"250322MIC000006","reqDno":"939151002225032210000201"}]
2025-03-24 12:56:51 - Save Patient Details API called for PACS 
2025-03-24 12:56:51 - Update Status API called
2025-03-24 12:56:51 - Response Body:  Status Updated
2025-03-24 12:56:51 - Data sends to Mestria is started ::  
2025-03-24 12:56:51 - Query  : SELECT hrgstr_fname,hrgstr_mname, hrgstr_lname, patient_gender, hrgnum_puk,hivnum_sample_no,hivnum_sample_type,  pat_sample_collection_date FROM  patient_org_test_details WHERE org_test_status = 0
2025-03-24 12:56:51 - Query  : SELECT hrgstr_fname,hrgstr_mname, hrgstr_lname, patient_gender, hrgnum_puk,hivnum_sample_no,hivnum_sample_type,  pat_sample_collection_date FROM  patient_org_test_details WHERE org_test_status = 0 and hivnum_sample_no=?
2025-03-24 12:56:51 - HL 7 :  MSH|^~\&|LIS|LAB|myla|BMX|20250324125651||OML^O33^OML_O33|MSG-20241007-101200-0377|P|2.5.1|||NE|AL||UNICODE UTF-8 PID|||939152100000382||Test Usr One    ^.^^^^^nill|CDAC TEST2|19681025|M|||nill^^nill^^nill^nill|||||S|PV1||E|GW-NEW CUBICAL WARD-J^8-FCGW-J-29^^ AIIMS^^^^^8-FCGW-J-29^||||^||||||||||||250322MIC00001SPM|1|250322MIC00001||BC^Blood Culture^99BMx|||^^|^^|||P^Patient^||||||20250324125651|SAC||||24008676 ORC|NW||||||||20250324125651TQ1|||||||||R^^OBR|1|714647||SU^SU^99BMx||||||^^||||||^|123456780
2025-03-24 12:56:53 - Error: Error connecting to server: Connection refused: connect
2025-03-24 12:56:53 - Stack Trace: java.lang.Exception: Error connecting to server: Connection refused: connect
	at Server.ServerConnector.sendToServer(ServerConnector.java:51)
	at Server.AIIMSLAB$6.doInBackground(AIIMSLAB.java:1856)
	at Server.AIIMSLAB$6.doInBackground(AIIMSLAB.java:1)
	at javax.swing.SwingWorker$1.call(SwingWorker.java:295)
	at java.util.concurrent.FutureTask.run(FutureTask.java:266)
	at javax.swing.SwingWorker.run(SwingWorker.java:334)
	at java.util.concurrent.ThreadPoolExecutor.runWorker(ThreadPoolExecutor.java:1149)
	at java.util.concurrent.ThreadPoolExecutor$Worker.run(ThreadPoolExecutor.java:624)
	at java.lang.Thread.run(Thread.java:750)

2025-03-24 12:57:10 - Data sends to Mestria is started  for sample no ::  250322MIC00001
2025-03-24 12:57:10 - Response from API: []
2025-03-24 12:57:10 - Sample no or cr no. not found: []
2025-03-24 12:57:10 - Query  : SELECT hrgstr_fname,hrgstr_mname, hrgstr_lname, patient_gender, hrgnum_puk,hivnum_sample_no,hivnum_sample_type,  pat_sample_collection_date FROM  patient_org_test_details WHERE org_test_status = 0 and hivnum_sample_no=?
